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Abstract 
 
 
Actinomycetes and fungi were successfully isolated from both New Zealand and 
Malaysian marine invertebrates and classified as facultatively marine based on their 
ability to grow on both sea water and non-sea water media. Most of the extracts 
obtained from selected isolates were cytotoxic. A clear preference of the actinomycetes 
for solid-state fermentation was observed, however, for fungi no significant preference 
was seen. Three isolates of Streptomyces spp., four Penicillium spp. and two 
Paecilomyces spp. whose extracts showed good cytotoxicity were selected for further 
investigation. 
 
A small-scale extract obtained from a solid culture of Streptomyces sp. (LA3L2) 
showed good cytotoxicity and a new cytotoxic metabolite was isolated from a large-
scale extract of Streptomyces sp. (LA3L2). This metabolite was characterized as S-
methyl 2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzothioate (5.15) and is only the third 
compound reported to contain the S-methyl benzothioate group. Two known 
compounds, montagnetol (5.16) and erythrin (5.18), were isolated from a further large-
scale cultivation of Streptomyces sp. (LA3L2) and is the first reported actinomycete to 
produce these lichen-related compounds. In addition, two known inactive metabolites 
(bohemamine (5.1) and bohemamine B (5.2)) were identified from the small-scale 
extract. Streptomyces sp. (LA3L2) was also investigated for the effect of temperature 
and salinity on growth and cytotoxicity and shown to produce bohemamine only at 20 - 
28ºC and 4% sea salt concentration on solid media. This isolate gave a low yield of 
active metabolite under all conditions. 
 
Small-scale extracts of two other Streptomyces spp. yielded three known cytotoxic 
metabolites. These were thiazostatin B (7.14) from Streptomyces sp. (LA5L4) and 
chromomycin A2 (7.1), chromomycin A3 (7.2) and chromomycin 02-3D (7.3) from 
Streptomyces sp. (LA3L1). 
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All four Penicillium spp. produced known metabolites. Penicillium sp. (LY1L5) yielded 
two known metabolites, cycloaspeptide A (7.4) and α-cyclopiazonic acid (7.5). α-
Cyclopiazonic acid (7.5) and three other known metabolites (roquefortine A (7.6), 
cyclopeptin (7.7) and viridicatin (7.8)) were isolated from Penicillum sp. (KK3T23). 
Penicillium sp. (KK3T8) produced brefeldin A (7.10), while mycophenolic acid (7.12) 
and brevianamide A (7.11) were produced by Penicillium sp. (KK4T14b). 
 
The effect of salinity on growth and cytotoxicity was investigated for the two 
Penicillium isolates producing the cytotoxic metabolite, α-cyclopiazonic acid (7.5). 
Saline conditions were not required for growth but metabolite production differed 
between the two isolates with respect to salinity. Isolate LY1L5 required saline 
conditions for α-cyclopiazonic production whereas isolate KK3T23 produced the 
metabolite under non-saline conditions and in concentrations of sea salt up to 6%. 
 
Three known compounds, indole-3-carboxylic acid (7.15), indole-3-carboxylate (7.17) 
and 5-carboxymellein (7.16) were identified from Paecilomyces sp. (PR5L9). 
Investigation of a small-scale extract obtained from a solid culture of another 
Paecilomyces sp. (PR10T2) resulted in the isolation and characterization of a unique 
structure of a symmetrical cyclic depsipeptide, epi-angolide (NAM 6-1). NAM 6-1 was 
considered as a new compound based on four homoisomeric configurations (A1, A2, A3 
and A4).  
 
  v 
 
(S) O
(S)
NH(S)O
(S)
HN
O
(S)
O
O
(S)
O
1
2
5
3
47
10
9 8
12
11
13
1'
2'
4' 7'
5'
10'
9'
8'
13'
11'
12'
6
3'
6' H H
 A1: (cyclo-L-α-hydroxyisovaleryl-L-isoleucyl-L-α-hydroxyisovaleryl-L-isoleucyl)
(R) O
(R)
NH(R)O
(R)
HN
O
(R)
O
O
(R)
O
1
2
5
3
47
10
9 8
12
11
13
1'
2'
4' 7'
5'
10'
9'
8'
13'
11'
12'
6
3'
6' H H
A2: (cyclo-D-α-hydroxyisovaleryl-D-isoleucyl-D-α-hydroxyisovaleryl-D-isoleucyl)
(A1) (A2)
 
 
(R) O
(R)
NH(S)O
(S)
HN
O
(R)
O
O
(S)
O
1
2
5
3
47
10
9 8
12
11
13
1'
2'
4' 7'
5'
10'
9'
8'
13'
11'
12'
6
3'
6' H H
(cyclo-L-α-hydroxyisovaleryl-L-isoleucyl-D-α-hydroxyisovaleryl-D-isoleucyl)
(A3)
 
 
(S) O
(S)
NH(S)O
(R)
HN
O
(S)
O
O
(R)
O
1
2
5
3
47
10
9 8
12
11
13
1'
2'
4' 7'
5'
10'
9'
8'
13'
11'
12'
6
3'
6' H H
(cyclo-L-α-hydroxyisovaleryl-D-isoleucyl-L-α-hydroxyisovaleryl-L-isoleucyl)
(A4)
 
 
  vi 
 
The value of dereplication procedures with respect to the rapid identification of 
metabolites and enhancement of in-house metabolite libraries is discussed. Structural 
elucidation of nine known metabolites (7.1, 7.2, 7.3, 7.5, 7.6, 7.7, 7.8, 7.10 and 7.11) 
was greatly aided by the in-house dereplication techniques using LC-MS-UV and 
AntiMarin database. 
 
A significant advantage was gained by the use of the CapNMR which enabled NMR 
characterization of very small quantities of metabolites (<20 µg). Approximately <5 µg 
of materials were required to perform 1D proton NMR experiments for the dereplication 
of seven known compounds; bohemamine (5.1), bohemamine B (5.2), thiazostatin B 
(7.14), indole-3-carboxylate (7.17) and 5-carboxymellein (7.16). 
 
Approximately 20 µg of materials were needed to acquire 1D and 2D (HSQC, HMBC 
and NOE) NMR spectra for structural elucidation of the new metabolite, S-methyl 2,4-
dihydroxy-6-isopropyl-3,5-dimethylbenzothioate (5.15). Some 8 µg of materials were 
sufficient to perform 1D and 2D (COSY, HSQC and HMBC) NMR experiments for 
complete structural characterization of two known metabolites, montagnetol (5.16) and 
erythrin (5.18). Approximately 10 µg of materials were needed to acquire 1D and 2D 
NMR (COSY, HSQC and HMBC) experiments for structural elucidation of the new 
compound, epi-angolide NAM 6-1 (A1, A2, A3 and A4).  
 
Rapid identification of known fungal metabolites enabled the in-house HPLC-UV/Rt 
library to be enhanced by eight metabolites (7.5, 7.6, 7.7, 7.8, 7.10, 7.11, 7.17 and 7.16). 
An HPLC-UV/Rt library for actinomycete metabolites was successfully established with 
the insertion of eight known metabolites (5.1, 5.2, 5.16, 5.18, 7.1, 7.2, 7.3 and 7.14). 
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Chapter 1 
 
 
Introduction 
 
 
1.1 Marine natural products 
 
Natural products, as the term implies, are chemical compounds originated from living 
organisms such as plants, animals and microorganisms. Traditionally, higher plants used 
to be the most prolific sources of drugs from nature and the use of medicinal plants is 
well documented throughout human history (Barton and Nakanishi, 1999). Marine folk 
medicine has been reported such as the seaweed remedies that were used by the Chinese 
and San Blas Indians in Panama, and the medicinal properties of some marine animals 
used by the Romans (Ruggieri, 1976). Although antibiotic properties of microorganisms 
were described in the late 1800s and early 1900s (Bugni and Ireland, 2004), it was later, 
when penicillin (1.1) was discovered in 1929 by Sir Alexander Fleming that 
microorganisms heralded the era of natural products. 
 
 
O
N
H
N
O
S
COOH
H H
(1.1)  
 
Chapter 1: Introduction 
_____________________________________________________________________________________ 
 2 
 
Since then, intensive studies of mainly soil-derived bacteria and fungi have shown that 
the microorganisms are a rich source of structurally unique pharmaceutically important 
bioactive substances (Fenical, 1993). Antibiotics, such as cephalosporin C (1.2), 
daptomycin (1.3), streptomycin (1.4), vancomycin (1.5), the antifungals amphotericin B 
(1.6) and griseofulvin (1.7), the antivirals acyclovir (1.8) and doxorubicin (1.9) play a 
pivotal role in medicine. 
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The rediscovery of high numbers of previously described metabolites has to some extent 
precluded the study of traditional terrestrial sources and has led researchers to explore 
unique habitats, such as the marine environment, for potentially new biosynthetic 
diversity. Scientists began to probe the oceans looking for sources of medicine in the 
middle of the 20th century. By the early 1950s, a toxin, later named holothurin (1.10) 
was reported from the Bahamian sea cucumber, Actinopyga agassizi (Atz, 1952; 
Nigrelli et al., 1967; Kitagawa et al., 1981). Although holothurin (1.10) was never 
commercialized, the search for drugs from marine sources continued. 
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Since the discovery of the sponge-derived nucleotides, spongothymidine (1.11) and 
spongouridine (1.12) (Bergmann and Feeney, 1951), it became evident that the ocean is 
a likely source of pharmaceuticals with a number of marine natural compounds now 
being marketed such as cytarabine (1.13) (also known as Ara-C) mainly used in the 
treatment of lymphomas and also for acute myelogenous leukemia, or are under clinical 
trials for many different diseases (Haefner, 2003). Some are undergoing clinical trials 
for treatment of cancer, analgesia, allergy, and cognitive diseases (Newman and Cragg, 
2004). 
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The potential of marine microorganisms as a source of antibiotics began after penicillin 
(1.1) was developed as a human antibiotic in the early 1940s. The earliest report 
indicating marine microorganisms as antibiotic producers occurred in 1945 when 
Giuseppe Brotzu described antibacterial activity of a fungus obtained from seawater 
samples (Abraham and Loder, 1972). The fungus identified as Cephalosporium 
acremonium (now named Acremonium chrysogenum) produced cephalosporin C (1.2). 
Studies reporting natural products from marine-derived microorganisms were few until 
the 1990s, however, a remarkable growth occurred through the 1990s (Faulkner, 
2000a). Marine microorganisms continue to be a productive and successful focus for 
much marine natural product research (Faulkner, 2000b; Faulkner, 2001; Faulkner, 
2002; Blunt et al., 2003; Blunt et al., 2004; Bugni and Ireland, 2004; Blunt et al., 2005; 
Blunt et al., 2006; Blunt et al., 2007). 
 
 
1.2 Marine microbe-invertebrate association 
 
Marine microorganisms are not taxonomically defined, but are classified according to 
their habitat and their physiology. This ecological definition has gained general 
acceptance by taxonomist (Furuya, 1986) although pragmatically, marine 
microorganisms can also be defined as microbes that have been isolated from marine 
sources on marine media (Faulkner, 1999). In marine habitats these microbes may occur 
suspended, on living or inanimate surfaces of epibionts, or as symbionts. Marine 
organisms such as the invertebrates are known to be important reservoirs for 
microorganisms. Marine invertebrates are those animals that lack of notochord, a 
characteristic of vertebrates and these include sponges, jellyfish, corals, sea stars, brittle 
stars and sea fans. Most marine invertebrates harbour microorganisms within their 
tissues where they reside in the extra- and intra-cellular spaces (Wilkinson, 1992). 
These become classical substrates for the isolation of marine microorganisms.  
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The striking similarity of some microbial metabolites and natural products from marine 
invertebrates has aroused much speculation in the past. The possibility that some 
metabolites derived from marine animals might originate from symbiotic bacteria living 
within the host tissues rather than from the host animals themselves has, therefore, been 
discussed intensely for many years (Bewley and Faulkner, 1998; Moore, 1999; Proksch 
et al., 2002; Piel, 2004). An example is the cyclodepsipeptide jasplakinolide (1.14) (syn. 
jaspamide), isolated from marine sponges (Jaspis spp). It is used as a molecular tool in 
cell biology being a cell permeable F-actin probe (Bubb et al., 1994) and shows a close 
structural relationship to chondramide D (1.15) known from the myxobacterium 
Chondromyces crocatus (Jansen et al., 1996). 
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Further evidence of symbiotic producers was demonstrated in a study on the 
associations of the sponge Theonella swinhoei with bacteria (Bewley et al., 1996). The 
study showed that the cytotoxic polyketide swinholide A (1.16) was mainly present in 
unicellular bacteria, while the antifungal peptide theopalauamide (1.17) was detected in 
a filamentous bacterium. 
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Marine microbes appeared to have adapted excellently to the marine environment, thus 
have gained special attention because of their diverse metabolic capabilities and their 
divergent physiologic lifestyles. Marine ecosystems contain several unique features that 
set them apart from other aquatic ecosystems, the main factor being the presence of 
dissolved compounds in seawater, particularly sodium chloride (NaCl). Salinity is 
expressed as the amount (in grams) of total dissolved salts present in 1 kg of water. 
Normal seawater with a salinity of 35 g/kg (or litre) of water is expressed as 35‰. 
Microorganisms, particularly fungi and yeasts are well known for their ability to grow 
in saline environments by adapting their osmoregulatory mechanisms that signal the 
production of osmolytes (e.g: polyols, amino acids) in conjunction with an increasing 
concentration of cytoplasmic ions (Harris, 1981; Bloomberg and Adler, 1992; Roberts, 
2005). For marine microorganisms, their cellular adaptation to moderate and high salt 
content is a fundamental biological process needed for survival and growth. It is 
postulated that marine microorganisms have different characteristics from those of 
terrestrial counterparts and, therefore, might produce different types of bioactive 
compounds. 
 
 
1.3 Marine actinomycetes 
 
Actinomycetes has been isolated from different niches of the marine realm, such as 
mangroves and the deep sea (Weyland, 1969; Walker and Colwell, 1975; Barcina et al., 
1987; Jensen et al., 1991; Rathnakala and Chandrika, 1993; Imada and Okami, 1995; 
Colquhoun et al., 1998; Stritzke et al., 2004) and from macroorganisms such as 
tunicates (Charan et al., 2004), and sponges (Lee et al., 1998; Lee et al., 2005). Earlier 
it was believed that marine actinomycetes were of terrestrial origin, however later it has 
become apparent that many are indigenous components of the marine world. 
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The definition of true marine actinomycetes is difficult but the ability of actinomycetes 
to grow in a marine environment has been demonstrated, notably in connection with 
their occurrence in salt-rich muds and sea areas close to the shore. Earlier studies 
showed that Streptomyces spp. can grow at 2 and 16% NaCl, while various species of 
Streptomyces and Nocardia grow well in the presence of 10% NaCl (Waksman, 1959). 
More recently, other studies have shown that various actinomycetes derived from 
marine sediments show good growth in the presence of NaCl (Jensen et al., 1991; 
Mincer et al., 2002; Kokare et al., 2004; Magarvey et al., 2004). Recently, the 
occurrence of an obligate Micromonospora sp. (Mincer et al., 2002) and Salinospora sp. 
(Mincer et al., 2002; Feling et al., 2003; Maldonado et al., 2005) has been reported. 
 
Among the microorganisms, actinomycetes were the most studied group because of 
their capacity to produce novel bioactive secondary metabolites. Actinomycetes are 
primarily saprophytic and are best known from soils where they contribute significantly 
to the turnover of complex biopolymers (Williams et al., 1984). Despite their 
importance in soil ecology, the role of actinomycetes as potential antibiotic producers 
became apparent in 1940, following the discovery of actinomycin (Waksman and 
Woodruff, 1940), and was fully realized by the 1980s, when actinomycetes accounted 
for almost 70% of the world’s naturally occurring antibiotics (Okami and Hotta, 1988). 
The decline in the discovery of new compounds form common soil-derived 
actinomycetes in the past two decades led to the attempted cultivation of rare or novel 
actinomycete taxa (Bull et al., 2000; Mincer et al., 2002). Although the exploitation of 
marine actinomycetes as a source for novel secondary metabolites is in its infancy, the 
discovery rate of novel secondary metabolites from marine actinomycetes has recently 
surpassed that of their terrestrial counterparts, as evident by the isolation of many 
different diverse structures in the past few years (Fiedler et al., 2005; Jensen et al., 
2005a). Some examples of particular interest are abyssomicin C (1.18), diazepinomicin 
(1.19) and salinosporamides (1.20). 
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(1.19)(1.18) (1.20)  
 
 
Abyssomicin C (1.18) is produced by a marine Verrucosispora strain (Riedlinger et al., 
2004). This novel polycyclic polyketide antibiotic is a potent inhibitor of para-
aminobenzoic acid biosynthesis and therefore, inhibits folic acid biosynthesis at an 
earlier stage than the well-known synthetic sulfa drugs (Bister et al., 2004; Lam, 2006). 
Abyssomicin C (1.18) shows potent activity against Gram-positive bacteria, including 
clinical isolates of multiple-resistant and vancomycin-resistant Staphylococcus aureus 
(Lam, 2006). Abyssomicin C (1.18) or its analog (Rath et al., 2005) has the potential to 
be developed as an antibacterial agent against drug-resistant pathogens (Lam, 2006). 
 
Diazepinomicin (1.19) (ECO-4601) is a metabolite produced by a Micromonospora 
strain (Charan et al., 2004) that possesses antibacterial, anti-inflammatory and antitumor 
activity. This unique farnesylated dibenzodiazepinone has a broad spectrum of in vitro 
cytotoxicity and has demonstrated in vivo activity against glioma, breast and prostate 
cancer in mouse models. The preclinical development of ECO-4601 as an anticancer 
agent has been completed by Ecopia BioSciences Inc. Ecopia filed Clinical Trial 
Application (equivalent to Investigational New Drug application in the USA) for ECO-
4601 in Canada on 3 January 2006 (Lam, 2006). 
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A novel β-lactone-γ-lactam, salinosporamide A (1.20) (NPI-0052) has been isolated 
from a fermentation broth of a new obligate marine actinomycete, Salinispora tropica 
(Feling et al., 2003; Maldonado et al., 2005). This compound (1.20) is an orally active 
proteasome inhibitor that induces apoptosis in multiple myeloma cells with mechanisms 
distinct from the commercial proteasome inhibitor anticancer drug Bortezomib 
(Chauhan et al., 2005). NPI-0052 is being developed by Nereus Pharmaceuticals, Inc. 
and represents the first clinical candidate for the treatment of cancer produced by saline 
fermentation of an obligate marine actinomycete (Lam, 2006). 
 
Strains of S. tropica also produced two unique macrolides, besides the production of 
NPI-0052 (1.20). These macrolides, sporolides A (1.21a) and B (1.21b) (Buchanan et 
al., 2005) appear to be synthesized from two different polyketides containing a large 
number (23 out of 24 carbon skeleton) of oxidized carbons. Even though sporolides 
have not demonstrated antimicrobial and anticancer activity, these unusual structures of 
sporolides demonstrate the potential of marine actinomycetes for the production of 
novel secondary metabolites (Lam, 2006). 
 
 
(1.21a):
(1.21b):
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The potential for the isolation of novel secondary metabolites from marine 
actinomycetes relies on the ability to isolate novel actinomycetes from marine 
environments. Some progress in the isolation strategies have been made recently. These 
techniques using enrichment, new selection methods and media (Magarvey et al., 2004; 
Jensen et al., 2005b; Mincer et al., 2005) have led to the isolation of novel 
actinomycetes derived from sediment. Further development work in improving isolation 
strategies in the recovery of marine actinomycetes from various sources is of paramount 
importance for ensuring success in this area. 
 
 
1.4 Marine fungi 
 
In the past, marine fungi have often been defined based on their ability to grow at 
certain seawater concentrations. As the definition cannot be strictly based on 
physiological aspects (Kohlmeyer, 1974; Hughes, 1975), a broad ecological definition 
was used namely; obligate marine fungi are those that grow and sporulate exclusively in 
a marine or estuarine habitat; facultative marine fungi are those from freshwater or 
terrestrial environment able to grow (and possibly also to sporulate) in the marine 
environment (Kohlmeyer, 1974). 
 
After the discoveries of penicillin (1.1) and cephalosporin C (1.2), a further milestone in 
the history of medicinal fungal products was the discovery of cyclosporin A (1.22) 
produced by Tolypocladium inflatum and Cylindrocarpon lucidum (Dreyfuss et al., 
1976). The antifungal agent griseofulvin (1.7) was isolated from Penicillium 
griseofulvum (Rehm, 1980) and the cholesterol biosynthesis inhibitor, lovastatin (1.23), 
isolated from Aspergillus terreus (Alberts et al., 1980) are two further metabolites of 
great pharmacological importance from fungi. 
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Although siccayne (1.24) (Fenical, 1997) was most likely the first antibiotic isolated 
from an obligate marine fungus (Bugni and Ireland, 2004), the compound had been 
previously isolated from a terrestrial species (Kupka et al., 1981). Overall, research on 
marine-derived fungi has led to the discovery of some 272 new natural products until 
2002 (Bugni and Ireland, 2004), and another 240 new structures from 2002 until 2004 
(Ebel, 2006), thus, providing evidence that marine-derived fungi have a potential to be a 
rich source of pharmaceutical leads. 
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Bugni and Ireland (2004) showed that fungi from marine invertebrates (sponges, corals 
and tunicates) showed the largest contribution to the total number of compounds 
described in the literature (40%) with the fungi from marine plants, driftwood or 
sediments accounting for 37%. The review by Ebel (2006) shows the majority of novel 
fungal secondary metabolites originate from inorganic matter (soil, sediments, sandy 
habitats and artificial substrates), while marine invertebrate-derived fungi contributed 
less than the marine plants (algae, sea grasses, mangrove plants and woody habitats). It 
noted that even if many of the marine-derived fungi are already known from terrestrial 
habitats, and have been chemically well studied, novel secondary metabolites continue 
to be detected. An example is the marine-derived Penicillium chrysogenum that was 
isolated from the sponge, Ircinia fasciculate. This isolate produced the sorbicillin-
derived alkaloid sorbicillacton A (1.25) (Bringmann et al., 2003) that showed selective 
cyctostatic activity against lymphoblasts and was able to protect human T cells against 
HIV-1. Preclinical evaluation of this compound has recently been initiated (Proksch et 
al., 2006). Some of the examples of fungal metabolites isolated from sponges, corals 
and tunicates are listed in Table 1.1. Many of these fungi have novel carbon skeletons 
thus providing further evidence of the potential of marine-derived fungi. 
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Table 1.1: Some examples of new metabolites from fungi derived from marine 
invertebrates (1994 – 2007). 
 
Fungi Marine 
invertebrates 
Metabolites Activities References 
unidentified sponge 
(Stylotella sp.) 
nectriapyrones A (1.26) and B (1.27) ns Abrell et al., 1994 
unidentified sponge 
(Jaspis aff. Johnstoni) 
chloriolins A (1.28), B (1.29) and C 
(1.30) 
ns Cheng et al., 1994 
unidentified sponge 
(Spirastrella vagabunda) 
14,15-secocurvularin (1.31) ns Abrell et al., 1996 
Gymnascella 
dankaliensis 
sponge 
(Halichondria japonica) 
gymnastatins A (1.32), B (1.33) and C 
(1.34) 
cytotoxic Numata et al., 1997;  
Amagata et al., 1998 
Coniothyrium sp. sponge 
(Ectyplasia perox) 
(3S)-(3',5'-dihydroxyphenyl) butan-2-
one (1.35) 
2-(1'(E)-propenyl)-octa-4(E),6(Z)-
diene-1,2-diol (1.36) 
antimicrobial 
 
inactive 
Holler et al., 1999 
Microsphaeropsis sp. sponge 
(Myxilla incrustans) 
microsphaeropsisin (1.37) antimicrobial Holler et al., 1999 
Aspergillus niger tunicate 
(Aplidium sp.) 
yanuthones A (1.38), B (1.39), C 
(1.40), D (1.41) and E (1.42) 
1-hydroxy-yanuthone A (1.43) and C 
(1.44) 
22-deacetyl-yanuthone A (1.45) 
antimicrobial Bugni et al., 2000 
Drechslera hawaiiensis sponge 
(Callyspongia aerizusa) 
spiciferol A (1.46) 
monocyclic spiciferone derivative 
(1.47) 
ns Edrada et al., 2000 
unidentified sponge iso-cladospolide B (1.48) and seco-
patulolide C (1.49), pandangolides 1 
(1.50) and 2 (1.51) 
inactive Smith et al., 2000 
Hortaea werneckii sponge 
(Aplysina aerophoba) 
hortein (1.52) inactive Brauers et al., 2001 
Cladosporium herbarum sponge 
(Callyspongia aerizusa) 
pandangolides 3 (1.53) and 4 (1.54) inactive Jadulco et al., 2001 
Penicillium cf. 
montanense 
sponge 
(Xestospongia exigua) 
xestodecalactone B (1.56) 
xestodecalactones A (1.55) and C 
(1.57) 
antifungal 
inactive 
Edrada et al., 2002 
Cladosporium herbarum sponge 
(Aplysina aerophoba) 
herbarins A (1.58) and B (1.59) inactive Jadulco et al., 2002 
Curvularia lunata sponge 
(Niphates olemda) 
lunatin (1.60) antibacterial Jadulco et al., 2002 
Penicillium citrinum sponge isocyclocitrinol A (1.61) and 22-
acetylisocyclocitrinol A (1.62) 
weak 
antibacterial 
Amagata et al., 2003 
Aspergillus versicolor sponge 
(Xestospongia exigua) 
aspergillitine (1.63) 
 
aspergiones A (1.64), B (1.65), C 
(1.66), D (1.67), E (1.68) and F (1.69) 
moderate 
antibacterial 
inactive 
Lin et al., 2003 
Penicillium 
brevicompactum 
sponge 
(Petrosia ficiformis) 
petrosifungins A (1.70) and B (1.71) ns Bringmann et al., 
2004 
Aspergillus niger sponge 
(Axinella damicornis) 
3,3′-bicoumarin bicoumanigrin (1.72) 
 
aspernigrin A (1.73) 
aspernigrin B (1.74) 
pyranonigrins A (1.75), B (1.76), C 
(1.77) and D (1.78) 
moderate 
cytotoxicity 
inactive 
neuroprotective  
inactive 
Hiort et al., 2004 
Penicillium sp. sponge 
(Axinella verrucosa) 
communesins C (1.79) and D (1.80) moderate 
antiproliferative 
Jadulco et al., 2004 
Phomospis asparagi sponge 
(Rhaphidophlus juniperina) 
chaetoglobosins-510 (1.81) and -540 
(1.82) 
chaetoglobosin-542 (1.83) 
antimicrofilament 
 
cytotoxic 
Christian et al., 2005 
Gymnascella 
dankaliensis 
sponge 
(Halichondria japonica) 
gymnastatins F (1.84) and G (1.85) 
gymnastatin H (1.86) 
cytotoxic 
inactive 
Amagata et al., 2006a 
unidentified sponge (Ianthella sp.) guangomides A (1.87) and B (1.88) weak 
antibacterial  
Amagata et al., 2006b 
Acremonium sp. sponge (Teichaxinella sp.) RHM1 (1.89) and RHM2 (1.90) weak cytotoxicity Boot et al., 2006 
Penicillium rugulosum sponge prugosenes A1 (1.91), A2 (1.92), A3 
(1.93), B1 (1.94), B2 (1.95), C1 
(1.96), and C2 (1.97) 
inactive Lang et al., 2007 
Penicillium 
aurantiogriseum 
sponge 
(Mycale plumose) 
aurantiomide A (1.98) 
aurantiomides B (1.99) and C (1.100) 
inactive 
moderate 
cytotoxicity 
Xin et al., 2007 
ns – not stated 
 
Chapter 1: Introduction 
_____________________________________________________________________________________ 
 16 
 
1.5 Screening approaches 
 
Biological and chemical screening of natural products is one of the earliest steps in drug 
discovery. In the 1950s and 1960s, most bioassays targeting diseases other than bacteria 
and fungal infections involved whole animal models of disease and these assays were 
not suitable for the study of complex mixtures such as natural products (Borris and 
Gould, 1999). Chemical screening was rather primitive, with chromatography meant 
gravity-fed open column or thin layer plates, spectroscopy meant infrared (IR) and 
ultraviolet (UV) and with mass spectrometry (MS) and nuclear magnetic resonance 
(NMR) was only beginning to come into routine use. Grams of pure compounds were 
required for complete identification and initial biological evaluation. 
 
Technology has changed since then with the development of various biological and 
chemical techniques, thus substantially compressing the time cycle while the sample 
requirements have been drastically reduced. The mode of action of current assays is 
fast, selective, quantitative and readily amenable to automation. High Performance 
Liquid Chromatography (HPLC) has been routinely employed in separation techniques 
and greatly facilitates assay guided isolation of active metabolites. While IR and UV 
spectra are still in use, modern spectroscopic method such as high resolution MS, 
multidimensional NMR and capillary-probe NMR (CapNMR) greatly simplified the 
identification of the metabolites. The discovery of novel metabolites in marine 
microorganisms has become more difficult due to the enormous number of known 
compounds already described in the literature. It is most important therefore to rapidly 
identify and exclude the known compounds at the earliest possible stage. This process is 
called dereplication, where properties of mixtures or pure metabolites are compared 
with literature data. Some widely used dereplication techniques are based on reverse-
phase liquid chromatography (LC) combined with diode array detection (Frisvad and 
Thrane, 1987; Yoshimura et al., 1994) or with MS (Landreau et al., 2002) or with 
UV/MS (Nielsen and Smedsgaard, 2003) or with MS/CapNMR (Hu et al., 2005). These 
techniques are conducted efficiently in combination with the rapidly growing chemical 
databases of known compounds (e.g: AntiMarin, AntiBase, SciFinder and others). 
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1.6 Scope of present study 
 
The main goals of the present investigation are the isolation of marine-derived 
actinomycetes and fungi, the application of techniques for chemical characterization of 
their metabolites and the effect of salinity on their growth and cytotoxicity. 
 
1.6.1 Isolation of marine actinomycetes and fungi 
 
Actinomycetes and fungi were isolated from New Zealand and Malaysian marine 
invertebrates. Tissue or liquid portions of these invertebrates were used in obtaining the 
isolates. Selected isolates were investigated for secondary metabolites production. 
 
1.6.2 Assessment of culture extracts for biological activity 
 
Small scale cultivation and extraction enabled biological activity testing. These tests 
mainly consisted of cytotoxic assay against P388 murine leukaemia cell lines (P388 
cells) and antimicrobial assay against the Gram-positive bacterium Bacillus subtilis, the 
Gram-negative bacterium Pseudomonas aeruginosa and the fungus Candida albicans. 
Cytotoxic and antimicrobial tests were undertaken. Cytotoxicity was assayed against the 
P388 cells and antimicrobial activity against the bacteria and fungus. 
 
1.6.3 Chemical characterization of bioactive compounds 
 
Rapid techniques were used to dereplicate and characterize new metabolites. Small-
scale or large-scale cultivation, extraction, and separation using chromatographic 
methods, mainly HPLC, was employed, in order to isolate pure metabolites. Structural 
elucidation was performed using mainly one dimensional (1D) or two dimensional (2D) 
CapNMR techniques. 
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1.6.4 Physiological studies on growth and production of 
metabolites 
 
The effect of salinity on growth and metabolite production of two Penicillium isolates 
was undertaken. The effect of salinity and temperature on growth and metabolite 
production of Streptomyces sp. was also carried out. 
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Chapter 2 
 
 
Experimental 
 
 
2.1 Isolation and cultivation media 
 
The antifungal agent, nystatin was incorporated in all actinomycetes isolation media. 
Combination of nystatin/gentamycin or nystatin/novobiocin was also used. Combination 
of the antibiotic solutions (chlortetracycline and streptomycin) was used in all fungal 
isolation media. Both isolation and cultivation media were adjusted to pH 7.0 (±0.2) 
prior to sterilization. Mineral salt constituents were prepared fresh before use. 
Antibiotic/antifungal solutions were stored frozen at -20ºC. 
 
2.1.1 Media for actinomycetes 
 
2.1.1.1 Starch casein agar medium (SCA) 
 
5.0 g soluble starch (BDH), 0.2 g casein (Sigma), 1.0 g KNO3 (BDH), 1.0 g NaCl 
(BDH), 1.0 g K2HPO4 (Sigma), 0.5 mL MgSO4 solution, 0.5 mL CaCO3 solution, 0.5 
mL FeSO4 solution, 10.0 g agar (Oxoid) and 20.0 g sea salt (Sigma) in 500 mL distilled 
water. 
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2.1.1.2 Starch casein agar-nystatin medium (SCA-N) 
 
5.0 g soluble starch (BDH), 0.2 g casein (Sigma), 1.0 g KNO3 (BDH), 1.0 g NaCl 
(BDH), 1.0 g K2HPO4 (Sigma), 0.5 mL MgSO4 solution, 0.5 mL CaCO3 solution, 0.5 
mL FeSO4 solution, 10.0 g agar (Oxoid) and 12 mL nystatin solution (Sigma) in 500 
mL natural seawater (100%). 
 
2.1.1.3 Starch casein agar-nystatin/gentamycin medium (SCA-NG) 
 
5.0 g soluble starch (BDH), 0.2 g casein (Sigma), 1.0 g KNO3 (BDH), 1.0 g NaCl 
(BDH), 1.0 g K2HPO4 (Sigma), 0.5 mL MgSO4 solution, 0.5 mL CaCO3 solution, 0.5 
mL FeSO4 solution, 10.0 g agar (Oxoid), 12 mL nystatin solution (Sigma) and 500 µL 
gentamycin (Sigma) solution in 500 mL natural seawater (100%). 
 
2.1.1.4 Starch casein agar-nystatin/novobiocin medium (SCA-NN) 
 
5.0 g soluble starch (BDH), 0.2 g casein (Sigma), 1.0 g KNO3 (BDH), 1.0 g NaCl 
(BDH), 1.0 g K2HPO4 (Sigma), 0.5 mL MgSO4 solution, 0.5 mL CaCO3 solution, 0.5 
mL FeSO4 solution, 10.0 g agar (Oxoid), 12 mL nystatin solution and 1.0 mL 
novobiocin solution in 500 mL natural seawater (100%). 
 
2.1.1.5 Starch casein broth medium (SCB) 
 
5.0 g soluble starch (BDH), 0.2 g casein (Sigma), 1.0 g KNO3 (BDH), 1.0 g NaCl 
(BDH), 1.0 g K2HPO4 (Sigma), 0.5 mL MgSO4 solution, 0.5 mL CaCO3 solution, 0.5 
mL FeSO4 solution and 20.0 g sea salt (Sigma) in 500 mL distilled water. 
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2.1.2 Media for fungi 
 
2.1.2.1 Peptone yeast glucose agar medium (PYGA) 
 
0.5 g peptone (Becton Dickinson), 0.5 g yeast extract (Oxoid), 1.0 g glucose (BDH), 
10.0 g agar (Oxoid) and 20.0 g sea salt (Sigma) in 500 mL distilled water. 
 
2.1.2.2 Peptone yeast glucose agar-chlortetracycline/streptomycin 
medium (PYGA-CS) 
 
0.5 g peptone (Becton Dickinson), 0.5 g yeast extract (Oxoid), 1.0 g glucose (BDH), 
10.0 g agar (Oxoid) and 5.0 mL antibacterial solution in 500 mL natural seawater 
(100%). 
 
2.1.2.3 Peptone yeast glucose broth  medium (PYGB) 
 
0.5 g peptone (Becton Dickinson), 0.5 g yeast extract (Oxoid), 1.0 g glucose (BDH) and 
20.0 g sea salt (Sigma) in 500 mL distilled water. 
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2.2 Sampling of marine invertebrates 
 
2.2.1 New Zealand samples 
 
The samples from Kaikoura and in Lyttleton Harbour, New Zealand were collected and 
identified by Mr. Dave Tattle of the School of Biological Sciences, University of 
Canterbury. Details of the sampling location are shown in Figure 2.1. Nine samples 
(four from Kaikoura and five from Lyttleton Harbour) were collected and listed in Table 
2.1. Samples were kept at -20ºC for 24 - 72 h prior to preparation. 
 
 
 
Figure 2.1: Sampling of New Zealand marine invertebrates showing the sampling sites 
at Kaikoura and Lyttleton Harbour. 
 
Kaikoura 
 Lyttleton Harbour 
sampling sites 
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Table 2.1: List of marine invertebrates collected from New Zealand waters. 
 
Sampling sites Marine invertebrates 
Kaikoura Sponge K2 
 Sponge K3 
 Golf ball sponge K4 
 Colonial tunicate K8 
Lyttleton Harbour Tunicate L1 
 Sponge L2 
 Tunicate L3 
 Golf ball sponge L4 
 Sponge L5 
 
 
2.2.2 Malaysian samples 
 
Permission for collecting samples in Pulau Redang and Pulau Payar Marine Parks 
Malaysia was granted by the Director-General of Fisheries Malaysia (Fisheries Act 
1985). The samples from these two marine protected areas were collected and identified 
by Mr. Zainuddin Illias of Fisheries Research Institute and his Scuba divers team from 
the Ministry of Natural Resources and Environment Malaysia. The samples were 
collected at a depth between 10 – 50 m at two sampling sites (see Figure 2.2). A total of 
17 samples were collected (14 from Pulau Redang Marine Park and three from Pulau 
Payar Marine Park) and listed in Table 2.2. The samples (14 marine inverterbrates) from 
Pulau Redang Marine Park were processed immediately at the Pulau Redang Wet Lab 
(Figure 2.3). The three samples from Pulau Payar Marine Park were kept at 0ºC for 24 h 
prior to preparation at Fisheries Research Institute, Penang. 
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Figure 2.2: Sampling of Malaysian marine invertebrates showing the sampling sites at 
Pulau Redang and Pulau Payar Marine Parks. 
 
 
Table 2.2: List of marine invertebrates collected from Malaysian waters. 
 
Sampling sites Marine invertebrates 
Pulau Redang Marine Park Tunicate PR1 (Didemnum sp.) 
 Soft coral tree PR2 (Dendronephthya sp.) 
 Soft coral tree PR3 (Dendronephthya sp.) 
 Nudibranch PR4 (Phyllidia sp.) 
 Sea fan PR5 
 Sea whip PR7 (Juncella sp.) 
 Yellow sponge PR8 
 Soft coral PR9 
 Sea fan PR10 
 Soft sponge PR11 
 Barrel sponge PR12 (Xestospongia sp.) 
 Brittle star PR13 
 Sponge PR14 
 Staghorn coral PR17 
Pulau Payar Marine Park Soft coral tree PP1 (Dendronephthya sp.) 
 Soft coral tree PP2 (Dendronephthya sp.) 
 Sea anemone PP4 
 
sampling sites 
Pulau Payar Marine Park Pulau Redang Marine Park 
Fisheries Research Institute, Penang 
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Figure 2.3: Immediate preparation of marine invertebrate samples at the Pulau Redang 
Wet Lab. 
 
 
2.3 Preparation of marine invertebrate samples 
 
Liquid and/or tissue portions of the marine invertebrates were used for the isolation of 
actinomycetes and fungi. In the case of some delicate samples, such as the tunicates, 
only the liquid portion was used. For samples such as hard corals (homogenization 
process was not applicable), a swabbing method was used. All marine invertebrate 
samples (fresh or frozen) were rinsed three times with sterile seawater before use. 
 
For the preparation of the liquid portion, samples were aseptically cut into smaller 
pieces (±10 mm
3
). The pieces were then placed in a mortar and homogenized with 10 
mL sterile seawater with a pestle. An aliquot of the liquid portions (150 – 200 µL) was 
spread on each of 60 plates containing isolation media for actinomycetes (SCA-N, 
SCA-NG and SCA-NN) or fungi (PYGA-CS). 
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For the preparation of the tissue portion, samples were aseptically cut into smaller 
pieces (±3 mm
3
) with stainless steel scissors. The tissue pieces (five – seven pieces) 
were aseptically placed onto each of 60 plates containing isolation media for 
actinomycetes (SCA-N, SCA-NG and SCA-NN) or fungi (PYGA-CS). 
  
The inoculated plates (20 each) were then incubated at 20, 28 and 37°C. For the 
immediately prepared samples (Pulau Redang Marine Park samples), the inoculated 
plates were maintained at 20ºC during the sample preparation and below 10ºC upon 
return from the island to the Fisheries Research Institute laboratory in Penang. Isolation 
plates were examined daily and developing colonies were transferred to fresh isolation 
plates until pure cultures obtained (see Figure 2.4). 
 
 
2.4 Maintenance of pure cultures 
 
For long-term maintenance, pure isolates of actinomycetes and fungi were maintained in 
10% glycerol at -80°C. Cultures under regular examination  were transferred monthly 
on a fresh medium (SCA – actinomycetes or PYGA – fungi) and kept at 20°C. The 
plates were wrapped with parafilm or plastic wrap to reduce drying. 
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Marine invertebrates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: General technique to isolate actinomycetes or fungi from tissue/liquid 
portions of marine invertebrates (adopted from Namikoshi et al., 2002). 
 
Rinse with sterile seawater (3X) 
Cut into pieces (±10 mm
3
) 
Homogenize (10 mL sterile seawater) 
Tissue portion (5 – 7 pieces) put onto plate Liquid portion (150 - 200 µL) spread onto plate 
Incubate inoculated plates at desired temperature 
Growth of isolates from tissue and liquid portions  
Tissue 
portion 
Liquid 
portion 
Repeated subculture on fresh media 
until pure isolate obtained  
Pure isolate 
Cut into pieces (±3 mm
3
) 
Visible growth of isolate transferred 
onto fresh medium (without antibiotic) 
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2.5 Identification of isolates 
 
Isolates were examined macroscopically and microscopically. The morphology of 
isolates was examined under a dissection microscope. Microscopic details such as 
hyphal reproductive structures and spores were examined using a compound 
microscope with magnification up to 400X. For slide preparation for examination under 
the compound microscope, a small piece of surface tissue from the colony was scraped 
and placed into a drop of 70% ethanol (EtOH) on a microscope slide. Once the EtOH 
had evaporated, a drop of lactophenol cotton blue was applied to the specimen. A 
coverslip was then gently placed over the drop of stain and pressed lightly. For long-
term storage of the slide, the coverslip was ringed with nail polish, repeated several 
times. 
 
Higher resolution images of these structures were obtained using a scanning electron 
microscope (SEM) with the aid of Mr. Neil Andrews, School of Biological Sciences, 
University of Canterbury. A mounted stub with double sided sticky tape was plunged 
into the culture area bearing spores. The specimen was then coated with a thin coating 
of Gold Palladium using a Polaron E5000 coater with the following conditions: 1.2 kV 
at 20 mA for 2 min. Micrographs were taken by a Lieca S440 at 10 kV and 80 pA with 
working distance approximately 10 mm.  
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2.6 Extraction 
 
2.6.1 Agar media 
 
Cultures of actinomycetes and fungi (both agar and mycelium) on agar plates (85 mm 
diameter) were cut into pieces and homogenized with EtOAc (25 mL/plate) using an 
Ultra-turrax (Janke & Kunkle) for 5 min or until the sample was sufficiently macerated. 
The ground agar was left sitting in the EtOAc overnight. The EtOAc was then pipetted 
off from the macerated agar using a micropipette. This process was repeated three 
times. The filtered EtOAc (from three extractions) were combined and taken to dryness 
under N2 (for large scale extraction, the extracts were dried on a rotary evaporator). The 
concentrated extract was transferred to a pre-weighed vial, dried under N2 and the dry 
weight determined. All dried extracts were dissolved in HPLC grade methanol (MeOH) 
at a concentration of 1 mg/mL prior to submission for bioassay or HPLC screening. 
 
2.6.2 Broth media 
 
Broth cultures of actinomycetes and fungi (10 mL) were homogenized with 10 mL 
EtOAc using an Ultra-turrax (Janke & Kunkle) for 5 min or until the samples were 
sufficiently macerated. The ground broth culture was left sitting in EtOAc overnight. 
The EtOAc was then filtered off from the macerated broth using a micropipette. This 
process was repeated three times. The filtered EtOAc (from three extractions) was 
combined and taken to dryness under N2. The concentrated extract was transferred to a 
pre-weighed vial, dried under N2 and the dry weight determined. All dried extracts were 
dissolved in a HPLC grade MeOH at a concentration of 1 mg/mL prior to submission to 
the bioassay or HPLC screening. 
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2.7 Bioassays 
 
2.7.1 P388 Assay 
 
All crude extracts (1 mg/mL) were initially screened for cytotoxicity against murine 
leukaemia cell lines P388 (P388 cells) (ATCC CCL 46, P388D1). An aliquot of 5 µL of 
each crude extracts was pipetted into 90 individual wells of a 96-well microtitre plate. 
This assay comprised of a serial dilution of the sample of interest followed by 
incubation for 72 h with P388 cells. Cell viability is determined colorimetrically by the 
addition of the yellow dye, MTT tetrazolium. Unhealthy or dead cells cannot metabolize 
this dye, leaving a yellow colour, whereas healthy cells reduce this dye to MTT 
formazan resulting in an intense purple colour. The concentration of sample required to 
reduce cell growth by 50% when compared to controls, is expressed as an IC50 in ng/mL 
(Perry et al., 1999). Samples that inhibited 50% of the growth of P388 cells were 
considered as potentially active and were subjected to a further assay to determine the 
concentrations required to inhibit the growth of P388 cells by 50% (IC50). 
 
2.7.2 Antimicrobial Assays 
 
Crude extracts were tested against the Gram-positive bacterium Bacillus subtilis, the 
Gram-negative bacterium Pseudomonas aeruginosa and the fungus Candida albicans. 
Bacterial and fungal suspensions were prepared in Roswell Park Memorial Institute-
1640 medium (RPMI-1640). The density of cells was read at 610 nm and adjusted to an 
optical density (OD) of 0.04 for B. subtilis, and 0.05 for P. aeruginosa and C. albicans. 
Aliquots of 200 µL of bacterial or fungal suspension were incubated with each crude 
extract for 24 h at 30ºC. The cell viability was determined colorimetrically by the 
addition of the blue dye, resazurin. Resazurin is a growth indicator and the presence of 
bacteria or fungi is indicated by oxygen emission which reacts with resazurin, 
generating a pink colour. 
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The UV absorption of each sample was read at 600 nm and compared against the UV 
absorption of the media control. Results are given as a percentage of cell viability (Lang 
et al., 2006). For the antimicrobial assay against bacteria, an aliquot of 10 µL of each 
crude extract (1 mg/mL) was pipetted into 90 individual wells of a 96-well microtitre 
plate. For the assay against fungi, 20 µL was pipetted into 90 individual wells of a 96-
well microtitre plate. 
 
 
2.8 Capillary-probe nuclear magnetic resonance 
(CapNMR) 
 
1
H, correlation spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), 
heteronuclear multiple bond correlation spectroscopy (HMBC) and nuclear overhauser 
effect (NOE) experiments were all recorded on a Varian INOVA 500 spectrometer at 
23°C, operating at 500 MHz.  The INOVA was equipped with a 500 MHz Protasis 
capillary NMR probe (Figure 2.5) for spectra reported in Chapters 5, 6 and 7. Chemical 
shifts are expressed in parts per million (ppm) on the δ scale, and were referenced to the 
appropriate solvent peaks: CDCl3 referenced to CHCl3 at δH 7.25 (
1
H); CD3OD 
referenced to CHD2OD at δH 3.31 (
1
H); DMSO-d6 referenced to CD3(CHD2)SO at δH 
2.50 (
1
H). Coupling constants (J) were expressed in Hz. 
 
 
 
Figure 2.5: Protasis capillary NMR probe. 
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The pure or partially pure compound obtained from the method described in Section 
2.9.3 was dissolved in 6 µL of deuterated MeOH and injected into an inlet capillary via 
a syringe. This was then followed by injection of 11 µL of deuterated MeOH to position 
the sample in the probe. All samples were retrieved into HPLC vials or inserts that were 
silated as described in Section 2.12. The formula for calculating the amount of material 
analyzed by the CapNMR is shown below. 
 
A (µg) = molecular weight of A x ∑ protons (solvent – A) x 0.35 
    ∑ protons of A        ∑ protons (solvent)    
 
 
2.9 High pressure liquid chromatography (HPLC) 
 
Analytical HPLC was carried out on a Dionex liquid chromatograph equipped with a 
UVD 340U diode array detector (DAD), and connected to an Alltech evaporative light 
scattering detector (ELSD) 800. For reverse-phase HPLC a Phenomenex Luna C18 (10 
x 250 mm, 5 µm) column was used. The standard gradient used was: 2 min of 10% 
ACN/H2O; a linear gradient to 75% ACN/H2O for 12 min; isocratic at 75% for another 
10 min; a linear gradient for 2 min to 100% ACN/H20 followed by isocratic at 100% 
ACN for 4 min then returned to 10% ACN/H20 in 2 min and re-equilibriated for 8 min 
with a flow rate of 1 mL/min and at 40°C. 
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2.9.1 HPLC screening of metabolites 
 
Bioactive samples were filtered through a 0.45 µm polytetrafluoroethylene (PTFE) 
membrane filters immediately prior to the HPLC screening. An aliquot of the samples 
(25 µg) was analyzed by reverse-phase analytical HPLC using the standard gradient 
solvent system given in Section 2.9.  For HPLC screening, the milli-Q H2O was 
acidified with 0.05% trifluoroacetic acid (TFA). The HPLC screening for significant 
peaks provides a basis for selection of extracts for further investigation. The presence of 
significant amount of metabolites was indicated by both the UV and ELSD traces 
(>10% of both the base peaks in the HPLC chromatogram).  
 
2.9.2 HPLC microtitre plate bioassay 
 
The HPLC MTT plate assay was conducted on selected extracts to determine the 
peak(s) responsible for the activity. An aliquot of the crude extract (250 µg) was 
analyzed by reverse-phase analytical HPLC using the standard gradient solvent system 
given in Section 2.9. For HPLC Microtitre Plate Bioassay, the milli-Q H2O was 
acidified with 0.05% TFA. The eluent was collected into 96 well polystyrene microtitre 
plates (master plate). ‘Daughter plates’ were made by taking an amount of 50 or 5 µL 
from the master plate to a new plate. These plates containing the eluents were then used 
for bioassay.  
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2.9.3 HPLC microtitre plate for CapNMR 
 
Sample for CapNMR analysis (500 – 750 µg) was separated by reverse-phase analytical 
HPLC using the standard gradient solvent system given in Section 2.9. The fractions 
were collected into 88 individual wells of a 96-well microtitre polypropylene plate and 
were dried using a centrifugal evaporator. The amount of sample collected from single 
or combined wells was determined by the ELSD traces of the chromatogram. A sample 
was considered worthwhile for further analysis if the traces showed at least 500% of the 
ELSD base peak. The pure or partially pure compound obtained from individual or 
combined wells of the plate was then subjected to CapNMR analysis. 
 
 
2.10 Liquid chromatography mass spectrometry 
(LCMS) 
 
High Resolution Liquid Chromatography Mass Spectra (HRLCMS) were recorded on a 
Waters 2790 HPLC system equipped with a Waters 996 photodiode array (PDA) 
detector coupled to a Micromass LCT spectrometer using a probe voltage of 3200 V, an 
operating temperature of 150°C and a source temperature of 80°C.  The carrier solvent 
was 50:50 ACN/H2O at 20 µL/min (for direct inject mode).  Typically, 10 µL of a 10 
µg/mL solution was injected.  Leucine enkephalin was used as the internal standard. 
The measurements were performed by Dr. Marie Squire, Mr. Robert Stainthorpe and 
Mr. Bruce Clark (Department of Chemistry, University of Canterbury). 
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2.11 Electrospray ionization mass spectrometry 
(ESIMS) 
 
High Resolution Electrospray Ionization Mass Spectra (HRESIMS) were recorded on a 
Micromass LCT spectrometer using a probe voltage of 3200 V, an operating 
temperature of 150°C and a source temperature of 80°C.  The carrier solvent was 50:50 
ACN/H2O at 20 µL/min (for direct inject mode).  Typically, 10 µL of a 10 µg/mL 
solution was injected.  Leucine enkephalin was used as the internal standard.  
Electrospray ionization mass spectra (ESIMS) reported in Chapters 5, 6 and 7 were 
recorded in positive and/or negative modes on a Micromass (Manchester, UK) 
quadrupole time of flight (QTOF-2) mass spectrometer. The measurements were 
performed by Dr. Marie Squire, Mr. Robert Stainthorpe and Mr. Bruce Clark 
(Department of Chemistry, University of Canterbury). 
 
 
2.12 Silanization of glass surfaces for CapNMR 
 
All items were immersed into dimethyldichlorosilane (DMDCS) solution (5% DMDCS 
in dichloromethane (DCM)) for 15 min. After pouring off the deactivating solution, the 
items were immediately rinsed with DCM. The items were then immediately covered 
with MeOH for 15 – 30 min. This step was performed immediately in order to minimize 
exposure to room moisture. The MeOH was drained off and the items dried in a 100ºC 
oven until completely dry. The DMDCS solution was prepared fresh before use. 
 
 
2.13 Solvents 
 
All solvents used in the chromatography technique were HPLC grade. Analytical grade 
solvents were used for other methods. 
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Chapter 3 
 
 
Preliminary screening 
 
 
3.1 Introduction 
 
The culturable microorganisms associated with marine invertebrates from New Zealand 
and Malaysian waters were explored for bioactivity and chemical interest. Within the 
Marine Chemistry Group at University of Canterbury, New Zealand, an integrated 
approach between research groups in microbiology and natural product chemistry is 
taken for marine natural products discovery. This chapter presents the groundwork that 
was conducted towards the search for biologically active metabolites from extracts of 
actinomycetes and fungi derived from marine invertebrates. 
 
 
3.2 Actinomycetes and fungi isolated from marine 
invertebrates 
 
Actinomycetes and fungi were isolated from New Zealand marine invertebrates 
collected off Kaikoura and in Lyttleton Harbour. Malaysian fungal strains were isolated 
from marine invertebrates collected in Pulau Redang Marine Park and Pulau Payar 
Marine Park. A total of 390 isolates were obtained from New Zealand (33 
actinomycetes and 179 fungi) and Malaysian samples (178 fungi). 
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The isolates were initially identified based on the morphology and cultural characteristic 
and due to a great number of isolates, only the genus was determined and in some cases, 
the isolates remained unidentified. Details of the procedures for sampling, isolation, 
cultivation and identification of isolates were discussed in Chapter Two 
(Experimental). 
 
3.2.1 New Zealand marine-derived actinomycetes 
 
Thirty-three isolates were obtained from seven marine invertebrates (Table 3.1). The 
majority of the actinomycetes were isolated from tissue portions of the four sponges: 
K2, K3, K4 and L2. Actinomycetes were not isolated from the remaining two 
invertebrates, namely tunicate L1 and golf ball sponge L4. 
 
 
Table 3.1: Actinomycetes isolated from New Zealand marine invertebrates. 
 
Sampling sites Marine invertebrates Portion used No. of isolates Isolation media Total 
Tissue 5 SCA-N Sponge K2 
Liquid 0  
5 
Tissue 4 SCA-N Sponge K3 
Liquid 0  
4 
Tissue 4 SCA-N Golf ball sponge K4 
Liquid 0  
4 
Kaikoura 
Colonial tunicate K8 Liquid 4 SCA-NG 4 
Tunicate L1 Liquid 0  0 
Tissue 5 SCA-NG Sponge L2 
Liquid 0  
5 
Tissue 0  Tunicate L3 
Liquid 2 SCA-N 
2 
Tissue 0  Golf ball sponge L4 
Liquid 0  
0 
Tissue 4 SCA-NG 
Lyttleton 
Harbour 
 
Sponge L5 
Liquid 5 SCA-NG 
9 
Total 33 
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3.2.2 New Zealand marine-derived fungi 
 
A total of 179 isolates were obtained from nine New Zealand marine invertebrates 
studied (see Table 3.2). It was noted that their abundance in tissue and liquid portions 
varied significantly in a number of cases. 
 
 
Table 3.2: Fungi isolated from New Zealand marine invertebrates. 
 
Sampling sites Marine invertebrates Portion used No. of isolates Total 
Tissue 13 Sponge K2 
Liquid 4 
17 
Tissue 15 Sponge K3 
Liquid 13 
28 
Tissue 14 Golf ball sponge K4 
Liquid 9 
23 
Kaikoura 
Colonial tunicate K8 Liquid 20 20 
Tunicate L1 Liquid 11 11 
Tissue 4 Sponge L2 
Liquid 9 
13 
Tissue 12 Tunicate L3 
Liquid 13 
25 
Tissue 4 Golf ball sponge L4 
Liquid 10 
14 
Tissue 15 
Lyttleton Harbour 
 
Sponge L5 
Liquid 13 
28 
Total 179 
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3.2.3 Malaysian marine-derived fungi 
 
The isolation of fungi from Malaysian marine invertebrates resulted in a large number 
of isolates but because of time limitation only 178 fungi were obtained in pure culture 
from a total of 17 marine invertebrates (see Table 3.3). 
 
 
Table 3.3: Fungi isolated from Malaysian marine invertebrates. 
 
Sampling sites Marine invertebrates Portion used No. of isolates Total 
Tissue 3 Tunicate PR1 
(Didemnum sp.) Liquid 4 
7 
Tissue 10 Soft coral tree PR2 
(Dendronephthya sp.) Liquid 7 
17 
Tissue 18 Soft coral tree PR3 
(Dendronephthya sp.) Liquid 7 
25 
Nudibranch PR4 
(Phyllidia sp.) 
Tissue 8 8 
Tissue 8 Sea fan PR5 
Liquid 7 
15 
Sea whip PR7 
(Juncella sp.) 
Tissue 3 3 
Yellow sponge PR8 Liquid 8 8 
Tissue 4 Soft coral PR9 
Liquid 1 
5 
Tissue 8 Sea fan PR10 
Liquid 12 
20 
Tissue 12 Soft sponge PR11 
Liquid 6 
18 
Tissue 1 Barrel sponge PR12 
(Xestospongia sp.) Liquid 2 
3 
Brittle star PR13 Tissue 4 4 
Tissue 17 Sponge PR14 
Liquid 4 
21 
Pulau Redang 
Marine Park 
Staghorn coral PR17 Liquid 4 4 
Soft coral tree PP1 
(Dendronephthya sp.) 
Tissue 7 7 
Soft coral tree PP2 
(Dendronephthya sp.) 
Liquid 5 5 
Tissue 2 
Pulau Payar 
Marine Park 
Sea anemone PP4 
Liquid 6 
8 
Total 178 
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3.3 Selection of isolates for bioactivity screening 
 
From the 390 isolates obtained from New Zealand and Malaysian marine invertebrates 
only 161 were further evaluated for the production of biologically active metabolites. 
The selection was based on the taxonomy of the isolates, unusual morphology and the 
diversity of reported secondary metabolite chemistry of related taxa. Some of the 
isolates were also randomly selected from productive genera such as Streptomyces, 
Acremonium, Penicillium and Xylaria. Fungal isolates that showed better growth on sea 
water media were also selected. Some examples of the selected isolates are shown in 
Figures 3.1 (a) and (b). 
 
 
 
 
 
 
(a): Examples of isolates selected for bioactivity screening based on productive genera.  
 
 
 
(b): Examples of isolates selected for bioactivity screening based on growth on sea 
water and non-sea water media. Left plates: sea water medium. Right plates: non-sea 
water medium.  
 
Figures 3.1: Examples of isolates selected for bioactivity screening. 
 
 A Malaysian 
Xylaria sp. (PR3L8) 
A New Zealand 
Acremonium sp. (KK2T4) 
A New Zealand 
Penicillium sp. (KK4T14b) 
A New Zealand 
Streptomyces sp. (KA4T1) 
A New Zealand Acremonium sp. (KK4L2) A New Zealand Verticillium sp. (KK4L7) 
A Malaysian Trichoderma sp. (PR3T12) A New Zealand Alternaria sp. (KK4T3) 
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Of the 161 isolates selected, 13 isolates were New Zealand actinomycetes, 91 New 
Zealand fungi and 57 Malaysian fungi. Each of the New Zealand actinomycetes was 
cultured on SCA and SCB media; the New Zealand fungal isolates were cultured on 
PYGA and PYGB media. For the Malaysian fungal isolates, 17 and 41 of the isolates 
were cultured on PYGA and PYGB media, respectively. Resultant cultures were 
extracted with EtOAc to yield a total of 266 extracts (see Table 3.4). All 266 extracts 
were “quick screened” against P388 cells, B. subtilis, P. aeruginosa and C. albicans. 
Extracts that inhibited >50% of the growth of P388 cells were further assayed to 
determine the concentrations required to inhibit the growth of the cells by 50% (IC50). 
Details of the cultivation, extraction and bioactivity screening procedures are given in 
Chapter Two (Experimental). The results are discussed below. 
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Table 3.4: Number of extracts produced from selected isolates cultured on agar and/or 
broth media. 
 
Origins of isolate No. of isolates selected Agar 
media 
Broth 
media 
Total 
Sponge K2 4 4 4 8 
Sponge K3 2 2 2 4 
Golf ball sponge K4 1 1 1 2 
Sponge L2 2 2 2 4 
Tunicate L3 2 2 2 4 
Sponge L5 2 2 2 4 
Sub-total (New Zealand actinomycetes) 13 13 13 26 
Sponge K2 10 10 10 20 
Sponge K3 16 16 16 32 
Sponge K4 14 14 14 28 
Tunicate K8 4 4 4 8 
Tunicate L1 6 6 6 12 
Sponge L2 12 12 12 24 
Tunicate L3 12 12 12 24 
Sponge L4 12 12 12 24 
Sponge L5 5 5 5 10 
Sub-total (New Zealand fungi) 91 91 91 182 
Tunicate PR1 (Didemnum sp. ) 4 1 3 4 
Soft coral tree PR2 (Dendronephthya sp.) 4 1 3 4 
Soft coral tree PR3 (Dendronephthya sp.) 9 3 6 9 
Nudibranch PR4 (Phyllidia sp.) 7 1 6 7 
Sea fan PR5 5 1 4 5 
Sea whip PR7 (Juncella sp.) 2 2 0 2 
Sponge PR8 2 1 1 2 
Soft coral PR9 2 1 1 2 
Sea fan PR10 4 2 2 4 
Soft sponge PR11 1 0 1 1 
Barrel sponge PR12 (Xestospongia sp.) 1 0 1 1 
Brittle star PR13 3 2 2 4 
Sponge PR14 1 1 0 1 
Staghorn coral PR17 2 0 2 2 
Soft coral tree PP1 (Dendronephthya sp.) 4 0 4 4 
Soft coral tree PP2 (Dendronephthya sp.) 2 0 2 2 
Sea anemone PP4 4 1 3 4 
Sub-total (Malaysian fungi) 57 17 41 58 
Total 161 121 145 266 
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3.4 Bioactivity of actinomycetes and fungi 
 
3.4.1 New Zealand actinomycetes 
 
The quick screen assay of the New Zealand actinomycetes showed that 25 of the 26 
extracts assayed were potentially active (growth inhibition >50%). Of the 25 extracts, 
23 inhibited only the growth of P388 cells and two were active against both P388 cells 
and B. subtilis. None of the extracts showed activity against P. aeruginosa or C. 
albicans. All 25 extracts were further assayed for IC50 against P388 cells and 9 of 25 
extracts showed IC50 values of <12,500 ng/mL. Two extracts (F5956 and F5934) 
showed a high level of cytotoxicity (IC50<97.5 ng/mL) and good cytotoxicity was 
shown by F5958 (IC50784 ng/mL). The results of bioactivity are shown in Table 3.5. 
 
 
Table 3.5: Bioactivity of New Zealand actinomycete extracts. 
 
Isolates Media Extracts A B C 
KA2T2 (unidentified) SCB F5921 84.0 na na 
 SCA F5943 88.9 na na 
KA2T5 (unidentified) SCB F5922 85.0 na na 
 SCA F5944 na na na 
KA2T7 (unidentified) SCB F5923 64.6 na na 
 SCA F5945 65.4 na na 
KA2T9 (unidentified) SCB F5924 88.0 na na 
 SCA F5946 101.4 na 9,563 
KA3T1 (Streptomyces sp.) SCB F5925 83.4 na na 
 SCA F5947 100.6 na na 
KA3T3 (Streptomyces sp.) SCB F5926 100.0 na na 
 SCA F5948 98.0 na 6,303 
KA4T1 (Streptomyces sp.)  SCB F5928 85.4 na 5,938 
 SCA F5950 81.6 na na 
LA2T4 (unidentified) SCB F5932 64.2 na na 
 SCA F5954 78.9 na 5,938 
LA2T5 (unidentified) SCB F5933 97.0 na na 
 SCA F5955 93.8 na na 
LA3L1 (Streptomyces sp.) SCB F5934 93.7 99.1 <97.5 
 SCA F5956 94.5 101.0 <97.5 
LA3L2 (Streptomyces sp.)  SCB F5936 79.8 na na 
 SCA F5958 81.5 na 784 
LA5T2 (unidentified) SCB F5937 80.2 na na 
 SCA F5959 86.9 na 2,094 
LA5L4 (Streptomyces sp.) SCB F5940 93.5 na na 
 SCA F5962 90.2 na 1,339 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: IC50 (ng/mL) against 
P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
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3.4.2 New Zealand fungi 
 
The quick screen assay of the New Zealand fungi showed that 94 of the 182 extracts 
assayed were potentially active (growth inhibition >50%). Of the 94 extracts, 89 were 
cytotoxic only against P388 cells, three were active against both P388 cells and B. 
subtilis, one was active against both P388 cells and C. albicans and the remaining 
extract was active only against B. subtilis. None of the extracts showed activity against 
P. aeruginosa. Of the total 93 extracts that were active against P388 cells in the quick 
screen assay, 32 showed IC50 values of <12,500 ng/mL. Good cytotoxicity (IC50<97.5 
ng/mL) was indicated in extract F5342 in particular, although a number of other extracts 
also showed promising results. The results of bioactivity are shown in Table 3.6. 
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Table 3.6: Bioactivity of New Zealand fungal extracts. 
 
Isolates Media Extracts A B C D 
KK 2T4 (Acremonium sp.) PYGB F5963 na na na na 
 PYGA F5907 70.7 na na na 
KK2T9 (Acremonium sp.) PYGB F5364 na na na na 
 PYGA F5349 na na na na 
KK2T10 (Spiromyces sp.) PYGB F5315 na na na na 
 PYGA F5967 na na na na 
KK2T11b (Penicillium sp.) PYGB F5316 na na na na 
 PYGA F5968 na na na na 
KK2T13b (Spiromyces sp.) PYGB F5386 na na na na 
 PYGA F5877 na na na na 
KK2T14b (Cladosporium sp.) PYGB F5317 na na na na 
 PYGA F5969 na na na na 
KK2T16 (Phoma sp.) PYGB F5365 na na na na 
 PYGA F5970 na na na na 
KK2T17b (Penicillium sp.) PYGB F5319 na na na na 
 PYGA F5971 na na na na 
KK2L1 (Cladosporium sp.) PYGB F5320 na na na na 
 PYGA F5972 na na na na 
KK2L6 (unidentified) PYGB F6104 54.5 na na na 
 PYGA F5878 na na na na 
KK3T2 (Dreschlera-like sp.) PYGB F5322 na na na na 
 PYGA F5880 na na na na 
KK3T4 (Alternaria sp.) PYGB F5323 na na na na 
 PYGA F5886 na na na na 
KK3T8 (Penicillium sp.) PYGB F5325 na na na na 
 PYGA F5350 96.7 na 72.7 5,403 
KK3T15 (Penicillium sp.) PYGB F5327 na na na na 
 PYGA F5888 na na na na 
KK3T18 (Acremonium sp.) PYGB F5366 na na na na 
 PYGA F5882 na na na na 
KK3T21 (Spiromyces sp.) PYGB F5389 na na na na 
 PYGA F5883 na na na na 
KK3T23 (Penicillium sp.) PYGB F5329 83.9 na na 4,967 
 PYGA F5890 78.8 na na 3,177 
KK3T25 (Acremonium sp.) PYGB F5367 na na na na 
 PYGA F5353 na na na na 
KK3T26 (Penicillium sp.) PYGB F5330 69.7 na na 8,240 
 PYGA F5891 90.0 na na 3,177 
KK3T28 (Phoma sp.) PYGB F5368 na na na na 
 PYGA F5895 61.8 na na na 
KK3L1 (Cladosporium sp.) PYGB F5331 na na na na 
 PYGA F5892 59.4 na na na 
KK3L2 (Cladosporium sp.) PYGB F5332 na na na na 
 PYGA F5893 76.2 na na na 
KK3L13 (unidentified) PYGB F5333 na na na na 
 PYGA F5881 88.9 na na na 
KK3L14 (unidentified) PYGB F5334 na na na na 
 PYGA F5973 na na na na 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: growth inhibition (%) 
against C. albicans; D: IC50 (ng/mL) against P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
 
Chapter 3: Preliminary screening 
_____________________________________________________________________________________ 
 46 
 
Table 3.6 (cont’d): 
 
Isolates Media Extracts A B C D 
KK3L15 (Spiromyces sp.) PYGB F5390 na na na na 
 PYGA F5884 na na na na 
KK 3L21 (unidentified) PYGB F5335 na na na na 
 PYGA F5894 54.3 na na na 
KK4T3 (Alternaria sp.) PYGB F5336 na na na na 
 PYGA F5857 56.5 na na na 
KK4T5 (unidentified) PYGB F5338 na na na na 
 PYGA F5865 61.2 72.5 na na 
KK4T6 (Penicillium sp.) PYGB F5339 na 64.3 na na 
 PYGA F5866 na na na na 
KK4T7a (Alternaria sp.) PYGB F5534 na na na na 
 PYGA F5859 na na na na 
KK4T7b (Penicillium sp.) PYGB F5340 na na na na 
 PYGA F5867 70.6 na na 6,303 
KK4T9 (unidentified) PYGB F5341 na na na na 
 PYGA F5910 55.6 na na na 
KK4T14b (Penicillium sp.) PYGB F5342 94.5 na na <97.5 
 PYGA F5868 95.7 na na 383 
KK4T19 (Spiromyces sp.) PYGB F5391 na na na na 
 PYGA F5885 na na na na 
KK4L2 (Acremonium sp.) PYGB F5392 na na na na 
 PYGA F5354 na na na na 
KK4L4a (Penicillium sp.) PYGB F5344 53.3 na na 7,100 
 PYGA F5870 57.2 na na na 
KK4L4b (Beauveria bassiana) PYGB F5374 na na na na 
 PYGA F5860 72.3 na na na 
KK 4L5c (Penicillium sp.) PYGB F5345 na na na na 
 PYGA F5871 68.6 na na na 
KK4L7 (Verticillium sp.) PYGB F5346 na na na na 
 PYGA F5861 101.7 na na 11,779 
KK4L8 (Penicillium sp.) PYGB F5347 94.6 na na 375 
 PYGA F5872 94.9 na na 883 
KK8L2 (unidentified) PYGB F5537 na na na na 
 PYGA F5875 74.1 na na na 
KK8L15 (Paecilomyces sp.) PYGB F5377 57.0 na na 9,282 
 PYGA F5876 82.4 na na 12,135 
KK8L23 (Beauveria sp.) PYGB F5574 66.9 na na na 
 PYGA F5863 60.2 na na na 
KK8L24 (Penicillium sp.) PYGB F5538 58.8 na na na 
 PYGA F5965 na na na na 
LY1L1 (unidentified) PYGB F5555 na na na na 
 PYGA F5974 na na na na 
LY1L2 (unidentified) PYGB F5369 52.0 na na 9,010 
 PYGA F5991 63.2 na na na 
LY1L4 (unidentified) PYGB F5557 71.8 na na na 
 PYGA F5992 59.9 na na na 
LY1L5 (Penicillium sp.) PYGB F5558 69.8 na na 5,938 
 PYGA F5975 65.2 na na 5,117 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: growth inhibition (%) 
against C. albicans; D: IC50 (ng/mL) against P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
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Table 3.6 (cont’d): 
 
Isolates Media Extracts A B C D 
LY1L6 (unidentified) PYGB F5378 77.6 na na 11,779 
 PYGA F5976 75.5 na na na 
LY1L7 (unidentified) PYGB F6106 na na na na 
 PYGA F5993 59.9 na na na 
LY2T1 (unidentified) PYGB F5379 na na na na 
 PYGA F5978 na na na na 
LY2T3 (unidentified) PYGB F5561 71.6 na na 10,456 
 PYGA F5986 na na na na 
LY2T4 (unidentified) PYGB F5380 na na na na 
 PYGA F5979 na na na na 
LY2L2 (unidentified) PYGB F5562 na na na na 
 PYGA F5987 50.9 na na 4,821 
LY2L4 (unidentified) PYGB F5564 76.4 na na 8,240 
 PYGA F5980 na na na na 
LY2L5 (unidentified) PYGB F5565 64.8 na na na 
 PYGA F5981 na na na na 
LY2L6 (unidentified) PYGB F5566 74.3 na na na 
 PYGA F5988 na na na na 
LY2L8 (unidentified) PYGB F5568 80.0 na na 8,240 
 PYGA F5989 na na na na 
LY2L9 (unidentified) PYGB F5371 na na na na 
 PYGA F5982 51.2 na na na 
LY2L10 (unidentified) PYGB F6107 59.3 na na na 
 PYGA F5983 95.1 na na 4,821 
LY2L11 (unidentified) PYGB F5383 na na na na 
 PYGA F5984 na na na na 
LY2L17 (unidentified) PYGB F6108 54.2 na na na 
 PYGA F5985 67.2 na na 12,135 
LY3T1 (unidentified) PYGB F5539 na na na na 
 PYGA F6097 62.2 na na na 
LY 3T2 (unidentified) PYGB F6120 62.2 na na na 
 PYGA F6101 63.8 na na na 
LY3T4a (unidentified) PYGB F6118 54.3 na na na 
 PYGA F6098 51.5 na na na 
LY3T8 (unidentified) PYGB F6111 na na na na 
 PYGA F5995 57.5 na na na 
LY3T11 (unidentified) PYGB F6119 67.4 na na 9,563 
 PYGA F6099 na na na na 
LY3L1 (unidentified) PYGB F5541 71.5 na na na 
 PYGA F6100 na na na na 
LY3L4 (unidentified) PYGB F6112 53.5 na na na 
 PYGA F5996 na na na na 
LY3L7 (unidentified)  PYGB F6116 na na na na 
 PYGA F6000 83.6 na na na 
LY3L12 (unidentified) PYGB F6117 69.6 na na na 
 PYGA F6096 66.3 na na na 
LY3L14 (unidentified) PYGB F6113 62.2 na na na 
 PYGA F5997 69.5 na na 11,779 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: growth inhibition (%) 
against C. albicans; D: IC50 (ng/mL) against P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
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Table 3.6 (cont’d):  
 
Isolates Media Extracts A B C D 
LY3L16a (unidentified) PYGB F6114 69.3 na na 8,240 
 PYGA F5998 76.1 na na 9,852 
LY3L19 (unidentified) PYGB F6115 na na na na 
 PYGA F5999 59.2 na na 9,852 
LY4T1 (unidentified) PYGB F5578 79.7 na na na 
 PYGA F5905 93.3 na na na 
LY4T4 (unidentified) PYGB F5579 55.7 na na na 
 PYGA F5906 72.0 na na na 
LY4T5 (unidentified) PYGB F5580 57.0 na na na 
 PYGA F5911 56.9 na na 5,938 
LY4L3 (unidentified) PYGB F5545 67.7 na na na 
 PYGA F5897 67.3 na na na 
LY 4L4 (unidentified) PYGB F5575 64.0 na na na 
 PYGA F5898 98.4 na na na 
LY 4L7 (Verticillium sp.)  PYGB F5547 63.2 na na na 
 PYGA F5900 95.1 na na na 
LY 4L8a (unidentified) PYGB F6109 na na na na 
 PYGA F6102 54.7 na na na 
LY 4L8b (unidentified) PYGB F6110 65.2 na na na 
 PYGA F6103 60.1 na na na 
LY 4L10 (unidentified) PYGB F5577 na na na na 
 PYGA F5901 98.6 na na na 
LY 4L11 (unidentified) PYGB F5548 51.5 na na na 
 PYGA F5902 na na na na 
LY4L13a (unidentified) PYGB F5542 na na na na 
 PYGA F5903 101.4 na na na 
LY4L13b (unidentified) PYGB F5543 61.1 na na na 
 PYGA F5904 na na na na 
LY5T9 (unidentified) PYGB F5550 97.2 111.7 na 1,300 
 PYGA F5914 100.5 112.5 na 458 
LY5T14 (unidentified) PYGB F5551 na na na na 
 PYGA F5915 60.6 na na na 
LY5T16 (Scopulariopsis sp.) PYGB F5372 na na na na 
 PYGA F5916 54.5 na na na 
LY5T24a (unidentified) PYGB F5552 50.8 na na na 
 PYGA F5917 86.1 na na na 
LY5L8 (Aspergillus sp.) PYGB F5373 na na na na 
 PYGA F5919 na na na na 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: growth inhibition (%) 
against C. albicans; D: IC50 (ng/mL) against P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
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3.4.3 Malaysian fungi 
 
The quick screening assay of the Malaysian fungi showed that 27 of 58 extracts assayed 
were potentially active (growth inhibition >50%). Of the 27 extracts, 24 showed activity 
only against P388 cells, two were active against both P388 cells and B. subtilis and the 
remaining extract inhibited only the growth of B. subtilis. None of the extracts showed 
activity against P. aeruginosa or C. albicans.  Of the 26 extracts that inhibited the 
growth of P388 cells in the quick screening assay, only 11 showed IC50<12,500 ng/mL. 
The strongest cytotoxic activity was shown by two extracts, namely F6448 and F6451 
(both with IC503,886 ng/mL). The results of bioactivity are shown in Table 3.7. 
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Table 3.7: Bioactivity of Malaysian fungi. 
 
Isolates Media Extracts A B C 
PR1T2 (unidentified) F6401 PYGB 51.3 na 4,938 
PR1T3 (unidentified) F6402 PYGB na na na 
PR1T4 (unidentified) F6403 PYGA na na na 
PR1L3 (unidentified) F6404 PYGB 59.0 na na 
PR2T2 (unidentified) F6406 PYGA 82.4 na 4,126 
PR2T4 (unidentified) F6407 PYGB 74.3 na na 
PR2T10 (unidentified) F6408 PYGB 93.4 na 5,911 
PR2L6 (unidentified) F6409 PYGB 50.4 na na 
PR3T3 (unidentified) F6410 PYGA na na na 
PR3T11 (unidentified) F6411 PYGB na na na 
PR3T12 (Trichoderma sp.) F6412 PYGB 79.9 na 7,512 
PR3T13 (unidentified) F6413 PYGB na na na 
PR3T19 (unidentified) F6414 PYGB 68.9 na na 
PR3L8 (Xylaria sp.) F6415 PYGB 92.0 na 4,004 
PR3L15 (unidentified) F6416 PYGA na na na 
PR3L16 (unidentified) F6417 PYGA na na na 
PR3L17 (unidentified) F6418 PYGB na na na 
PR4T2 (unidentified) F6419 PYGB na na na 
PR4T3 (unidentified) F6420 PYGB na na na 
PR4T4 (unidentified) F6421 PYGB na na na 
PR4T5 (unidentified) F6422 PYGB na na na 
PR4T7 (unidentified) F6423 PYGA 60.3 100.6 na 
PR4T8 (unidentified) F6424 PYGB 64.0 na na 
PR4T9 (unidentified) F6425 PYGB na na na 
PR5T2 (unidentified) F6426 PYGB 78.9 na 12,133 
PR5T3 (unidentified) F6427 PYGA na na na 
PR5T4 (unidentified) F6428 PYGB 53.8 na na 
PR5T6 (unidentified) F6429 PYGB na na na 
PR5L9 (Paecilomyces sp.) F6430 PYGB 66.0 na 10,445 
PR7T2 (unidentified) F6432 PYGA na na na 
PR7T3 (unidentified) F6433 PYGA 58.5 na na 
PR8L5 (unidentified) F6434 PYGA na na na 
PR8L8 (unidentified) F6435 PYGB 62.5 na na 
PR9T5 (unidentified) F6436 PYGA na na na 
PR9L1 (unidentified) F6437 PYGB na na na 
PR10T2 (Paecilomyces sp.) F6439 PYGA 86.8 na 12,881(*) 
PR10T8 (unidentified) F6440 PYGB 66.2 na na 
PR10L10a (unidentified) F6441 PYGA na na na 
PR10L10b (unidentified) F6443 PYGB na na na 
PR11T4 (unidentified) F6444 PYGB 59.9 na 8,726 
PR12T1 (unidentified) F6445 PYGB na na na 
PR13T1 (unidentified) F6446 PYGA 53.6 na na 
PR13T2 (unidentified) F6447 PYGB 55.7 na na 
PR13T2 (unidentified) F6448 PYGA 92.3 na 3,886 
PR13T6 (unidentified) F6449 PYGB na na na 
A: growth inhibition (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: IC50 (ng/mL) against 
P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL; (*) extract F6439 (IC50>12,500 ng/mL) was selected 
due to interesting chemical properties (see Chapter Six – A Malaysian Paecilomyces sp. (PR10T2)). 
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Table 3.7 (cont’d): 
Isolates Media Extracts A B C 
PR14T8 (unidentified) F6450 PYGA na na na 
PR17L2 (unidentified) F6451 PYGB 92.4 na 3,886 
PR17L5 (unidentified) F6452 PYGB na na na 
PP1T2 (unidentified) F6453 PYGB 91.3 na na 
PP1T3 (unidentified) F6454 PYGB na na na 
PP1T4 (unidentified) F6455 PYGB na na na 
PP1T7 (unidentified) F6456 PYGB na na na 
PP2L4 (unidentified) F6457 PYGB 88.2 na 12,500 
PP2L5 (unidentified) F6458 PYGB na na na 
PP4L3 (unidentified) F6459 PYGB na 109.7 na 
PP4L6 (unidentified) F6460 PYGB 93.0 104.6 na 
PP4T1 (unidentified) F6461 PYGA na na na 
PP4T2 (unidentified) F6462 PYGB na na na 
A: growth inhibiton (%) against P388 cells; B: growth inhibition (%) against B. subtilis; C: IC50 (ng/mL) against 
P388 cells; na: growth inhibition <50% or IC50>12,500 ng/mL. 
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3.5 HPLC screening of bioactive extracts 
 
HPLC screening for significant peaks provides a basis for selection of extracts for 
further investigation. The presence of significant amounts of metabolites was indicated 
by both the UV and ELSD traces (>10% of both the base peaks in the HPLC 
chromatogram). The HPLC-ELSD profile was used to indicate the amount of these 
metabolites present in the extract since HPLC-ELSD is generally considered a quasi-
universal detector of the quantity of an analyte in a sample (Higgs et al., 2001). Fungal 
extracts that contained significant peak(s) were further screened to establish if any of 
the peak(s) match in both UV chromophores and retention time (Rt) with known 
compounds within the in-house HPLC-UV/Rt library database. If all significant peaks 
resulted in ‘known hits’, further work on that extract was discontinued. Details of the 
procedures are discussed in Chapter Two (Experimental). 
 
A total of 54 extracts that showed IC50<12,500 ng/mL in the P388 assay or inhibited 
>50% of the growth of B. subtilis or C. albicans in the antimicrobial quick screen assay 
were subjected to HPLC screening. Of the total 54 extracts examined, only eight 
extracts were chosen for further investigation based on good cytotoxicity and significant 
traces of metabolites. An extract (F6439; IC5012,881 ng/mL) was also further 
investigated due to interesting chemical properties. These nine extracts were obtained 
from isolate LA3L2 (see Chapter Five - Secondary metabolites from marine-derived 
Streptomyces sp. (LA3L2)), isolate PR10T2 (see Chapter Six - A Malaysian 
Paecilomyces sp. (PR10T2)), isolates LY1L5 and KK3T23 (see Chapter Four - New 
Zealand Penicillium spp. and Chapter Seven - Application of rapid techniques for 
chemical characterization of metabolites) and isolates LA3L1, KK3T8, KK4T14b, 
LA5L4 and PR5L9 (see Chapter Seven - Application of rapid techniques for chemical 
characterization of metabolites). 
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Some examples of bioactive extracts that were not selected for further study because of 
the presence of known and/or insignificant quantity of metabolites are given below. 
 
Example 1: 
 
Six extracts were not investigated further due to the presence of known metabolites are 
listed in Table 3.8. An example is presented below using the results obtained from 
extract F6451.  
 
 
Table 3.8: Dereplication of metabolites from fungal extracts using the in-house HPLC-
UV/Rt library database. 
 
Metabolites Isolates Extracts (media) 
dihydrosterigmatocystin PR17L2 F6451 (PYGB) 
indole-3-carboxylic acid LY5T9 F5550 (PYGB) , F5914 (PYGA) 
Meleagrine PR2T2 F6406 (PYGA) 
mycophenolic acid KK4L8 F5347 (PYGB), F5872 (PYGA) 
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The HPLC screening of F6451 showed one significant peak eluting at 16.8 min (Figure 
3.2). A search of the HPLC-UV/Rt library database for this peak showed matches in 
both UV chromophores and Rt to the known compound, dihydrosterigmatocystin (see 
Figure 3.3). Since the main significant peak resulted in an exact match with the known 
compound further work was not carried out. 
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Figure 3.2: HPLC chromatogram of F6451 showing overlay of ELSD detection (top) for 
the main peak eluted at 16.8 min. 
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MALAYSIA #52F6451 : Peak #14 16.8 min
-10.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
200 250 300 350 400 450 500 550 595
%
nm
246.7
205.6
324.6
Library Hit: Dihydrosterigmatocystin 999.95
 
Figure 3.3: UV spectrum of the main peak eluted at 16.8 min (black) showing the UV 
library hit (red) with the known dihydrosterigmatocystin in the HPLC-UV/Rt library 
database. 
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Example 2: 
 
Examples of extract that were not chosen due to insignificant traces of metabolites are 
shown by using results obtained from isolates KK3T26 and LA2T4. 
 
a) Isolate KK3T26 (F5891 vs. F5330) 
 
Extracts F5891 and F5330 were obtained from cultures of isolate KK3T26 grown on 
agar medium (PYGA) and broth medium (PYGB), respectively. Both extracts showed 
cytotoxicity but were not active in the antimicrobial assays. Extract F5891 was more 
cytotoxic (IC503,177 ng/mL) than F5330 (IC508,240 ng/mL). HPLC screening showed 
that neither extract F5891 or F5330 produced significant amounts of metabolites as 
indicated by ELSD traces (Figure 3.4). These extracts were not further investigated. 
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Figure 3.4: HPLC chromatogram showing ELSD traces of crude extracts of isolate 
KK3T26 obtained from agar medium (F5891 - bottom) in comparison with broth 
medium (F5330 - top). 
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b) Isolate LA2T4 (F5954) 
 
Extract F5954 (IC505,938 ng/mL) was obtained from cultures of isolate LA2T4 grown 
on agar medium (SCA). HPLC-PDA detected six metabolites with significant UV 
chromophores (see Figure 3.5). The HPLC-ELSD profile indicated that the traces of all 
six metabolites were <10% of the ELSD base peak. Although the UV chromophores of 
these peaks were significant, the HPLC-ELSD profile showed otherwise and this extract 
therefore, was not pursued further. 
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Figure 3.5: HPLC chromatogram of F5954 showing six metabolites as detected by UV 
(top) and ELSD (bottom). The peaks showing traces >10% of the UV base peak but 
none of them showing traces >10% of the ELSD base peak. 
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Example 3: 
 
Some isolates produced similar metabolites when grown on both agar and broth media, 
but differed in the amount of metabolite produced. Extracts that produced greater 
quantitites of metabolites were chosen for further investigation. An example is shown in 
extracts F5956 and F5934 obtained from isolate LA3L1. 
 
a) Isolate LA3L1 (F5956 vs. F5934)   
 
Extracts F5956 and F5934 were obtained from cultures of isolate LA3L1 grown on agar 
medium (SCA) and broth medium (SCB), respectively. Both extracts showed 
significant cytotoxicity (IC50<97.5 ng/mL) and were active against B. subtilis (>99% 
inhibition). HPLC screening showed that extracts F5956 and F5934 produced similar 
metabolites (Figure 3.6). Extract F5956, however, produced larger ELSD traces of 
peaks 1, 2 and 3 compared to F5934. In this case, only F5956 was chosen for further 
investigation. 
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Figure 3.6: HPLC chromatogram showing ELSD traces of crude extracts of isolate 
LA3L1 obtained from agar medium (F5956 - bottom) in comparison with broth medium 
(F5934 - top). 
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3.6 Discussion 
 
This study adopted the isolation technique of Namikoshi et al. (2002) for both the tissue 
and liquid portions of the investigated marine invertebrates. This technique enabled the 
isolation of many isolates of actinomycetes from the tissue portions of four sponges 
(K2, K3, K4 and L2), however, none were isolated from the liquid portions. Two 
isolates were isolated from liquid portions of a tunicate (L3) and none from its tissue 
portions, while the tissue and liquid portions of another sponge (L5) yielded four and 
five isolates, respectively. Many fungi could be isolated from tissue and liquid portions 
of the invertebrates. It is interesting to note that a larger percentage of Penicillia were 
isolated from New Zealand samples than was seen from invertebrates from Malaysia. In 
light of the world-wide distribution of Penicillia it is unlikely that there is a selectivity 
of association from New Zealand samples and a more likely explanation is that of time 
that the samples were in storage before isolation was attempted. In the case of 
Malaysian samples, they were processed immediately after collection but those from 
New Zealand were stored for up to three days at -20ºC which may have acted as a 
selective mechanism. 
 
The results from the quick screen assay showed that of 266 extracts assayed, 146 (55%) 
were potentially active. Of the 146 extracts, 136 (93%) were active only against P388 
cells; seven (5%) against both P388 cells and B. subtilis, one (1%) against both P388 
cells and C. albicans and two (1%) against only B. subtilis. Of the 144 extracts that 
were potentially active in the P388 quick screen assay, only 52 (36%) inhibited 50% of 
the growth of P388 cells at a concentration of <12,500 ng/mL (IC50<12,500 ng/mL). 
None of the extracts assayed inhibited the growth of P. aeruginosa. The actinomycetes 
screened, mostly Streptomyces spp. showed good cytotoxicity. The lack of finding 
bioactivity in some isolates such as Acremonium and Aspergillus is perhaps surprising 
because members of these genera are prolific producers of secondary metabolites, many 
of them cytotoxic (Bugni and Ireland, 2004; Ebel, 2006). 
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HPLC screening showed that some of the extracts obtained from agar and/or broth 
media showed variations in the production of metabolites. The cytotoxicity of New 
Zealand actinomycetes was dominated by extracts that originated from agar culture 
medium - six of eight isolates showed activity only when cultured on SCA medium. Of 
24 New Zealand fungal isolates that produced cytotoxic extracts, nine were active only 
when cultured on PYGA medium, seven were active only when cultured on PYGB 
medium, and the remaining eight isolates were active when cultured on both media. As 
for the Malaysian fungal isolate, only one isolate that was cultured on both media 
showed higher cytotoxicity when cultured on PYGA medium. These observations 
cannot be considered significant since not all Malaysian samples were cultured on both 
PYGA and PYGB media. Differences in solid and liquid media in the production of 
metabolites has been noted by many workers (Espinosa and Webb, 2003; Gonzalez et 
al., 2003) however, solid media is difficult in commercial situations and in nearly all 
cases liquid fermentation is used. 
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Chapter 4 
 
 
New Zealand Penicillium spp. 
 
 
4.1 Introduction 
 
Marine-derived fungi may be defined as these fungi – be they obligate or facultatively 
marine – that are isolated from the marine environment (Kohlmeyer and Kohlmeyer, 
1979). It is not always clear, however, whether all these isolates actually grow in this 
saline environment or are itinerants. For those who are active in the marine world then 
osmoregulatory mechanisms must be in place. Osmoregulation is energetically costly 
and it has been postulated that such fungi exhibit decreased amounts or rate of 
secondary metabolite production in the presence of salt (Bugni and Ireland, 2004). Salt-
dependent strains of marine-derived fungi for metabolite production have been 
described for Penicillium spp. (Bugni and Ireland, 2004). Some studies have indicated 
that production of metabolites from marine-derived fungi is sensitive to seawater 
concentration (Miller and Savard, 1989; Masuma et al., 2001). This would have 
implications in drug discovery programmes using marine-derived organisms. In this 
study, two isolates of marine-derived Penicillium spp. showing cytotoxicity were 
assessed for their tolerance to salinity (0, 2, 4, 6, 8 and 10% sea salt concentration) in 
respect to their growth and cytotoxic metabolite production. 
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4.2 Penicillium sp. (LY1L5) 
 
Penicillium sp. (LY1L5) was isolated from liquid portions of a tunicate collected in 
Lyttleton Harbour in 2004. 
 
 
4.2.1 Cultural characteristics and morphology 
 
Morphological characteristics of isolate LY1L5 are shown in Figure 4.1. Cultures on 
Czapek medium 20 – 25 mm diameter on ten days at 25ºC, mycelium white, reverse 
yellow or brownish. Cultures on PYGA (4% sea salt) medium 30 - 35 mm diameter 
after ten days at 25ºC, mycelium black, reverse greyish. Cultures on PYGA (0% sea 
salt) medium 25 - 30 mm diameter after ten days at 25ºC, mycelium white, reverse 
yellow or brownish. Stipes and metulae with smooth walls, conidiophores with two-
stage-branched, biverticillate on PYGA (4% sea salt) medium. Phialides four to eight 
per metulae, ampulliform, 4.0 – 6.0 x 2.0 – 2.5 µm; conidia spheroidal, spinose, 1.5 – 
2.0 µm diameter, in chains with small connectives between the conidia. 
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Figure 4.1: Colony and morphological characteristics of Penicillium sp. (LY1L5); (a) 
colonies on Czapek medium at 25ºC, 10 days; (b) colonies on PYGA (4% sea salt) 
medium at 25ºC, 30 days; (c) colonies on PYGA (0% sea salt) medium at 25ºC, 30 
days; (d) – (e) SEM of conidiophores and conidia on PYGA (4% sea salt) medium at 
25ºC, 10 days (d) conidiophores; (e) conidia. 
 
(a) 
(d) (e) 
(b) (c) 
2µm* 
2µm* 
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4.2.2 Metabolite profile 
 
Penicillium sp. (LY1L5) produced both cycloaspeptide A (7.4) and α-cyclopiazonic 
acid (7.5) (see Chapter Seven - Application of rapid techniques for chemical 
characterization of metabolites). Its metabolite profile was compared with those 
Penicillium spp. reported to produce cycloaspeptide A (7.4) (five species) and α-
cyclopiazonic acid (7.5) (six species) (see Table 4.1). The comparison showed that none 
of the 11 Penicillium spp. produced both cycloaspeptide A (7.4) and α-cyclopiazonic 
acid (7.5) (Frisvad et al., 2004; Frisvad et al., 2006). 
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Table 4.1: Comparison of secondary metabolite profile of Penicillium sp. (LY1L5) with 
the reported Penicillium spp. producing cycloaspeptide A (7.4) and α-cyclopiazonic 
acid (7.5). 
 
Penicillium spp. cycloaspeptide A (7.4) α-cyclopiazonic acid (7.5) 
Penicillium sp. (LY1L5) + + 
P. jamesonlandense +  
P. ribeum +  
P. lanosum +  
P. soppii +  
P. algidum +  
P. camemberti  + 
P. commune  + 
P. dipodomyicola  + 
P. griseofulvum  + 
P. patulum  + 
P. palitans  + 
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4.3 Penicillium sp. (KK3T23) 
 
Penicillium sp. (KK3T23) was isolated from tissue portions of a sponge collected off 
Kaikoura in 2004. 
 
 
4.3.1 Cultural characteristics and morphology 
 
Morphological characteristics of isolate are shown in Figure 4.2. Cultures on Czapek 
medium 30 – 35 mm diameter on ten days at 25ºC, mycelium greenish yellow, reverse 
pale brown. Cultures on PYGA (4% sea salt) medium 45 - 50 mm diameter on ten days 
at 25ºC, mycelium green, reverse pale brown. Cultures on PYGA (0% sea salt) medium 
35 - 40 mm diameter on ten days at 25ºC, mycelium green, reverse pale brown. Stipes 
bearing terminal penicilli, typically terverticillate on PYGA (4% sea salt) medium. 
Rami one to two per penicillus, 12.0 – 14.0 x 3.0 – 3.5 µm;  metulae 7.5 – 9.0 x 2.5 – 
3.5 µm; phialides four to eight per metulae, ampulliform, 7.0 – 8.0 x 2.0 – 3.0  µm; 
conidia subspheroidal to ellipsoidal, 3.0 – 4.0 x 3.0 – 3.5 µm diameter, with smooth 
walls, borne in irregular chains. 
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Figure 4.2: Colony and morphological characteristics of Penicillium sp. (KK3T23); (a) 
colonies on Czapek medium at 25ºC, 10 days; (b) – (d) SEM of conidiophores and 
conidia on PYGA (4% sea salt) medium at 25ºC, 10 days; (b) conidiophores; (c) 
phialides; (d) conidia. 
 
(a) (b) 
(c) (d) 
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4.3.2 Metabolite profile 
 
Penicillium sp. (KK3T23) produced α-cyclopiazonic acid (7.5), roquefortine A (7.6), 
cyclopeptin (7.7) and viridicatin (7.8) (see Chapter Seven - Application of rapid 
techniques for chemical characterization of metabolites). Its metabolite profile was 
compared with those Penicillium spp. reported to produce α-cyclopiazonic acid (7.5), 
roquefortine A (7.6), cyclopeptin (7.7), viridicatin (7.8) and (see Table 4.2). The 
comparison showed that only P. palitans produced three of the metabolites produced by 
isolate KK3T23; α-cyclopiazonic acid (7.5), cyclopeptin (7.7) and viridicatin (7.8). 
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Table 4.2: Comparison of secondary metabolite profile of Penicillium sp. (KK3T23) 
with the reported Penicillium spp. producing α-cyclopiazonic acid (7.5), roquefortine A 
(7.6), cyclopeptin (7.7) and viridicatin (7.8). 
 
Penicillium spp. Secondary metabolitesa 
 α-cyclopiazonic acid  roquefortine A* cyclopeptin viridicatin 
 (7.5) (7.6) (7.7) (7.8) 
Penicillium sp. (KK3T23) + + + + 
P. camemberti + *   
P. commune + *   
P. dipidomyicola + *   
P. griseofulvum + *   
P. patulum + *   
P. palitans + * + + 
P. albocoremium  * + + 
P. allii  * + + 
P. caseifulvum  * + + 
P. commune  * + + 
P. crustosum  * + + 
P. discolor  * + + 
P. echinulatum  * + + 
P. freii  * + + 
P. hirsutum  * + + 
P. neoechinulatum  * + + 
P. polonicum  * + + 
P. radicicola  * + + 
P. solitum  * + + 
P. tulipae  * + + 
P. venetum  * + + 
P. vulpinum  * + + 
a results obtained from Frisvad et al., 2004; * not reported in Frisvad et al., 2004. 
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4.4 Effect of salinity on growth and production of 
metabolites 
 
The original cultivation conditions (PYGA medium, temperature 25°C, pH 7.0±0.2 and 
4% sea salt) that produced the cytotoxic activity were used as a basis to study the 
response of salinity to growth and production of metabolites in Penicillium sp. (LY1L5) 
and Penicillium sp. (KK3T23). Salinity in this study is expressed as sea salt 
concentration (%) incorporated in the media. A salinity range of 0, 2, 4, 6, 8 and 10% 
(PYGA medium; pH 7.0±0.2) was used. Cultures were incubated at 25°C and the 
colony diameter (three replicates) was measured every 2 days for 30 days. Cultures 
were harvested after 30 days incubation and extracted. The extracts (1 mg/mL) were 
assayed for cytotoxicity against P388 cells and their metabolites production assessed by 
HPLC. The presence of cycloaspeptide A (7.4), α-cyclopiazonic acid (7.5), roquefortine 
A (7.6), cyclopeptin (7.7) and viridicatin (7.8) was confirmed by their UV 
characteristics as described in Chapter Seven (Application of rapid techniques for 
chemical characterization of metabolites). Details of the procedures are described in 
Chapter Two (Experimental). 
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4.4.1 Penicillium sp. (LY1L5) 
 
The growth of Penicillium sp. (LY1L5) was enhanced in the presence of salt (Figure 
4.3), but the growth decreased at 10% salinity. Growth rate declined after 18 – 20 days 
incubation. Cytotoxicity of extracts is shown in Table 4.3. This isolate showed better 
IC50 values at salinity of 4 and 6%, but was not active in the absence of salt. 
 
 
 
Figure 4.3: Effect of salinity on growth of Penicillium sp. (LY1L5) on PYGA medium 
(pH 7.0±0.2; 25°C). 
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Table 4.3: Effect of salinity on cytotoxicity of Penicillium sp. (LY1L5) on PYGA 
medium (pH 7.0±0.2; 25°C; 30 days). 
 
Salinity (%) Cytotoxicity against P388 cells 
 Extracts IC50 (ng/mL) 
0 F5975-A >12,500 
2 F5975-B 7,976 
4 F5975-C 6,664 
6 F5975-D 6,664 
8 F5975-E 7,741 
10 F5975-F 9,837 
 
 
The ELSD traces of all six extracts are shown in Figure 4.4. All extracts showed traces 
of cycloaspeptide A (7.4). Traces of the cytotoxic α-cyclopiazonic acid (7.5) were 
detected only in five active extracts (F5975-B, F5975-C, F5975-D, F5975-E and F5975-
F) but none in the inactive extract (F5975-A). 
 
Chapter 4: New Zealand Penicillium spp. 
_____________________________________________________________________________________ 
 73 
 
mV
15.0 16.0 17.0 18.0
mV
min
500
1,000
1,500
2,000
0
500
1,000
1,500
2,000
0
500
1,000
1,500
2,000
0
mV
mV
mV
500
1,000
1,500
2,000
0
500
1,000
1,500
2,000
0
500
1,000
1,500
2,000
0
mV
15.0 16.0 17.0 18.0
min
F5975-C(4%) F5975-F (10%)
F5975-E (8%)
F5975-D (6%)F5975-A (0%)
F5975-B (2%)
(7.4)
(7.5)
(7.4)
(7.5)
(7.4)
(7.5)
(7.4)
(7.5)
(7.4)
(7.5)
(7.4)
(7.5)
 
Figure 4.4: ELSD traces of cycloaspeptide A (7.4) and α-cyclopiazonic acid (7.5) from 
extracts of Penicillium sp. (LY1L5) cultured on PYGA medium (pH 7.0±0.2; 25°C; 30 
days) at salinity of 0, 2, 4, 6, 8 and 10%. 
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4.4.2 Penicillium sp. (KK3T23) 
 
The growth of Penicillium sp. (KK3T23) was enhanced in the presence of salt (Figure 
4.5) up to a level of 6% but growth decreased at levels higher than this. Growth rate 
declined after 16 – 18 days of incubation. Cytotoxicity of the extracts is shown in Table 
4.4. Maximum salinity was observed at 4% salinity and no activity was recorded at 8 or 
10% salinity. 
 
 
 
Figure 4.5: Effect of salinity on growth of Penicillium sp. (KK3T23) on PYGA medium 
(pH 7.0±0.2; 25°C). 
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Table 4.4: Effect of salinity on cytotoxicity of Penicillium sp. (KK3T23) on PYGA 
medium (pH 7.0±0.2; 25°C; 30 days). 
 
Salinity (%) Cytotoxicity against P388 cells 
 Extracts IC50 (ng/mL) 
0 F5890-A 12,133 
2 F5890-B 10,445 
4 F5890-C 3,177 
6 F5890-D 6,664 
8 F5890-E >12,500 
10 F5890-F >12,500 
 
 
The ELSD traces of all six extracts are shown in Figure 4.6. Four cytotoxic extracts 
(F5890-A, F5890-B, F5890-C and F5890-D) contained traces of the cytotoxic α-
cyclopiazonic acid (7.5). Two extracts F5890-E and F5890-F, that were inactive in the 
P388 assay did not contain α-cyclopiazonic acid (7.5). 
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Figure 4.6: ELSD traces of α-cyclopiazonic acid (7.5), roquefortine A (7.6), cyclopeptin 
(7.7) and viridicatin (7.8) from extracts of Penicillium sp. (KK3T23) cultured on PYGA 
medium (pH 7.0±0.2; 25°C; 30 days) at salinity of 0, 2, 4, 6, 8 and 10%. 
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4.5 Discussion 
 
The effect of salinity on the growth of these two marine-derived Penicillium isolates 
reflects the observations made by Munoz (2006) on two other Penicillium spp. isolated 
from a hypersaline environment. In that study, P. chrysogenum and P. citrinum showed 
that the NaCl concentrations for their growth ranged between 5 – 10%. An algal-derived 
P. dravuni (Janso et al., 2005) also showed greater growth with increasing salinity up to 
a level of 10% NaCl. A study on a sponge-derived isolate of Penicillium sp. showed that 
growth was not affected by seawater concentrations (Masuma et al., 2001). The ability 
of marine-derived fungi to grow in saline conditions has been studied by using different 
concentrations of seawater by Barghoorn (1944), Sguros and Simms (1964) and Jones 
and Jennings (1964); NaCl and artificial sea water by Sguros and Simms (1964). In 
these studies, fungal growth was determined by dry weight measurements except for the 
study by Barghoorn (1944) who utilized colony diameter. These studies were reviewed 
by Jennings (1983) and summarized that the growth of higher marine fungi can be 
optimal at 100% seawater, but more frequently optimal growth is at a lower percentage. 
The results from this study showed that salinity affected the growth of the two 
Penicillum spp., however, a more extensive study needs to be done to obtain more 
comprehensive results because growth may also be dependent upon other parameters 
such as temperature whether or not adaptation by the fungi to salinity has occurred. The 
interacting effects of temperature and salinity on growth of marine fungi have been 
demonstrated by Ritchie (1957). 
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The effect of salinity on bioactivity of marine-derived Penicillium spp. has been 
described by Bugni and Ireland (2004). Three Penicillium spp. exhibited increasing 
antimicrobial activity with increasing concentrations of artificial sea water (Bugni and 
Ireland, 2004). A few studies have been reported on the effect of salinity on bioactivity 
of other marine-derived fungi. Three marine-derived Aspergillus spp. and an 
unidentified marine fungus showed enhanced antibacterial activity in the presence of 
seawater (Masuma et al., 2001). A marine fungus Leptosphaeria oraemaris (Miller and 
Savard, 1989) also showed that antibacterial activity was greatest at higher salinities 
(>22‰) and toxicity of extracts to brine shrimp larvae was greatest at 14, 18 and 22‰. 
These findings were consistent with the results obtained from Penicillium sp. (LY1L5) 
and Penicillium sp. (KK3T23) where the effect of salinity varied between different 
isolates. 
 
Terverticillate Penicillium spp. are common producers of α-cyclopiazonic acid (7.5), 
together with other metabolites such as cyclopeptin (7.7) and viridicatin (7.8) (Frisvad 
et al., 2004). The metabolite profile of isolate KK3T23 correlates well with such 
terverticillate penicilli. Most α-cyclopiazonic acid-producers are terrestrial species such 
as P. camemberti, P. commune, P. dipodomyicola, P. griseofulvum and P. palitans. 
Only P. palitans is recorded as producing α-cyclopiazonic acid (7.5), cyclopeptin (7.7) 
and viridicatin (7.8) (Frisvad et al., 2004) and hence isolate KK3T23 may well be of 
this species especially as this isolate closely matches the morphological description of 
P. palitans as described by Pitt (1979). The marine-derived isolate KK3T23 produced 
similar metabolites to terrestrial isolates. This correlates well with the work of Sonjak et 
al. (2005) on P. crustosum strains isolated from various ecological niches. That study 
showed that metabolite production was consistent irrespective of geographic origin or 
habitat. 
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Cycloaspeptide A (7.4) was first isolated from Aspergillus sp. (Kobayashi et al., 1987) 
and has only been found in five species of psychrotolerant Penicillium, namely P. 
ribeum (Dalsgaard et al., 2004; Frisvad et al., 2006), P. algidum (Dalsgaard et al., 2005) 
and P. jamensonlandense, P. lanosum and P. soppii (Frisvad et al., 2006). It was also 
noted in this study that the ELSD traces of cycloaspeptide A (7.4) in isolate LY1L5 
were more prominent than the cytotoxic α-cyclopiazonic acid (7.5) at all ranges of 
salinity (0 – 10%). The consistency in cycloaspeptide A (7.4) production by this isolate 
was similar to those reported for the cold-tolerant strains of Penicillium. Based on this, 
isolate LY1L5 is suggested to have a closer association with the groups of Penicillium 
that produced cycloaspeptide A (7.4). 
 
Isolate LY1L5 has small, spinose conidia unlike the α-cyclopiazonic acid-producers that 
have bigger, smooth-walled conidia. Similarly isolate LY1L5 could not be matched 
with other cycloaspeptide A (7.4) producing Penicillia. Further work needs to be 
conducted to identify the species of isolate LY1L5. 
Chapter 5: Secondary metabolites from marine-derived Streptomyces sp. (LA3L2) 
_____________________________________________________________________________________ 
 80 
 
 
Chapter 5 
 
 
Secondary metabolites 
from marine-derived 
Streptomyces sp. (LA3L2) 
 
 
5.1 Introduction 
 
The genus Streptomyces is represented in nature by the largest number of species among 
all the genera of actinomycetes and numbers over 500 species. The name Streptomyces 
was introduced in 1943 for the aerial mycelium-producing actinomycetes. Members of 
this genus are Gram-positive filamentous microorganisms found predominantly in soil 
and in decaying vegetation. They are noted for their distinct earthy odour, resulting 
from production of a volatile metabolite, geosmin. Species of Streptomyces exhibit a 
unique morphological differentiation among the prokaryotes by the formation of spores 
on their aerial mycelium, superimposed upon the vegetative growth (Waksman, 1959). 
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5.1.1 Bioactive metabolites from marine-derived 
Streptomyces spp. 
 
The interest in the antibiotics produced by Streptomyces is of long standing. It all began 
with the discovery of actinomycin by Waksman and his colleagues in 1940, followed by 
streptomycin in 1943 and numerous other compounds later. These included grisein and 
neomycin. During the last decade, there has been increasing number of novel 
metabolites possessing potent bioactivity isolated from marine-derived Streptomyces 
(Kelecom, 1999; Kelecom, 2002; Laatsch, 2006; Lam, 2006). Many of them are 
cytotoxic and come from a wide variety of chemical structures such as macrolides, α-
pyrones, lactones, indoles, terpenes and quinones. Table 5.1 lists some selected novel 
bioactive metabolites that have been isolated from marine-derived Streptomyces from 
1996 to 2007. 
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Table 5.1: Bioactive metabolites from marine-derived Streptomyces spp. reported 
during the period 1996 – 2007. 
 
Isolates Metabolites Activities References 
Streptomyces sp. 
(marine sediment) 
wailupamycin A 
3-epi-5-deoxyenterocin 
antibacterial 
 
Sitachitta et al., 1996 
Streptomyces sp. 
(marine sediment) 
 
dihydrophencomycin methyl ester antibacterial Pusecker et al., 1997 
S. halstedii olivaceous 
(marine sediment) 
 
halawanones A and B 
 
antibacterial Ford et al., 1998 
Streptomyces sp. 
(marine sediment) 
 
cyclomarin A antitumour; 
antiflammatory 
Renner et al., 1999 
Streptomyces sp. 
(seawater sample) 
 
watasemycins A and B antibacterial Sasaki et al., 2002 
S. hygroscopicus 
(marine fish,  
Halichoeres bleekeri) 
 
halichoblelide 
 
antitumour Yamada et al., 2002 
Streptomyces sp. 
(marine sediment) 
 
komodoquinone A neuritogenic activity Itoh et al., 2003 
Streptomyces sp. 
(unidentified marine 
invertebrate) 
3,6-disubstituted indole 1 and 2 antitumour Lopez et al., 2003 
Streptomyces sp. 
(marine sediment) 
 
bonactin antibacterial; 
antifungal 
Schumacher et al., 
2003 
S. aureoverticillatus 
(marine sediment) 
 
aureoverticillactam antitumour Mitchell et al., 2004 
Streptomyces sp. 
 
caprolactones antitumour Stritzke et al., 2004 
Streptomyces sp. 
(unidentified marine 
sponge) 
 
dehydroxynocardamine 
desmethylenylnocardamine 
weak inhibition 
against recombinant 
enzyme 
 
Lee et al., 2005 
Streptomyces sp. 
 
chinikomycins A and B antitumour Li et al., 2005 
Streptomyces sp. 
(marine sediment) 
glyciapyrrole A antitumour Macherla et al., 2005 
S. nodosus 
(marine sediment) 
 
lajollamycin antibacterial; 
antitumour 
Manam et al., 2005 
Streptomyces sp. 
(marine sediment) 
 
daryamides A, B and C antitumour Asolkar et al., 2006 
S. corchorusii 
(marine sediment) 
 
resistomycin 
tetracenomycin D 
antitumour, weak 
antibacterial 
Adinarayana et al., 
2006 
Streptomyces sp. 
(marine sediment) 
 
azamerone antitumour Cho et al., 2006 
Streptomyces sp. 
(marine plant, 
Salicornia herbacea) 
 
methylanthraquinone antitumour Huang et al., 2006 
Streptomyces sp. 
(marine sediment) 
 
propylanthraquinone antibacterial Poumale et al., 2006 
Streptomyces sp. 
(marine sediment) 
 
piperazimycins A, B and C 
 
antitumour Miller et al., 2007 
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5.1.2 Pyrrolizidines 
 
Pyrrolizidine alkaloids are a group of compounds that contain nitrogen in a heterocyclic 
ring. Although these metabolites are commonly found in plants (Culvenor, 1980), a 
novel member of the pyrrolizidines was discovered from an Actinosporangium sp. in 
1980 (Doyle et al., 1980; Nettleton et al., 1980). The compound, named bohemamine 
(5.1), was found to have an unusual tricyclic structure reminiscent of the pyrrolizidine 
alkaloids, except for the inconsistency in the substitution pattern. 
 
In recent years, it has been established that Streptomyces spp. are the main producers of 
the bohemamines. A new compound, NP25302 (5.5), was isolated from Streptomyces 
sp. in 2003 (Zhang et al., 2003b), followed by three others, namely bohemamine B 
(5.2), bohemamine C (5.3) and 5-chlorobohemamine C (5.4) which were isolated from a 
marine-derived Streptomyces sp. (Bugni et al., 2006). 
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A revision of the structure of three bicyclic alkaloids (5.6, 5.7 and 5.8) that had been 
isolated from a Streptomyces sp. (Hu et al., 2003) led to three new metabolites (5.9, 
5.10 and 5.11) being described that possessed structures similar to bohemamines 
(Snider et al., 2004). 
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5.1.3 S-methyl benzothioates 
 
A novel antitumor antibiotic, resorthiomycin was produced in a broth culture of S. 
collinus and the unusual structure (5.12) was proposed (Tahara et al., 1990). The 
structure was revised in 1991 (Tahara et al., 1991) and a rare S-methyl benzothioate 
structure (5.13) was proposed in the revision. S. collinus remained the only reported 
producer of this unusual structural type until a comparable structure (5.14) was 
identified from a sclerotium-colonizing isolate of the fungus, Mortierella vinacea 
(Soman et al., 1999). To date, resorthiomycin (5.13) and mortivinacin A (5.14) are the 
only secondary metabolites reported for the S-methyl benzothioate group of metabolites. 
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5.1.4 Streptomyces sp. (LA3L2) 
 
Streptomyces sp. (LA3L2) was obtained from liquid portions of a New Zealand marine 
tunicate, collected at Lyttleton Harbour in May 2004. Extracts were obtained from 
cultures of isolate LA3L2 grown on SCA and SCB media and coded F5958 and F5936, 
respectively. Both extracts were assayed for cytotoxic and antimicrobial activities. 
F5958 exhibited significant cytotoxicity (IC50784 ng/mL) against P388 cells, but was 
not active against B. subtilis, P. aeruginosa and C. albicans. F5936 was not active 
against P388 cells or the microorganisms tested (see Chapter Three – Preliminary 
screening). 
 
This isolate was further investigated because it showed good activity against P388 cells 
(IC50784 ng/mL), but the active metabolites were not significantly produced. For this 
reason, a large scale cultivation of Streptomyces sp. (LA3L2) was carried out to 
generate the production of metabolites. The ability of the CapNMR technique to 
chemical characterization the desired metabolites using the one and two dimensional 
NMR techniques is fully investigated. 
 
Streptomyces sp. (LA3L2) was obtained from the liquid portions of a New Zealand 
marine tunicate, collected at Lyttleton Harbour in May 2004. Extracts were obtained 
from cultures of isolate LA3L2 grown on SCA and SCB media and coded F5958 and 
F5936, respectively. Both extracts were assayed for cytotoxic and antimicrobial 
activities. F5958 exhibited significant cytotoxicity (IC50784 ng/mL) against P388 cells, 
but was not active against B. subtilis, P. aeruginosa and C. albicans. F5936 was not 
active against P388 cells or the microorganisms tested (see Chapter Three – 
Preliminary screening). 
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5.2 Characterization of isolate LA3L2 
 
The isolate appeared as a yellowish colony on SCA medium (see Figure 5.1 (a-b)). The 
isolate was initially identified as Streptomyces sp. based on the characteristic ‘earthy 
odour’ of the culture and on its cultural characteristics. The growth of hyphae was 
initially whitish yellow and then changed to yellow when mature, with the formation of 
white aerial mycelia. The substrate mycelium of this isolate adhered strongly to the 
medium, while the aerial mycelium was thicker than the substrate mycelium. This 
isolate was Gram-positive and grew best in between 20 - 36°C, again an important 
characteristic of the genus Streptomyces. 
 
The identification of isolate LA3L2 as belonging to the genus Streptomyces was further 
supported by SEM microscopic characteristics. Preobrazhenskaia et al. (1959) stated 
that cultures of Streptomyces with a white, yellow, greenish yellow, yellow-gray, pink 
or lilac mycelium have smooth spores. This isolate produced a chain of single celled 
smooth surfaced spores (see Figure 5.1 (c-d)). Details of the procedures for isolation, 
cultivation and identification are given in Chapter Two (Experimental). 
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Figure 5.1 Characterization of a marine-derived Streptomyces sp. (LA3L2); (a) New 
Zealand tunicate; (b) colony on SCA (30 days); (c) chain of single celled spores under 
SEM and (d) smooth-surfaced spores under SEM. 
 
(a) (b) 
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Part A: Pyrrolizidines from F5958 
 
5.3 Investigation of a small-scale extract (F5958) 
 
An aliquot of the crude extract (F5958) was chromatographed on reverse-phase C18 
HPLC using the standard gradient (see Chapter Two - Experimental) revealing three 
main compounds, NAM 5-1, NAM 5-2 and NAM 5-3 appearing at Rt 10.0 – 12.5 min. 
The extract was further assayed to determine the compound(s) responsible for the 
cytotoxicity. The result from the HPLC MTT plate assay (see Chapter Two - 
Experimental) indicated that activity was not due to any of the three main compounds 
(NAM 5-1, NAM 5-2 and NAM 5-3), but correlated with the compounds eluted over the 
period Rt 15.0 – 18.5 min (see Figure 5.2). 
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Figure 5.2: HPLC chromatogram of F5958 showing overlay of ELSD detection (top) for 
compounds NAM 5-1, NAM 5-2 and NAM 5-3. 
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Compounds NAM 5-1, NAM 5-2 and NAM 5-3 were shown to have virtually identical 
UV chromophores, suggesting that they were very closely related in structure (Figure 
5.3). 
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Figure 5.3: UV profile overlay for compounds NAM 5-1, NAM 5-2 and NAM 5-3. 
 
 
Although compounds NAM 5-1, NAM 5-2 and NAM 5-3 were eluted over the inactive 
region, further investigation was carried out to establish the nature of the metabolites. 
The HPLC fractionation of crude extract of F5958 successfully purified compounds 
NAM 5-2 and NAM 5-3, however no suitable amount of compound NAM 5-1 was 
obtained in the attempt. Compounds NAM 5-2 and NAM 5-3 were investigated using 
the CapNMR technique discussed in Sections 5.3.1 and 5.3.2 below. Further attempt to 
investigate the metabolites eluted over the cytotoxic region (Rt 15.0 – 18.5 min) is 
discussed in Section 5.4. 
 
NAM 5-1 
NAM 5-2 
NAM 5-3 
Chapter 5: Secondary metabolites from marine-derived Streptomyces sp. (LA3L2) 
_____________________________________________________________________________________ 
 91 
 
5.3.1 Compound NAM 5-2 
 
The 
1
H NMR spectral data for compound NAM 5-2 obtained with the CapNMR probe 
in CD3OD clearly showed the presence of three singlet methyls at δH 1.37, 1.96 and 2.22 
and a doublet methyl at δH 1.47 (Figure 5.4). 
 
 
ppm1.52.02.53.03.54.04.55.05.56.0  
Figure 5.4: 
1
H NMR spectrum of compound NAM 5-2 in CD3OD obtained from F5958. 
Crosses indicate impurities. 
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This compound was shown to have a molecular mass of 263 Da ([M+H])
+
 (Figure 5.5). 
A search in the AntiMarin database for compounds with four methyl groups (three 
singlets and one doublet) and molecular weight of 261 – 263 Da, revealed nine possible 
structures for compound NAM 5-2. 
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Figure 5.5: ESIMS spectrum of compound NAM 5-2. 
 
 
Eight of the known compounds were excluded due to the presence of methylene protons 
(–CH2-) in their structures, which were not detected in the 
1
H NMR spectrum presented 
in Figure 5.4. Hence, bohemamine (5.1) was the only potential structure for compound 
NAM 5-2.  
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It should be noted that the structure of bohemamine (5.1), first reported in 1980 (Doyle 
et al., 1980) was later renumbered when Bugni and co-workers (2006) isolated the 
known bohemamine (5.1). The numbering of bohemamine (5.1) is presented in Figure 
5.6. 
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Figure 5.6: Numbering of bohemamine (5.1): (a) from Doyle et al. (1980); (b) from 
Bugni et al. (2006). 
 
 
The proton chemical shifts of compound NAM 5-2 were consistent with bohemamine 
(5.1) based on the comparison of its 
1
H NMR data (Table 5.2) to those reported for 
bohemamine (5.1) in CDCl3 (Doyle et al., 1980) and in DMSO-d6 (Bugni et al., 2006). 
The structure of compound NAM 5-2, was thus assigned as bohemamine (5.1). 
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Table 5.2: Comparison of 
1
H NMR data of compounds NAM 5-2 and (5.1). 
 
δ 1H, ppm multiplicity (JHH Hz) Position
 a 
NAM 5-2b 5.1c 5.1d 
1    
2 5.58, s 5.67, s 5.34, s 
3    
4 3.89, q (6.6) 3.87, q (~7) 3.80, br, q (6.7) 
5 3.61, d (3.0)  3.58, q 3.73, br, d (3.4) 
 3.71, d (3.0)   
6 3.72, d (3.0)  3.60, d (3.4) 
7    
8 1.37, s 1.38, s 1.20, s 
9 1.47, d (6.8) 1.57, d (~7) 1.35, d (6.7) 
1'    
2' 5.85, s 5.88, br, s 5.90, dq (1.3, 1.0) 
3'    
4' 1.96, s 1.94, d (~1) 1.87, d (1.0) 
5' 2.22, s 2.28, d (~1) 2.12, d (1.3) 
NH  9.2, br, s 10.10, br, s 
a These positions were renumbered (Bugni et al., 2006); b These data were recorded at 500 MHz using CD3OD; 
c These data were recorded using CDCl3 (Doyle et al., 1980); 
d These data were recorded using DMSO-d6 (Bugni et 
al., 2006). 
 
 
5.3.2 Compound NAM 5-3 
 
Based on the similarity of their UV chromophores, NAM 5-3 was closely related in 
structure to compound NAM 5-2 (see Figure 5.3). The structural feature of compound 
NAM 5-2 (5.1) was then used as a basis to identify compound NAM 5-3. Compound 
NAM 5-3 had a molecular mass of 265 Da ([M+H])
+
. A search in the AntiMarin 
database using the molecular weight of 263 – 265 Da led to two known bohemamines, 
namely bohemamine B (5.2) and bohemamine C (5.3).  
 
 
N
NHO
O
OH
N
NHO
O
OH
(5.2) (5.3)
11
2 2
3 3
4 4
55
6 6
77
8 8
99
1' 1'
2' 2'
3' 3'
4' 4'
5' 5'
 
 
Chapter 5: Secondary metabolites from marine-derived Streptomyces sp. (LA3L2) 
_____________________________________________________________________________________ 
 95 
 
Both compounds (5.2 and 5.3) were reported as having similar UV spectral data to 
compound NAM 5-3, therefore the investigation using the 
1
H NMR data was necessary. 
The 
1
H NMR spectrum of compound NAM 5-3 (Figure 5.7) indicated almost identical 
methyl signals at δ 1.31, 1.95 and 2.21, and almost similar signals of vinyl protons at δ 
5.77 and 5.94, to those observed in Figure 5.4 for compound NAM 5-2. There were 
dissimilarities in the chemical shifts for a doublet methyl (δ 1.07) and methine protons 
(δ 4.0 and 4.6) for compound NAM 5-3 compared to those of compound NAM 5-2. 
These variations were likely due to the presence of two additional hydrogen atoms in 
compound NAM 5-3 in comparison to compound NAM 5-2.  
 
 
ppm1.52.02.53.03.54.04.55.05.56.0  
Figure 5.7: 
1
H NMR spectrum of compound NAM 5-3 in CD3OD obtained from F5958. 
Crosses indicate impurities. 
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The 
1
H NMR data of compound NAM 5-3 were compared to those reported for 
bohemamines B (5.2) and C (5.3) (Bugni et al., 2006). The results are shown in Table 
5.3. It was deduced from Table 5.3 that the data of compound NAM 5-3 were more 
comparable to bohemamine B (5.2) than to those reported for bohemamine C (5.3). 
Variations in the values were recognized, however this was expected since the chemical 
shifts of compound NAM 5-3 were referenced against a different solvent peak to those 
of bohemamine B (5.2). Based on these data, compound NAM 5-3 was identified as 
bohemamine B (5.2). 
 
 
Table 5.3: Comparison of 
1
H NMR data of compounds NAM 5-3 to those reported for 
compounds 5.2 and 5.3. 
 
δ1H, ppm multiplicity (JHH Hz) Position 
NAM 5-3a 5.2b 5.3b 
1    
2 5.77, s 5.56, s 5.40, s 
3    
4 4.0, t (6.5, 6.4) 3.86, dq (6.5, 6.4) 3.92, dq (6.7, 8.7) 
5 4.6, dddd (10.0, 5.6, 6.4, 3.8) 4.44 dddd (10.1, 5.9, 6.4, 
3.5) 
α 1.75, d (13.2) 
β 2.57, ddd (13.2, 8.7, 3.9) 6 1.75, dd (11.9, 10.0) α 1.55, dd (12.2, 10.1) 3.84, t (3.9) 
 1.90, dd (11.9, 5.6) β 1.69, dd (12.2, 5.9)  
7    
8 1.31, s 1.13, s 1.07, s 
9 1.07, d (6.6) 0.90, d (6.5) 1.25, d (6.7) 
1'    
2' 5.94, br, s 5.98, dq (1.0, 0.9) 5.98, br, s 
3'    
4' 1.95, s 1.88, d (0.9) 1.88, br, s 
5' 2.21, s 2.12, d (1.0) 2.12, br, s 
NH - 10.24, br, s 10.24, br, s 
OH - 4.82, d (3.5) 4.92,  d (3.5) 
a These data were recorded at 500 MHz in CD3OD;  
b These data were recorded at 500 MHz in DMSO-d6 (Bugni et 
al., 2006). 
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Part B: A new S-methyl benzothioate from F5958-A 
 
5.4 Investigation of a large scale extract (F5958-A) 
 
As the small scale extract (F5958) produced only small amount of metabolites over the 
cytotoxic region (Rt 15.0 – 18.5 min), the isolate was re-grown on a large scale to 
generate the production of the desired metabolites. Extraction of 60 plates yielded a 
dark brown crude extract (45.7 mg) coded F5958-A. The bioactivity of F5958-A was 
compared to that of the small scale extract (F5958). P388 assay showed that F5958-A 
possessed greater cytotoxicity (IC50383 ng/mL) than F5958 (IC50784 ng/mL). An 
aliquot of F5958-A was screened by HPLC and the chromatogram showed that it 
contained three main compounds; namely NAM 5-1, NAM 5-2 and NAM 5-4 (see 
Figure 5.8). 
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Figure 5.8: HPLC chromatograms of F5958-A showing overlay of ELSD detection 
(top) for compounds NAM 5-1, NAM 5-2 and NAM 5-4. 
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From these three peaks, only two (NAM 5-1 and NAM 5-2) were in common with those 
for F5958 based on the UV spectra. Compound NAM 5-3 was no longer present in this 
F5958-A extract. Peak NAM 5-4 was an additional compound eluted at 15.5 min to 
those produced by F5958. The UV spectra of compounds NAM 5-1, NAM 5-2 and 
NAM 5-4 are shown in Figure 5.9. 
 
It was interesting to note that the HPLC MTT plate assay of F5958 showed that the 
cytotoxic region was detected over the region 15.0 – 18.5 min. As there was a 
practicable amount of compound NAM 5-4 produced in the cytotoxic region, an attempt 
was made to isolate and identify this compound and establish if this was a new 
metabolite. 
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Figure 5.9: UV profile overlay for compounds NAM 5-1, NAM 5-2 and NAM 5-4 from 
F5958-A. 
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5.4.1 Isolation and purification of compound NAM 5-4 
 
F5958-A was fractionated to isolate the three compounds NAM 5-1, NAM 5-2 and 
NAM 5-4. The extract was initially defatted with petroleum ether (Pet. Ether) yielding 
21.6 mg of Pet. Ether layer (Fraction 1) and further partitioning with H2O and EtOAc 
(1:1) resulted in 1.4 mg H2O layer (Fraction 2) and 22.7 mg EtOAc layer (Fraction 3). 
Fraction 3 was further chromatographed on HPLC to obtain pure compounds NAM 5-1 
and NAM 5-2 and a sub-fraction 3a (see Figure 5.10). 
 
An aliquot of sub-fraction 3a was injected on to the HPLC and the fractions were 
collected into a microtitre plate (Figure 5.11). The pure compound NAM 5-4 was 
obtained from well F10 of the microtitre plate and analyzed using the CapNMR 
technique. Details of the experimental are shown in Chapter Two (Experimental). 
Further work to elucidate the structure of compound NAM 5-4 is discussed in the 
following sections. No further work was carried out on compound NAM 5-1 due to 
insufficient 
1
H NMR spectral data. 
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Figure 5.10: Isolation and purification of compound NAM 5-4 from F5958-A. 
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Figure 5.11: HPLC chromatogram of F5958-A (sub-fraction 3a) showing the main 
compound NAM 5-4 collected into well F10 of the microtitre plate (from 1 x 750 µg 
injection). 
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5.4.2 Structural elucidation of NAM 5-4 
 
Compound NAM 5-4 was obtained from HPLC fractionation of sub-fraction 3a. The 
first attempt at purification yielded an almost pure compound (4 µg) as the 
1
H NMR 
spectrum displayed sharp and well defined signals in (Figure 5.12). The spectrum 
indicated the presence of three singlet methyls at δH 2.07, 2.18 and 2.41 and an 
isopropyl group, represented by two doublets at δH 1.29 and to a multiplet methine 
group at δH 3.1. 
 
 
ppm1.52.02.53.03.54.04.55.0  
Figure 5.12: 
1
H NMR spectrum of NAM 5-4 in CD3OD obtained from first HPLC MTT 
purification. Crosses indicate impurities. 
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ESIMS data for this compound (see Figure 5.13) indicated that the mass to be 255 Da 
([M+H]
+
). A search in AntiMarin database using the spectral data from 
1
H NMR and 
ESIMS resulted in no hits for any compounds within the database. 
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Figure 5.13: ESIMS spectrum of compound NAM 5-4. 
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As the amount of pure compound obtained was relatively low for further analysis, more 
of sub-fraction 3a was purified to collect more material. Sub-fraction 3a (2 x 500 µg) 
was injected into the HPLC to collect approximately 20 µg of pure material using the 
microtitre plate. Even though some minor impurities were still present (as illustrated in 
the 
1
H NMR spectrum (Figure 5.14)), HMBC and HSQC DEPT experiments were 
performed and the results were sufficient to elucidate the structure of NAM 5-4. 
 
 
ppm1.01.52.02.53.03.54.04.55.0  
Figure 5.14: 
1
H NMR spectrum of compound NAM 5-4 in CD3OD obtained from 
second HPLC MTT purification. Crosses indicate impurities. 
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From the HSQC DEPT spectrum (Figure 5.15), the chemical shifts of the protons at δ 
1.29, 2.07, 2.18 and 2.41 were correlated with the chemical shifts of their directly 
bonded carbons (
1
JCH couplings). 
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Figure 5.15: HSQC DEPT experiment of compound NAM 5-4. Crosses indicate 
impurities. 
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The HMBC spectrum clearly illustrated the presence of a hexasubstituted benzenoid 
system (Figure 5.16). The position of one aryl methyl group at δ 2.07 was established 
by strong HMBC correlations with two oxygen-bearing carbons (C-2, δ 149.2 and C-4, 
δ 155.5) and with one higher field carbon (C-3, δ 110.2), thus placing this group 
between two oxygenated aromatic carbons. The position of the other aryl methyl group 
was further established by strong HMBC connections of the signal at δ 2.18 with one 
oxygen-bearing carbon (C-4, δ 155.5) and two carbons (C5, δ 115.5 and C-6, δ 139.9). 
One of the two remaining aromatic carbons was substituted by an isopropyl group, 
proved by a long-range correlation of two methyl groups (δ 1.29) with the carbon (C-6, 
δ 139.9), leaving the C-1 position to be substituted by the carbonyl group (C-7, δ 198.4), 
which had a long-range HMBC correlation to the methyl group (δ 2.41). The long range 
couplings of this compound are shown schematically in Figure 5.17. 
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Figure 5.16: HMBC spectrum of compound NAM 5-4. Crosses indicate impurities. 
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Figure 5.17: HMBC correlations of compound NAM 5-4. 
 
 
The positions of the isopropyl and the carbonyl group were further confirmed by NOE 
experiment (Figures 5.18 (a) – (e)). When the methine proton CH (δ 3.1, m) and methyl 
proton CH3 (δ 2.18, s) signals were irradiated, the signal of CH3 (δ 1.29, d) was 
enhanced (Figures 5.18 (c) and (e), respectively). Irradiation of the methyl proton CH3 
(δ 1.29, d) enhanced the methine proton CH (δ 3.1, m) and methyl proton CH3 (δ 2.18, 
s) signals (Figure 5.18 (a)). No signals were enhanced when the two methyl groups CH3 
(δ 2.07, s) and CH3 (δ 2.41, s) were irradiated and these are shown in Figures 5.18 (b) 
and (d), respectively. These data from NOE experiment confirmed the relationship 
between the methine group (C-10, δ 31.6) and the two methyls (C-11, δ 20.7; C-12; δ 
20.7) and the attachment overall of the isopropyl group at C-6 (δ 139.9). 
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Figures 5.18: 1D NOE NMR spectra for compound NAM 5-4 showing:  
(a) Irradiation of CH3 (δ 1.29, d) signal, enhanced CH (δ 3.1, m) and CH3 (δ 2.18, s) 
signals; 
(b) Irradiation of CH3 (δ 2.07, s), no signals were enhanced; 
(c) Irradiation of CH3 (δ 2.18, s), enhanced CH3 (δ 1.29, d) signal; 
(d) Irradiation of CH3 (δ 2.41, s), no signals were enhanced and; 
(e) Irradiation of CH (δ 3.1, m) and CH3 (δ 2.18, s) signals, enhanced CH3 (δ 1.29, d) 
signal. 
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As previously stated, the mass of this compound was 255 Da ([M+H]
+
). The ESIMS 
spectrum presented in Figure 5.13 also indicated the presence of an ion at m/z 207, 
which corresponded to the loss of 47 mass unit ([M-SCH3]
+
), thus a methyl thiol group 
was proposed. Confirmation of this group was supported by the HRESIMS
+
 spectrum, 
which corresponded to a molecular formula of C13H19O3S. The HRESIMS
+
 of 
compound NAM 5-4 was recorded as 255.1043 Da and the calculated mass for 
C13H19O3S was 255.1055 Da (∆ = of -4.7 ppm). 
 
At this point, the 
1
H and 
13
C chemical shifts for the proposed methyl thiol group of 
compound NAM 5-4 were compared with those for the two reported S-methyl 
benzothiates (5.13 and 5.14). Table 5.4 shows that chemical shifts of the methyl thiol 
group of compound NAM 5-4 were typical of compounds 5.13 (Tahara et al., 1991) and 
5.14 (Soman et al., 1999). These data confirmed that the methyl thiol group (C-13, δ 
11.4) was attached at the C-7 (δ 198.4).  
 
 
Table 5.4: Comparison of 
1
H NMR and 
13
C NMR data for methyl thiol group of 
compounds NAM 5-4, 5.13 and 5.14. 
 
NAM 5-4a 5.13b 5.14c 
δH δC δH δC δH δC 
2.41, s 11.4 2.45, s 13.1 2.46, s 13.1 
 
- 198.4 - 198.2 - 198.3 
a These data were recorded using CD3OD; 
b These data were recorded using CDCl3 (Tahara et al., 1991); 
c These data 
were recorded using CDCl3 (Soman et al., 1999). 
 
CH3-S-C=O 
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A complete list of NMR spectral data for NAM 5-4 is presented in Table 5.5. As there 
were no absolute matches for this structure found, the designated compound NAM 5-4 
was therefore considered a new structure and named S-methyl 2,4-dihydroxy-6-
isopropyl-3,5-dimethylbenzothioate (5.15).  
 
 
Table 5.5: NMR data of compound NAM 5-4.  
 
Position δ 13C, ppm  δ 1H, ppm multiplicity (JHH Hz) 
1 122.2 (C)  
2 149.2 (C)  
3 110.2 (C)  
4 155.5 (C)  
5 115.5 (C)  
6 139.9 (C)  
7 198.4 (C)  
8 7.2 (CH3) 2.07, s 
9 12.1 (CH3) 2.18, s 
10 31.6 (CH) 3.1, m 
11 20.7 (CH3) 1.29, d (7.2) 
12 20.7 (CH3) 1.29, d (7.2) 
13 11.4 (CH3) 2.41, s 
 
 
 
 
 
S
OOH
HO
(5.15)
13
4
5
6
2 7
8
9 12
11
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Part C: Phenolic carboxylic acid derivatives from 
F7089 
 
 
5.5 Investigation of a large scale extract (F7089) 
 
The second large scale extraction was carried out during the investigation of F5958-A 
as an attempt to obtain more of the metabolites in the cytotoxic region (15.0 – 18.5 
min). The extraction of 118 plates gave a dark brown crude extract (99.8 mg) which re-
named F7089. Bioactivity of F7089 was compared to that of the other two extracts 
(F5958 and F5958-A). The P388 assay showed that F7089 possessed slightly higher 
cytotoxicity (IC50606 ng/mL), compared to F5958 (IC50784 ng/mL), but lower than that 
for F5958-A (IC50383 ng/mL). 
 
The HPLC screening of extract F7089 showed that the attempt to obtain more of the 
desired metabolites within the cytotoxic region (15.0 – 18.5 min) from extract F7089 
had been unsuccessful. The screening revealed three main compounds, NAM 5-2, NAM 
5-5 and NAM 5-6 which were eluted over 8.0 – 12.5 min (Figure 5.19). The UV spectra 
of compounds NAM 5-2, NAM 5-5 and NAM 5-6 are shown in Figure 5.20. Based on 
these UV spectra, compound NAM 5-2 was in common with those of extracts F5958 
and F5958-A as discussed in Sections 5.3 and 5.4. Compound NAM 5-2 was identified 
as bohemamine (5.1) (see Section 5.3). Compounds NAM 5-5 and NAM 5-6, however 
were additional compounds to those produced by F5958 (see Figure 5.2) and F5958-A 
(see Figure 5.8). Although compounds NAM 5-5 and NAM 5-6 were eluted over the 
inactive region, these compounds were further analyzed to establish the nature of the 
metabolite. Further investigation into compounds NAM 5-5 and NAM 5-6 is discussed 
below.  
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Figure 5.19: HPLC chromatogram of extract F7089 showing overlay of ELSD detection 
(top) for compounds NAM 5-2, NAM 5-5 and NAM 5-6. 
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Figure 5.20: UV spectra overlay of compounds NAM 5-2, NAM 5-5 and NAM 5-6. 
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5.5.1 Isolation and purification of compounds NAM 5-5 and 
NAM 5-6 
 
The crude extract F7089 (3 x 250 µg) was injected onto the HPLC and compounds 
NAM 5-5 and NAM 5-6 were collected into microtitre plates (see Figure 5.21). Both 
compounds were analyzed with the CapNMR technique and the structural elucidation is 
discussed below. 
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Figure 5.21: HPLC chromatogram of F7089 showing compounds NAM 5-5 and NAM 
5-6 collected into wells of the HPLC microtitre plate. 
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5.5.2 Structural elucidation of NAM 5-5 
 
An amount calculated to be approximately 8 µg of compound NAM 5-5 was analyzed 
by the CapNMR technique. The 
1
H NMR spectrum (see Figure 5.22) revealed one 
singlet methyl (δH 2.53) and two aromatic protons at δH 6.15 and 6.22. 
 
 
ppm1.52.02.53.03.54.04.55.05.56.06.5  
Figure 5.22: 
1
H NMR spectrum of compound NAM 5-5 in CD3OD obtained from 
F7089. Crosses indicate impurities. 
 
 
The positive ion ESIMS (see Figure 5.23) suggested that the smaller signal at 273 Da 
was the parent ion ([M+H]), consistent with the main signal at 295 Da being the 
([M+Na]) ion. The other peak that could be the parent ion ([M+H]) was 391 Da, which 
correlated well with a ([M+Na]) signal at 423 Da. None of the signals in the negative 
ion ESIMS could be rationalized as a parent ion, therefore the mass ([M+H]) of 
compound NAM 5-5 could possibly be 273 or 391 Da. 
 
x 
x 
x x 
x 
x 
solvent 
solvent 
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Figure 5.23: ESIMS spectrum of compound NAM 5-5. 
 
 
A search in the AntiMarin database using the 
1
H NMR and MS spectral data (one 
singlet methyl and molecular mass of 271 – 273 Da) resulted in ten hits. The meta-
coupling pattern of the aromatic protons (δH 6.15 and 6.22) and the presence of the 
aromatic methyl in compound NAM 5-5 excluded nine of the ten known compound (see 
Figure 5.24). None of the nine hits obtained from the other search using the molecular 
mass of 389 – 391 Da matched with the 
1
H NMR features of compound NAM 5-5. 
 
[M+H]+ 
[M+Na]+ [M+H]
+ 
[M+Na]+ 
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Figure 5.24: Screenshot of AntiMarin database search result for compound NAM 5-5 
using the 
1
H NMR and MS spectral data showing the hit with montagnetol (5.16). 
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The search showed that montagnetol (5.16) was the only possible known structure for 
compound NAM 5-5. This mono-aryl compound (5.16) was first isolated from the 
Indian lichen Rocella montagnei (Rao et al., 1941; Rao et al., 1942a; Rao et al., 1942b). 
This compound (5.16) was also reported from another lichen, Ramalina hierrensis 
(Gonzalez et al., 1992) where the structure of montagnetol (5.16) was deduced based on 
the 
1
H NMR spectral data of montagnetol penta acetate (5.17) that was obtained after 
the acetylation of montagnetol (5.16). 
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The UV absorption of montagnetol (5.16) (Culberson, 1969) fits with that observed for 
compound NAM 5-5, however no publication on NMR spectral data for montagnetol 
(5.16) was available for comparison with the NMR data of compound NAM 5-5. 
Compound NAM 5-5 was then further analyzed with COSY, HSQC and HMBC 
experiments to give the complete characterization of this structure. These spectra are 
shown in Figures 5.25, 5.26 and 5.27, respectively. 
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Figure 5.25: COSY spectrum of compound NAM 5-5. 
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Figure 5.26: HSQC DEPT spectrum of compound NAM 5-5. 
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Figure 5.27: HMBC spectrum of compound NAM 5-5. 
 
 
The meta-coupled aromatic protons at δH 6.15 and 6.22 were attached to carbons at δC 
100.9 and 111.5, respectively (see Figure 5.26). The proton at δH 6.22 showed COSY 
correlation with the methyl protons at δH 2.53 and a long range correlation to the carbon 
at δC 104.8. The chemical shifts of three of the aromatic carbons (δC 100.9, 111.5 and 
104.8) indicated the typical influence of phenolic groups. As the first two carbons (δC 
100.9 and 111.5) were in ortho or para-relationship, the position of the third aromatic 
carbon (δC 104.8) could be deduced. Further, the position of the methyl group (δH 2.53; 
δC 23.8) was established by its strong 
3
JCH correlations with the aromatic carbons at δC 
111.5 and 104.8 and a 
2
JCH correlation with the carbon at δC 143.9. 
 
δC 143.9 δC 111.5 δC 104.8 
δC 104.8 
δC 70.1 
δC 73.1 
δC 171.8 
δC 70.1 
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The presence of two -CH2- groups in compound NAM 5-5 was indicated by the COSY 
and HSQC correlations. These were the protons at δH 3.64 and 3.79, both coupled to 
each other and attached to the same carbon at δC 63.7 and another two protons at δH 4.39 
and 4.58 that were coupled to each other and both attached to the carbon at δC 67.1. The 
proton at δH 3.89 (δC 70.1) was coupled to both protons of the CH2 group (δH 4.39 and 
4.58) and to one proton at δH 3.64 (δC 73.1). This proton (δH 3.64; δC 73.1) in turn was 
coupled to both protons of the other CH2 group (δH 3.64 and 3.79). Long range coupling 
was shown by one of the CH2 proton (δH 3.64) to the carbons at δC 70.1 and 73.1. The 
HMBC spectrum also revealed the correlations of the other CH2 proton (δH 4.39) to the 
carbons at δC 70.1 and to the carbon at δC 171.8. The chemical shifts of the carbons 
observed from the 
1
JCH correlations indicated the presence of four oxygenated carbons 
at δC 63.7, 67.1, 70.1 and 73.1. Since the CH2 carbon (δC 67.1) was suggested to be 
oxygenated and had two protons (δH 4.39 and 4.58) attached to it, the long range 
correlation of the proton at δH 4.39 to the carbon at δC 171.8 had to be a 
3
JCH correlation, 
thus confirming the position of the carbon at δC 171.8. Based on these data, two 
fragments of the structure of compound NAM 5-5 were suggested as illustrated in 
Figures 5.28 (a) and (b). 
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Figures 5.28 (a) and (b): Two fragments of compound NAM 5-5 deduced from COSY, 
HSQC and HMBC correlations.  
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In the first fragment presented in Figure 5.28 (a), the chemical shift of the methyl group 
at δH 2.53 suggested that the methyl group was in a peri-position with respect to the 
carbonyl group. Therefore, the carbonyl group (δC 171.8) had to be adjacent to the 
aromatic carbon at δC 104.8. Based on the assumption that all three oxygenated carbons 
(δC 63.7, 70.1 and 73.1) in the second fragment (Figure 5.28 (b)) were attached to 
hydroxyl, the structure of compound NAM 5-5 fits with those reported for montagnetol 
(5.16). 
 
The ACD/Labs prediction software was then used to simulate the 
1
H and 
13
C NMR 
chemical shifts of montagnetol (5.16) for comparison with the experimental data 
obtained for compound NAM 5-5 (see Table 5.6). The comparison showed that the 
calculated data for montagnetol (5.16) and compound NAM 5-5 were almost identical, 
suggesting that compound NAM 5-5 was indeed montagnetol (5.16). 
 
 
Table 5.6: Comparison of 
1
H and 
13
C NMR data of compound NAM 5-5 and of the 
simulated values of montagnetol (5.16). 
 
Position NAM 5-5 b 5.16a 
 δH δC δH δC 
1 (-C=O)  171.8  171.2 
2  104.8  104.9 
3 (-OH)    165.9 
4 6.15 100.9 6.15 102.5 
5 (-OH)    161.5 
6 6.22 111.5 6.19 112.0 
7  143.9  144.9 
8 2.53 23.8 2.48 24.7 
1' 4.39; 4.58 67.1 4.35; 4.49 65.4 
2' 3.89 70.1 4.45 70.4 
3' 3.64 73.1 3.62 72.9 
4' 3.64; 3.79 63.7 3.62; 3.76 62.8 
a
 These data were simulated by ACD/Labs software, version 10; 
b
 These data were recorded at 500 MHz 
in CD3OD. 
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5.5.3 Structural elucidation of NAM 5-6 
 
The 
1
H NMR spectrum of compound NAM 5-6 (Figure 5.29) indicated identical proton 
signals at δH 2.5 – 6.5 to those of compound NAM 5-5 (see Figure 5.22). Based on the 
integrals, compound NAM 5-6 contained an additional methyl group at δH 2.57 and 
additional two aromatic protons at δH 6.67, compared to those of compound NAM 5-5 
(see Figure 5.22). The structural features of compound NAM 5-5 (5.16) were then used 
as a basis to identify compound NAM 5-6. 
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Figure 5.29: 
1
H NMR spectrum of compound NAM 5-6 in CD3OD obtained from 
F7089. Crosses indicate impurities. 
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Compound NAM 5-6 was shown to have a molecular weight of 421.81 Da based on the 
presence of ion signal at 420.81 Da ([M-H])
-
 (see Figure 5.30). 
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Figure 5.30: ESIMS spectrum (negative ionization) of compound NAM 5-6. 
 
 
A search in the AntiMarin database using the molecular weight of 421 – 423 Da and 
two methyl groups led to four hits. These were erythrin (5.18), ochrindole-D (5.19), 
anthracophyllin (5.20) and thaxtomin B (5.21). Based on the structural features of 
compound NAM 5-5 assigned as montagnetol (5.16), erythrin (5.18) was found to be 
the only possible structure for compound NAM 5-6. The UV absorption of erythrin 
(5.18) was reported having UV (MeOH), λmax (log ε) mµ: 269 (4.0) and 303 (4.3) 
(Culberson, 1969). This data was almost identical to those observed for compound 
NAM 5-6 as presented in Figure 5.20. 
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Erythrin (5.18), like montagnetol (5.16) was also isolated from the Indian lichen Rocella 
montagnei in the 1940s (Rao et al., 1942b). Erythrin (5.18) was then reported from 
other lichens, Opegrapha platycarpa (Huneck et al., 1968a) and Dirina spp. (Huneck et 
al., 1968b). As there was no published NMR spectral data for erythrin (5.18), COSY 
and HSQC experiments were performed to allow structural elucidation of compound 
NAM 5-6. The COSY and HSQC spectra are shown in Figures 5.31 and 5.32, 
respectively. 
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Figure 5.31: COSY spectrum of compound NAM 5-6. 
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Figure 5.32: HSQC DEPT spectrum of compound NAM 5-6. 
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The data for compound NAM 5-6 were compared with that of compound NAM 5-5 
(5.16) and the ACD/Labs software simulation for erythrin (5.18) (see Table 5.7). The 
1
H 
and 
13
C NMR data of compound NAM 5-6 at position C-1', C-2', C-3' and C-4' were 
consistent with compound NAM 5-5 (5.16) and the calculated value for erythrin (5.18). 
The comparison between the experimental data for compound NAM 5-6 showed that 
the calculated data for erythrin (5.18) were almost identical, leading to the assignment 
of compound NAM 5-6 as erythrin (5.18). 
 
 
Table 5.7: Comparison of 
1
H and 
13
C NMR data of compound NAM 5-6, compound 
NAM 5-5 and the simulated values of erythrin (5.18). 
 
Position NAM 5-6 a NAM 5-5 a 5.18b 
 δH δC δH δC δH δC 
4 6.67 107.9 6.15 100.9 6.79 107.75 
6 6.67 107.9 6.22 111.5 6.56 113.70 
8 2.57 23.1 2.53 23.8 2.77 24.27 
1' 4.45; 4.65 67.2 4.39; 4.58 67.1 4.35; 4.49 68.40 
2' 3.91 69.8 3.89 70.1 4.45 70.40 
3' 3.65 72.1 3.64 73.1 3.62 73.11 
4' 3.65; 3.79 62.3 3.64; 3.79 63.7 3.62; 3.76 64.40 
8' 6.23 100.6 na na 6.27 112.80 
10' 6.30 111.6 na na 6.21 101.7 
12' 2.57 21.8 na na 2.48 24.27 
a These data were recorded at 500 MHz in CD3OD; 
b These data were simulated by ACD/Labs software, version 10; 
na: not applicable. 
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Part D: Effect of temperature and salinity on growth 
and cytotoxicity of Streptomyces sp. (LA3L2) 
 
5.6 Initial screening 
 
The cultivation conditions of Streptomyces sp. (LA3L2) used for preliminary screening 
(SCA medium, pH 7.0±0.2; 4% salinity) were used as a basis to determine its optimum 
temperature for growth. Growth as colony diameter was measured at 0, 7, 10, 17, 20, 
24, 28, 32, 36, 40, 44 and 50°C every two days for 30 days. Details of the procedures 
are given in Chapter Two (Experimental). 
 
The growth of Streptomyces sp. (LA3L2) after 10, 20 and 30 days incubation is shown 
in Figure 5.33. Growth occurred between 10 and 40°C with an optimum of 32 – 36°C. 
No growth was observed at 0, 7 or at 45°C and above. An experiment to investigate the 
interaction of temperature and salinity on growth was conducted at five temperatures 
(20, 24, 28, 32 and 36°C) where reasonable growth was attained. 
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Figure 5.33: Effect of temperature on growth on Streptomyces sp. (LA3L2) on SCA 
medium (pH 7.0±0.2; 4% salinity) after 10, 20 and 30 days incubation. 
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5.7 Effect of temperature and salinity on growth 
 
Salinity (0, 2, 4, 6, 8 and 10%) was tested at five temperatures (20, 24, 28, 32 and 36ºC) 
on SCA medium (pH 7.0±0.2). Growth diameter was measured for every 2 days for 30 
days. Details of the procedures are discussed in Chapter Two (Experimental). 
 
The results after 30 days incubation are shown in Figures 5.34. The isolate grow at all 
sea salt concentrations tested. At all temperatures growth increased up to 6% salinity 
and at the lowest incubation temperature (20°C) growth increased to 8% salinity. 
 
 
 
Figure 5.34: Effect of salinity on growth on Streptomyces sp. (LA3L2) on SCA medium 
(pH 7.0±0.2) at 20, 24, 28, 32 and 36ºC after 30 days incubation. 
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5.8 Effect of temperature and salinity on 
cytotoxicity 
 
Cultures from the effect of temperature and salinity on growth experiment were 
harvested after 30 days incubation and extracted. The extracts (1 mg/mL) were assayed 
for cytotoxicity against P388 cells and their metabolite profiles assessed by HPLC. The 
metabolites were confirmed by their UV characteristics as described in Section 5.3 
(bohemamine and bohemamine B), Section 5.4 (S-methyl benzothioate), Section 5.5 
(montagnetol and erythrin). Details of the procedures are discussed in Chapter Two 
(Experimental). 
 
The results of the effect of temperature and salinity on cytotoxicity are shown in Table 
5.8. All extracts were active against the P388 cells at all temperatures and salinity 
tested. Cytotoxicity was best at a temperature of 24ºC and 4% salinity (see Figure 5.35). 
Cytotoxicity increased with increasing salinity up to 4% but in most instances the 
activity decreased at higher salinity levels. 
 
 
Table 5.8: Effect of salinity on cytotoxicity of Streptomyces sp. (LA3L2) on SCA 
medium (pH 7.0±0.2; 30 days). 
 
Salinity (%) Cytotoxicity against P388 cells (IC50 ng/mL) 
 Temperature (ºC) 
 20 24 28 32 36 
0 712 296 372 1339 1225 
2 513 138 187 783 783 
4 296 <97.5 123 655 783 
6 857 516 501 712 783 
8 1225 599 501 1055 783 
10 6381 857 1055 2906 4154 
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Figure 5.35: Effect of temperature and salinity on cytotoxicity of Streptomyces sp. 
(LA3L2) cultured on SCA medium (pH 7.0±0.2) after 30 days incubation. *IC50 
(ng/mL) was expressed in log values (1/log IC50 value). 
 
 
The results of the HPLC profiles (see Figure 5.36) are represented by five extracts 
obtained from isolates cultured at 4% salinity at five temperatures (20, 24, 28, 32 and 
36ºC). Although all five extracts showed cytotoxicity below 1,000 ng/mL, none of the 
ELSD traces in the HPLC chromatogram showed significant production of metabolites 
in the cytotoxic region (15.0 – 18.5 min). The presence of cytotoxic S-methyl 
benzothioate (NAM 5-4) was significantly detected from the UV traces of one extract 
(24ºC) (see Figure 5.36). The remaining extracts (20, 28, 32 and 36ºC) showed only 
minor UV traces of the metabolite. Bohemamine was the only metabolite that was 
significantly produced at 20, 24 and 28ºC, but not at higher temperatures (32 and 36ºC). 
Bohemamine B, montagnetol and erythrin was not produced in significant amount in 
any of the five extracts. 
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Figure 5.36: HPLC chromatogram of five extracts obtained from Streptomyces sp. 
(LA3L2) cultured on SCA medium (pH 7.0±0.2; 4% salinity) at 20, 24, 28, 32 and 36ºC 
showing traces of metabolites. 
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5.9 Discussion 
 
Large scale cultivations of Streptomyces sp. (LA3L2) were undertaken to generate 
production of bioactive metabolites for structure elucidation. Streptomyces sp. (LA3L2) 
was targeted for large scale cultivation because it showed good activity against P388 
cells (IC50784 ng/mL), however, active metabolites were not significantly produced. It 
became apparent in the second large scale cultivation that isolate LA3L2 was 
inconsistent in producing the desired bioactive metabolites, but did show consistent 
production of other compounds.  
 
This isolate produced bohemamine significantly in both the small and large scale 
cultivations, while bohemamine B was inconsistently produced in these conditions. The 
bohemamines are a rare pyrrolizidines group of compounds with an unusual 
methylation pattern and presence of amide nitrogen. To date, bohemamines have only 
been reported from actinomycetes. Bohemamine was isolated from Actinosporangium 
sp. (Doyle et al., 1980; Nettleton et al., 1980); bohemamine, bohemamine B, 
bohemamine C and 5-chlorobohemamine C from a marine-derived Streptomyces sp. 
(Bugni et al., 2006); NP25302 from Streptomyces sp. (Zhang et al., 2003b) and three 
metabolites with a similar pyrrolizidine ring system from a Streptomyces sp. (Hu et al., 
2003). Bohemamine and bohemamine B isolated from LA3L2 were found to be inactive 
in both the cytotoxic and antimicrobial assays. Bugni et al. (2006) similarly found 
bohemamine and bohemamine B inactive in the HCT-116 colon carcinoma cell line and 
antimicrobial assays. 
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The first large scale cultivation revealed small amounts of a new cytotoxic metabolite - 
S-methyl 2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzothioate. This metabolite was 
determined as one of the cytotoxic components from HPLC MTT plate assay but was 
inactive against bacteria or fungi. Tahara et al. (1991) reported the production of 
resorthiomycin (S-methyl 2,4-dihydroxy-5-(3-hydroxybutyl)-3,6-dimethylbenzothioate) 
from a soil-derived S. collinus which exhibited cytotoxicity against mouse leukemia 
cells and the human hepatoma cell line but was inactive against bacteria and fungi 
(Suzuki et al., 1990). Mortivinacin A (S-methyl 2,4-dihydroxy-3,5,6-
trimethylbenzothioate) was reported from a sclerotium-colonizing isolate of the fungus, 
Mortierella vinacea and was active against C. albicans, B. subtilis and S. aureus 
(Soman et al., 1999). The new metabolite is thus only the third compound of this group 
to be characterized. 
 
The attempt to obtain other cytotoxic metabolites in the second large scale cultivation 
was unsuccessful. Two other different metabolites, however, were produced and 
characterized by CapNMR. These were montagnetol and erythrin, two lichen-related 
metabolites. Both montagnetol and erythrin were first isolated from the Indian lichen 
Rocella montagnei (Rao et al., 1942b). Montagnetol was then reported from another 
lichen, Ramalina hierrensis (Gonzalez et al., 1992) while erythrin was isolated from 
other lichens; Opegrapha platycarpa (Huneck et al., 1968a) and Dirina spp. (Huneck et 
al., 1968b). Structural similarities between natural products of fungal origin are 
common with those of lichens such as averythrin from the lichen Solorina crocea 
(Yutaka et al., 1970) and the fungus Herpotrichia rhodosticta (Van Eijk and Roeijmans, 
1984). The depsidones were reported from lichens such as Erioderma phaeorhizum (Bin 
Hamat et al., 1992); Phaeographis sp. (Elix et al., 2003) and Usnea sp. 
(Kathirgamanathar et al., 2005) and also from fungi such as an unidentified endophytic 
fungus (Pittayakhajonwut et al., 2006) and the mangrove-derived fungus Preussia 
aurantiaca (Poch and Gloer, 1991). Similarities between secondary metabolites 
originating from actinomycetes with those of lichens have not been previously reported. 
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Inconsistent metabolite production in suceeding fermentations is often seen and presents 
problems for commercialization of metabolites. Both genetic and environmental causes 
have been cited for such occurrences. Streptomyces sp. (LA3L2) was a marine-derived 
organism and in an attempt to determine the possible effects of environmental 
parameters such as salinity and temperature on growth and metabolite production a 
series of experiments was conducted. Isolate LA3L2 was shown to be able to grow on 
media containing up to 10% sea salt. Growth of Streptomyces spp. appears to be 
variable in respect to salinity. A Streptromyces sp. derived from the sponge, Dendrilla 
nigra (Selvin et al., 2004) showed growth up to 8% NaCl concentration, but did not 
grow at 10% NaCl concentration. It has been reported that a strain of Streptomyces sp., 
isolated from shallow sea mud failed to grow at 15ºC in medium containing 3.5% NaCl 
(Okami, 1974). The influence of NaCl concentration and temperature on growth and 
metabolite production in Streptomyces spp. has been demonstrated in only a few studies. 
Sultan et al. (2002) found that 2% NaCl concentration and 37.5ºC were the optimum 
cultivation conditions for antibacterial metabolite production in a soil-derived 
Streptomyces sp. The effect of salinity on metabolite production in S. avermitilis 
showed variations. The content of palmitoleic acid in S. avermitilis increased with 
increasing salinity up to 12% NaCl concentration but avermectin production decreased 
after 0.5% NaCl concentration (Rezanka and Votruba, 1998).  
 
Streptomyces sp. (LA3L2) showed that after 30 days incubation, the optimum 
temperature for growth (32 - 36ºC) was higher than the optimum temperature for 
cytotoxic metabolite production (24ºC). This is consistent with the typical effect of 
temperature on growth and metabolite production by mesophilic actinomycetes 
(Votruba and Vanek, 1989). The temperature optimum for secondary metabolism is 
often lower than that for primary metabolism and replicative growth of the producing 
organism (Weinberg, 1974). The cultivation of microorganisms at sub-optimal 
temperatures decreases the demand for substrate supporting primary metabolism (Farrel 
and Rose, 1967; Demain, 1968; Votruba and Vanek, 1989). The influence of 
temperature on maximal and minimal yield of secondary metabolites in some species of 
Streptomyces is shown in Figure 5.37.  
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Figure 5.37: The influence of temperatures permitting vegetative growth on secondary 
metabolism. Circle: temperature at which maximal yield of secondary metabolite is 
obtained; arrow tips: temperature at which minimal yields of secondary metabolite are 
obtained (Adapted from Votruba and Vanek (1989)). Physicochemical factors affecting 
actinomycete growth and secondary metabolism. In Shapiro, S. (ed.). Regulation of 
secondary metabolism in actinomycetes. CRC Press. Inc. p 274). 
 
 
Cultural conditions of 24ºC and 4% salinity led to an extract showing greatest 
cytotoxicity (IC50<97.5 ng/mL), however, ELSD traces of this extract did not show 
significant traces of the characterized cytotoxic metabolites. Secondary metabolite 
production in microbes is strongly influenced by growth medium (such as carbon and 
nitrogen sources and micronutrients) and cultural conditions. These factors need to be 
examined in attempts to optimize production of any required metabolite. 
 
This isolate produced three different structural classes of natural products – the 
pyrrolizidines, S-methyl benzothioate and phenolic carboxylic derivatives. This 
indicates isolate LA3L2 is likely to have a wide range of biosynthetic capabilities. Thus, 
the One Strain-Many Compounds (OSMAC) concept of Bode et al. (2002) could be 
worthy of application in the case of Streptomyces sp. (LA3L2) using nutritional and 
environmental conditions. 
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Chapter 6 
 
 
A Malaysian 
Paecilomyces sp. (PR10T2) 
 
 
 
6.1 Introduction 
 
Fungi belonging to the genus Paecilomyces, which is mainly an insect pathogenic group 
have been a source of a wide range of bioactive natural products (Isaka et al., 2003). 
Examples include paecilodepsipeptide A (antimalarial and antitumour 
cyclohexadepsipeptide) from P. cinnamomeus (Isaka et al., 2007), deoxymilitarinone A 
(neuritogenic pyridone alkaloid) from the insect pathogenic fungus P. farinosus (Cheng 
et al., 2006), paecilotoxins (highly toxic linear peptides, also designated as 
leucinostatins) from P. lilacinus (Fukushima et al., 1983a; Fukushima et al., 1983b; 
Mikami et al., 1989), paeciloquinones (anthraquinones, protein tyrosine kinase 
inhibitors) from P. carneus (Frendenhagen et al., 1995), paecilosetin (an antibiotic 
tetramic acid derivative) from P. farinosus (Lang et al., 2005) and a series of 
trichothecanes from P. tenuipes (Kikuchi et al., 2004a; Kikuchi et al., 2004b; Kikuchi et 
al., 2004c). Representative secondary metabolites from marine-derived Paecilomyces 
spp., however, are quite small with only a few reported so far. These are paecilospirone, 
a spiroacetal compound, isolated from marine Paecilomyces sp. (Namikoshi et al., 
2000), the polyketide, deoxynortrichoharzin, isolated from a sponge-derived 
Paecilomyces cf. javanica (Rahbaek et al., 1998) and sorbicillinoid urea, isolated from 
intertidal P. marquandii (Cabrera et al., 2006). 
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6.2 Paecilomyces sp. (PR10T2) 
 
Isolate PR10T2 was obtained from the tissue portion of a sea fan collected in Pulau 
Redang Marine Park, Malaysia in September 2005 (see Figure 6.1). Stock cultures are 
maintained at the Fisheries Research Institute Malaysia, Pulau Pinang. The isolate was 
identified on the basis of colony morphology and sporulation characteristics as a 
Paecilomyces sp. by Assoc. Prof. Anthony Cole, School of Biological Sciences, 
University of Canterbury. 
 
 
 
Figure 6.1: left: sea fans; right: a 7 day-culture of Paecilomyces sp. (PR10T2) on PYGA 
medium.  
 
 
The extract from this isolate was further investigated because the metabolite responsible 
for the activity exhibited no UV/Rt correlation with known compounds when analyzed 
by HPLC. This chapter presents the investigation of extract F6439 using the CapNMR 
technique. 
 
Photographed by Zainuddin Illias, 
Department of Fisheries Malaysia 
Location: Pulau Redang Marine 
Park, Malaysia, September 2005 
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6.3 Investigation of small scale extract (F6439) 
 
Extract F6439 was obtained from the small scale extraction of isolate PR10T2 (see 
Chapter Two - Experimental) and exhibited moderate cytotoxicity (IC5012,881 ng/mL) 
against P388 cells, but was not active against B. subtilis, P. aeruginosa and C. albicans 
(see Chapter Three – Preliminary screening). The HPLC screening revealed that one 
of the compounds, NAM 6-1 eluted at 17.5 min (see Figure 6.2) coincided with the 
bioactivity region observed for the extract. 
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Figure 6.2: HPLC chromatogram of F6439 showing overlay of ELSD detection for 
compound NAM 6-1. 
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The UV spectrum of compound NAM 6-1 is shown in Figure 6.3, but showed no exact 
match to any of the compounds in the HPLC-UV/Rt library. 
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Figure 6.3: UV profile for compound NAM 6-1. 
 
 
A total of 1750 µg of the crude extract (F6439) was injected on to the HPLC (by four 
times injections) and the compounds were collected into microtitre plates. The HPLC 
chromatogram of the first injection of the crude extract (1000 µg) is shown in Figure 
6.4. Details of the HPLC MTT procedures are discussed in Chapter Two 
(Experimental). The pure compound (10 µg) was obtained from the total 1750  µg of the 
crude extract by combining two wells (F10 and F11) of the four microtitre plates and 
was analyzed using the CapNMR technique. The other minor metabolites (NAM 6-2 
and NAM 6-3) were not further investigated due to insufficient amount of materials 
obtained. 
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Figure 6.4: HPLC chromatogram of 1000 µg of crude extract F6439 showing the main 
compound NAM 6-1 collected into wells F11 and F10 of the microtitre plate. 
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6.4 Structural elucidation of compound NAM 6-1 
 
The 
1
H NMR spectrum of NAM 6-1 (see Figure 6.5) clearly showed the presence of one 
triplet and three doublet methyls (δH 0.8 – 1.1). NAM 6-1 had a molecular mass of 427 
Da ([M+H]
+
) (see Figure 6.6). A search in the AntiMarin database based on four methyl 
groups (three doublets and a triplet) and a molecular weight of 425 – 427 Da resulted in 
no match with compounds in the database. It was then noted that the molecular mass of 
compound NAM 6-1 ([M+H]
+
 427 Da) was rather too high to fit readily with the 
1
H 
NMR features unless the compound was a symmetric dimer of some description. 
 
 
 
 
ppm1.01.52.02.53.03.54.04.55.05.56.0  
Figure 6.5: 
1
H NMR spectrum of NAM 6-1 in CD3OD obtained from F6439. Insert: 
enlargement of four methyl groups. * signal is reduced in intensity by partial saturation 
arising from irradiation of the HDO signal at δH 4.87. Crosses indicate impurities. 
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Figure 6.6: ESIMS spectrum of compound NAM 6-1. 
 
 
An attempt was then made to search in the AntiMarin database for compounds with 
double the number of protons used in the original search that is, a search for compounds 
with a total of eight methyl groups (six doublets and two triplets) and molecular mass of 
425 – 427 Da. This resulted in one hit (see Figure 6.7). 
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Figure 6.7: Screenshot of AntiMarin database search result for compound NAM 6-1 
using the 
1
H NMR and MS spectral data resulting in 1 hit. 
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This compound was angolide (6.1), a cyclic depsipeptide reported from the fungi, 
Pithomyces spp. (Macdonald and Shannon, 1964; Russel, 1965; Ellis et al., 1966; 
Russel, 1988). Angolide (6.1) had a molecular mass of 427 Da ([M+H]
+
), but the 
structural identification had been based only on acid hydrolysis of the amino acids 
(Macdonald and Shannon, 1964; Russel, 1965; Ellis et al., 1966; Okotore and Russel, 
1972; Russel, 1988). 
 
As there had been no publication of NMR spectral data for angolide (6.1) to compare 
with the acquired NMR data of NAM 6-1, further NMR experiments were conducted. 
Compound NAM 6-1 was analyzed with COSY, HSQC and HMBC experiments to 
allow complete structural elucidation. The HSQC and HMBC spectra are shown in 
Figures 6.8 and 6.9, respectively. 
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Figure 6.8: HSQC DEPT spectrum of compound NAM 6-1. 
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Figure 6.9: HMBC spectrum of compound NAM 6-1. 
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The COSY spectrum showed strong coupling between the protons at δH 2.11 and 4.82. 
The proton at δH 2.11 in turn was coupled to methyl protons at δH 1.01 and 1.05. The 
1
JCH correlation in the HSQC spectrum (Figure 6.8) showed that the protons at δH 1.01, 
1.05 and 2.11 were attached to carbons at δC 17.3, 18.4 and 30.7, respectively. The 
proton at δH 4.82 was attached to a carbon at δC 80.8, indicated that this carbon was 
oxygenated. The HMBC spectrum (Figure 6.9) showed long range correlation of both 
the methyl protons at δH 1.01 and 1.05 to carbons at δC 30.7 (δH 2.11) and 80.8 (δH 
4.82). The methyl protons (δH 1.01 and 1.05) and carbons (δC 18.4 and 17.3) were self-
correlated, while the proton at δH 4.82 showed long range correlations with carbons at 
δC 18.4 (δH 1.05) and 30.7 (δH 2.11). Two high field carbon resonances at δC 169.8 and 
171.0, suggesting of carbonyl groups, were correlated with the proton at δH 4.82 (δC 
80.8). Based on these data, a fragment of the structure of compound NAM 6-1 was 
defined as illustrated in Figure 6.10. This corresponds to a valyl-type side chain. 
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Figure 6.10: First fragment of compound NAM 6-1 deduced from COSY, HSQC and 
HMBC correlations.  
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Two protons at δH 1.24 and 1.58 were strongly coupled to each other and to the methyl 
protons (δH 0.95, t). The 
1
JCH correlation from the HSQC spectrum showed that the two 
protons at δH 1.24 and 1.58 were attached to the same carbon (δC 24.8), confirming to 
the coupling pattern of the triplet methyl (δH 0.95, δC 9.5). The methylene protons (δH 
1.24 and 1.58) also showed weak coupling with the proton at δH 1.96 (δC 35.1), which in 
turn strongly coupled to the doublet methyl protons (δH 0.99) and to the proton at δH 
4.33. The carbon assignment of this proton (δH 4.33, δC 58.8) suggested that this carbon 
was possibly attached to a nitrogen. In the HMBC spectrum these were long range 
correlation of both methyl protons (δH 0.95 and 0.99) to carbons at δC 24.8 (δH 1.24; 
1.58) and δC 35.1 (δH 1.96). The methyl protons at δH 0.99 were also correlated to the 
carbon at δC 58.8 (δH 4.33). The proton at δH 1.24 showed long range correlation with 
carbon at δC 35.1 (δH 1.96) and a weak correlation with a carbon at δC 14.8 (δH 0.99). It 
was noted that the two carbon signals at δC 169.8 and 171.0 that were correlated with 
the proton at δH 4.82 (δC 80.8) previously mentioned also showed correlation with the 
proton at δH 4.33 (δC 58.8). Interpretation of these data suggested the other structural 
fragment of NAM 6-1 is an isoleucyl (see Figure 6.11). 
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δH0.95
δC9.5
δH1.24
δC35.1
δC24.8
δC169.8
δH1.96
O
O
δC171.0
δH1.58
Me
δC58.8
δH4.33
δH0.99
δC14.8
N
 
Figure 6.11: Second fragment of compound NAM 6-1 deduced from COSY, HSQC and 
HMBC correlations. 
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As both the valyl and isoleucyl-type side chains in NAM 6-1 were correlated with both 
carbonyl groups at δC 169.8 and 171.0, two peptide fragments of (-hydroxyisovaleryl-
isoleucyl-) were suggested. The only linkage possible for these two fragments was to 
form a cyclo (-hydroxyisovaleryl-isoleucyl-hydroxyisovaleryl-isoleucyl-). The apparent 
symmetry of the molecule comes from the observation of only one set of methyl, 
methine and methylene resonances for each of the two hydroxyisovaleryl and two 
isoleucyl sub-structures. Confirmation of the symmetric nature came from close 
examination of the sets of α-protons. These protons, δH 4.33 and 4.82, are closer to the 
chiral centres than the methyl groups. Again, only two clear set of doublets were 
observed (see Figure 6.5). If NAM 6-1 had been asymmetric, the four protons were 
expected to give four sets of doublets for the protons in the NMR spectrum. 
 
The ACD/Labs prediction software was then used to simulate the 
1
H and 
13
C NMR 
chemical shifts of angolide (6.1) for comparison with the experimental data obtained for 
compound NAM 6-1 (see Table 6.1). The comparison showed that the calculated data 
for angolide (6.1) and compound NAM 6-1 were almost identical suggesting that 
compound NAM 6-1 was similar to the structural features of angolide (6.1) as a 12-
membered ring cyclic tetradepsipeptide with an ester-amide-ester-amide sequence of 
linkages. 
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Table 6.1: Comparison of 
1
H and 
13
C NMR data of compound NAM 6-1 and of the 
simulated values of angolide (6.1). 
 
Position NAM 6-1b (6.1)a 
 δH δC δH δC 
1  171.0  175.0 
2 4.33 58.8 3.99 57.6 
3 1.96 35.1 1.91 36.1 
 - - - - 
4 1.24 24.8 1.41 27.1 
 1.58  1.65  
5 0.99 14.8 0.95 15.6 
6 0.95 9.5 1.12 11.6 
7 (-NH-)   5.41  
8  169.7  169.6 
9 4.82 80.8 5.19 77.2 
10 2.11 30.7 2.36 34.0 
11 1.01 17.3 0.95 17.4 
12 1.05 18.4 0.96 19.0 
13 (-O-)     
a These data were simulated by ACD/Labs software, Version 10; b These data were recorded at 500 MHz in CD3OD. 
 
 
A question, however arose regarding the structural configuration of NAM 6-1 to those 
of angolide (6.1). The reported angolide (6.1) contained a mixture of L and D-amino 
acids (two L-α-hydroxyisovaleryl, one L-isoleucine and one D-allo-isoleucine) and its 
structure (6.1) (cyclo-L-α-hydroxyisovaleryl-L-isoleucyl-L-α-hydroxyisovaleryl-D-allo-
isoleucyl) is asymmetric. NAM 6-1 on the other hand, was deduced based on the NMR 
spectral data as symmetric. 
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A symmetrical form of NAM 6-1 must accommodate a homoisomeric configuration of 
the peptide fragments. The reasonable structures for NAM 6-1 that could be drawn 
based on homoisomeric configurations were (cyclo-L-α-hydroxyisovaleryl-L-isoleucyl-
L-α-hydroxyisovaleryl-L-isoleucyl) (or its enantiomer) (see Figure 6.12) which would 
have a two-fold axis of symmetry, or (cyclo-L-α-hydroxyisovaleryl-L-isoleucyl-D-α-
hydroxyisovaleryl-D-isoleucyl) (see Figure 6.13) with a centre of inversion. The 
1
H 
NMR data alone would not distinguish another possible diastereoisomer, also with a 
centre of inversion, (cyclo-L-α-hydroxyisovaleryl-D-isoleucyl-L-α-hydroxyisovaleryl-
L-isoleucyl) (see Figure 6.14). These possible configurations of NAM 6-1 therefore did 
not fit with the reported angolide (6.1), and NAM 6-1 must therefore be considered as a 
new compound. 
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Figure 6.12: Homoisomeric configurations of NAM 6-1: (a) (cyclo-L-α-
hydroxyisovaleryl-L-isoleucyl-L-α-hydroxyisovaleryl-L-isoleucyl) and (b) its 
enantiomer. 
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Figure 6.13: Homoisomeric configuration of NAM 6-1: (cyclo-L-α-hydroxyisovaleryl-
L-isoleucyl-D-α-hydroxyisovaleryl-D-allo-isoleucyl). 
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Figure 6.14: Homoisomeric configuration of NAM 6-1: (cyclo-L-α-hydroxyisovaleryl-
D-allo-isoleucyl-L-α-hydroxyisovaleryl-L-isoleucyl). 
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6.5 Discussion 
 
Cyclic depsipeptides are group of metabolites characterized by the occurrence of at least 
one ester linkage (Faulkner, 1994; Burja et al., 2001; Faulkner, 2002). They are of great 
interest because they possess a diverse range of bioactivity including antitumour, 
antibiotic, antifungal, immunosuppressant and anti-inflammatory activities. Various 
types of cyclodepsipeptides have been reported from marine-derived fungi such as the 
spicellamides A and B from Spicellum roseum (Kralj et al., 2007), zygosporamide from 
Zygosporium masonii (Oh et al., 2006), guangomides A and B from an unidentified 
sponge-derived fungus  (Amagata et al., 2006b), IB-01212 from Clonostachys sp. (Cruz 
et al., 2006), aspergillicins A – E from marine sediment-derived Aspergillus carneus 
(Capon et al., 2003), N-methylsansalvamide A from algal-derived Fusarium sp. (Cueto 
et al., 2000), sansalvamide from a sea grass-derived Fusarium sp. (Belofsky et al., 
1999) and exumolides A and B cyclic hexadepsipeptides from a  marine plant-derived 
Scytalidium sp. (Jenkins et al., 1998). 
 
Cyclic depsipeptides have not been reported from marine-derived Paecilomyces spp. 
previously. Two compounds, however, have been reported from terrestrial counterparts. 
The cyclic hexadepsipeptide, beauvericin has been isolated from P. fumosoroseus and 
P. tenuipes (Klaric and Pepeljnjak, 2005). An antimalarial and antitumour 
cyclohexadepsipeptide, paecilodepsipeptide A, was recently reported from P. 
cinnamomeus (Isaka et al., 2007). Marine invertebrates are known to be sources of 
structurally bioactive cyclic depsipeptides. Some noteworthy examples include the 
antitumour metabolites, arenastatin A from the Okinawan sponge, Dysidea arenaria 
(Kobayashi et al., 1994a; Kobayashi et al., 1994b), didemnins from a Caribbean 
tunicate, Trididemnum solidum (Rinehart et al., 1981), jasplakinolide from the Indo-
Pacific sponge, Jaspis cf. Johnstoni (Crews et al., 1986) and geodiamolides from the 
sponge, Geodia sp. (Chan et al., 1987). 
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Production of cyclic depsipeptides has been reported for microorganisms associated 
with marine invertebrates. Examples are the dolastatins from the Western Indian Ocean 
sea hare, Dolabella auricularia (Pettit, 1997) and from the cyanophyte Symploca sp. 
(Luesch et al., 2001) and kahalalide from the mollusc, Elysia rufescens and its dietary 
alga, Bryopsis sp. (Bonnard et al., 2003). 
 
The source of Paecilomyces sp. (PR10T2) was Pulau Redang Marine Park Malaysia 
which is surrounded by the South China Sea, a part of the China Sea. The China Sea 
(consisting of China Bo Sea, China Yellow Sea, East China Sea and South China Sea) 
(Zhang et al., 2003a) is regarded of showing great potential as a source of marine 
natural products (see Figure 6.16). The Chinese terrestrial waters of South China Sea 
have received some attention (Lin et al., 2000; Yang et al., 2002; Yin et al., 2005; Yang 
et al., 2006) for natural product discovery from marine microorganisms, however, the 
Malaysian zone is virtually unexplored, with only metabolites from several species of 
the red algae Laurencia (Vairappan et al., 2001; Vairappan, 2003; Vairappan et al., 
2004), a sponge (Fernandez et al., 1992) and a crinoid (Shao et al., 2007) reported in the 
international literature. 
 
 
 
Figure 6.16: Citations for source regions for the period 2001–2005 as a percentage of 
the totals for 1965–2005 (from Blunt et al., 2007). 
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In this study, the amount of NAM 6-1 used for characterization (approximately 10 µg), 
while sufficient for establishing the structure by 1D and 2D NMR spectroscopy was 
insufficient to allow chemical analysis and establish the relative and absolute 
stereochemistry. Further attempts will be carried out to culture the producing isolate to 
obtain a greater amount of NAM 6-1 for this final definition work on the 
stereochemistry. 
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Chapter 7 
 
 
Application of rapid techniques 
for chemical characterization 
of metabolites 
 
 
7.1 Introduction 
 
Rapid identification of natural products is an important step to distinguish between 
known and unknown compounds and consequently allowing the exclusion of known 
compounds at an earlier stage. Over the years, numerous approaches have been 
undertaken including chromatography-based approaches combined with MS or NMR 
spectroscopy and the establishment of UV spectra libraries and commercial databases. 
 
NMR spectroscopy is probably the most versatile technique for the determination of 
molecular structures. The NMR technique has become increasingly more important in 
natural products studies with the rapid development and diversification of NMR 
spectroscopy. In natural products studies many of the bioactive metabolites produced 
are of small amount and often in an amount lower than required to carry out complete 
structural elucidation. With recent development of new probe technologies, the 
utilization of NMR as a tool for rapid characterization of metabolites has become 
increasingly more important. 
 
Chapter 7: Application of rapid techniques for chemical characterization of metabolites 
_____________________________________________________________________________________ 
 157 
 
One advancement was the production of a CapNMR - designed to allow NMR 
experiments by using amounts of materials much less than required for a conventional 
probe. Normal data acquisition using a NMR regular probe requires at least 1.0 – 2.0 mg 
of pure material. In the case of simple small molecules, 1D NMR coupled with MS may 
be enough to characterize the structure of a compound. Most natural products, however, 
are not small molecules and certainly not simple, therefore 2D NMR techniques are 
required. Among the most commonly used are HSQC and HMBC experiments. In these 
cases, greater quantities of pure metabolite are required, depending somewhat on the 
molecular structure of the compound, for an adequate 2D NMR spectrum to be 
achieved. The sensitivity of the capillary-scale NMR probe to enhance structural 
elucidation by using only small amount of natural product has been described for the 
plants, Penstemon centranthifolius (Hu et al., 2005) and firefly, Lucidota atra 
(Gronquist et al., 2005). 
 
The CapNMR technique is currently utilized by the Marine Chemistry Group in 
conjunction with the AntiMarin database with MS and UV data as a tool to enhance 
dereplication as well as to obtain a rapid NMR data acquisition for characterization of 
new metabolites by using 2 – 50 µg of purified material. Less than <50 µg sample is 
required to perform both 1D proton and 2D homonuclear NMR experiments. The NMR 
features such as methyl groups and aromatic spin systems that can usually be 
recognized from the 1D spectrum, along with MS and UV data can make the search 
profile in the AntiMarin database highly discriminating as the database contains NMR 
data besides other various molecular descriptors such as MS and UV. For a more 
complex structure, about 30 – 50 µg of sample are needed to acquire 2D heteronuclear 
spectra such as HMBC or HSQC. 
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Prior to the CapNMR technique, the group’s approach to rapid dereplication utilized the 
LC-MS-UV technique in combination with the AntiMarin database. This technique 
allows the dereplication of mixtures of natural products and requires only a small 
amount of the crude extract (1 mg/mL) and operating in conjunction with HPLC time-
of-flight mass spectrometry (TOFMS) analysis. The utilization of LC combined with 
MS has been developed to detect the presence of known secondary metabolites from 
microorganisms (Filtenbort et al., 1983; Frisvad et al., 1989; Smedsgaard and Frisvad, 
1996; Higgs et al., 2001). Another technique that combined UV spectra with LC-MS 
(LC-MS-UV) was used to develop a database of 474 mycotoxin and fungal metabolites 
(Nielsen and Smedsgaard, 2003). This database is very useful as a dereplication tool for 
many metabolites originating from fungi such as Penicillium spp. and Aspergillus spp. 
With this technique, the UV spectrum was still a valuable tool for rapid identification 
for metabolites with characteristic UV chromophores. However, the limitation within 
this technique lies with the fact that not all metabolites have characteristic UV spectra 
and in some cases of isomers with similar molecular formula, the UV spectra are 
identical. 
 
Work of the University of Canterbury Marine Chemistry group is presently focused on 
fungal metabolites and an in-house HPLC-UV/Rt library database for known fungal 
metabolites by using the Chromeleon software on the Dionex analytical HPLC has been 
established. The dereplication of fungal metabolites using the library database is carried 
out by establishing whether any of the significant peaks showed matches (both UV 
chromophore and Rt) with any known compounds already present within the database. 
With the current rapid techniques being applied by the group, more known compounds 
will be inserted progressively into the library database thus enhancing it use for future 
dereplication. 
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The application of 1D and 2D CapNMR techniques for structural elucidation of 
metabolites was presented in Chapter Five (Secondary metabolites from marine-
derived Streptomyces sp. (LA3L2)) and Chapter Six (A Malaysian Paecilomyces sp. 
(PR10T2)). This chapter presents an overview of the application of the CapNMR and 
LC-MS-UV techniques for chemical characterization of metabolites in selected 
bioactive extracts obtained from marine-derived actinomycetes and fungi. 
Characterization of known structural features by using <10 µg pure or partially pure 
samples is described by using the CapNMR technique. The reliability of LC-MS/UV 
technique to dereplicate mixtures of natural products in selected extracts is also 
demonstrated. The utilization of the HPLC-UV/Rt library database is briefly mentioned. 
 
 
7.2 Dereplication using LC-MS-UV 
 
Five bioactive extracts that contain significant peak(s) that were not readily dereplicated 
using the HPLC-UV/Rt library database are further investigated using the LC-MS-UV 
technique. These extracts were F5956 from a Streptomyces sp. (Section 7.2.1) and four 
Penicillium spp. extracts namely F5975 (Section 7.2.2), F5890 (Section 7.2.3), F5350 
(Section 7.2.4) and F5868 (Section 7.2.5). Details of the procedures were discussed in 
Chapter Two (Experimental). 
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7.2.1 Extract F5956 
 
Extract F5956 was obtained from a SCA culture medium of Streptomyces sp. (LA3L1). 
This small-scale extract showed good cytotoxicity (IC50<97.5 ng/mL) and was active 
against B. subtilis (101% inhibition). The HPLC screening of F5956 revealed three main 
peaks, NAM 7-1, NAM 7-2 and NAM 7-3 appearing over the bioactive region (Rt 14.0 
– 17.0 min) as illustrated in Figure 7.1. These three peaks were shown to have virtually 
identical UV chromophores, suggesting that they were closely related in structure 
(Figure 7.2).  
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Figure 7.1: HPLC chromatogram of F5956 showing overlay of ELSD detection (top) for 
compounds NAM 7-1, NAM 7-2 and NAM 7-3 eluted over the bioactive region. 
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Figure 7.2: UV profile overlay for NAM 7-1, NAM 7-2 and NAM 7-3 of F5956. 
 
 
The extract was subjected to HPLC TOFMS (negative ionization) analysis to further 
investigate compounds NAM 7-1, NAM 7-2 and NAM 7-3. The desired compounds 
(NAM 7-1, NAM 7-2 and NAM 7-3) were determined by correlating the total ion 
current (TIC) traces of the HPLC TOFMS spectrum with the UV profiles of the HPLC 
chromatogram (see Figure 7.3). The MS of compounds NAM 7-1, NAM 7-2 and NAM 
7-3 were then determined from the corresponding TIC traces.  
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Figure 7.3: TIC chromatogram (negative) of F5956. A: TIC traces of TOFMS; B: 
overlay of UV profile from the corresponded TIC traces; C: overlay of corresponded 
HPLC-UV traces. 
 
 
The results obtained for compound NAM 7-3 are discussed first in order to facilitate the 
discussion on the dereplication of compounds NAM 7-1 and NAM 7-2. Compound 
NAM 7-3 had the molecular mass of 1210 Da ([M-H]
-
) (see Figure 7.4). 
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Figure 7.4: MS spectrum obtained from TIC traces of TOFMS of compound NAM 7-3 
showing the ([M-H]
-
) of 1210 Da. 
 
 
Only two known compounds with molecular mass of 1210 - 1212 Da showed matches 
with compound NAM 7-3 in the AntiMarin database and these were chromomycin A2 
(7.1) and calichemicin a3l (7.1a). The UV spectrum of compound NAM 7-3 was 
compared to those of the two known compounds. It showed that the UV spectrum of 
compound NAM 7-3 was consistent with that reported for chromomycin A2 (7.1) 
(Miyamoto et al., 1967; Yoshimura et al., 1988), leading to the assignment of NAM 7-3 
as chromomycin A2 (7.1). 
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Based on the similarity of their UV chromophores, NAM 7-3 was closely related in 
structure to compounds NAM 7-1 and NAM 7-2. The structural features of the 
chromomycin group of compounds were then used as a basis to identify compounds 
NAM 7-1 and NAM 7-2. Compound NAM 7-2 has a molecular mass of 1182 Da ([M-
H]
-
). A search in the AntiMarin database showed 15 matches with known compounds 
with molecular mass of 1182 – 1184 Da. Of 15 hits, only one was related to 
chromomycin and this was chromomycin A3 (7.2). The UV spectral data of compound 
NAM 7-2 was consistent with that reported for chromomycin A3 (Miyamoto et al., 
1967; Yoshimura et al., 1988), and was thus identified as chromomycin A3 (7.2). 
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Compound NAM 7-1 has a molecular mass of 1140 Da ([M-H]
-
). A search of 
AntiMarin database based on the molecular masses of 1140 – 1142 Da resulted in 34 
hits, of which only one correlated with the chromomycins named chromomycin 02-3D 
(7.3). The UV spectral data of compound NAM 7-1 was consistent with that for 
chromomycin 02-3D (7.3), which was a mono-deacetyl chromomycin reported by 
Kawano et al. (1990). Based on this, compound NAM 7-1 was thus identified as 
chromomycin 02-3D (7.3). 
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7.2.2 Extract F5975 
 
Extract F5975 was obtained from a PYGA culture medium of Penicillium sp. (LY1L5). 
This small-scale extract showed fair cytotoxicity (IC505,117 ng/mL) but was inactive in 
the antimicrobial assays. The HPLC screening of F5975 showed the presence of two 
significant peaks, NAM 7-4 and NAM 7-5 eluted at 16.2 and 17.6 min, respectively 
(Figure 7.5). The HPLC MTT plate assay showed only compound NAM 7-5 was 
responsible for the activity. 
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Figure 7.5: HPLC chromatogram of F5975 showing overlay of ELSD detection (top) for 
compounds NAM 7-4 and NAM 7-5. 
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The UV spectra of compounds NAM 7-4 and NAM 7-5 are shown in Figure 7.6. 
Compound NAM 7-4 showed a match with the known compound, cycloaspeptide A 
(7.4) from the HPLC-UV/Rt library database, while no exact matches were found for 
compound NAM 7-5. 
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Figure 7.6: UV profile of F5975 showing overlay of compound NAM 7-4 (black) and 
the UV library hit (red) with the known cycloaspeptide A (7.4) in the HPLC-UV/Rt 
library database. An overlay of the UV spectrum of compound NAM 7-5 is shown in 
blue. 
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Compound NAM 7-5 was analyzed by HPLC TOFMS and MS spectrum is shown in 
Figure 7.7. The MS spectrum showed the presence of a dimeric cluster ion [2M+H]
+
 
that assigned the [M+H]
+
 ion as 337. A search in the AntiMarin database on compounds 
with molecular weight of 335 – 337 Da resulted in 207 hits. Further search in the 
published database on fungal metabolites (Nielsen and Smeedsgaard, 2003) resulted in a 
match with the known α-cyclopiazonic acid (7.5). 
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Figure 7.7: MS spectrum of compound NAM 7-5 obtained from TIC traces of F5975. 
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7.2.3 Extract F5890 
 
Extract F5890 was obtained from a PYGA culture medium of Penicillium sp. 
(KK3T23). This small-scale extract showed fair cytotoxicity (IC503,177 ng/mL) but was 
inactive in the antimicrobial assays. The HPLC screening showed three main peaks 
NAM 7-6, NAM 7-7 and NAM 7-8 eluted over the inactive region (10.0 – 15.0 min) 
and a cytotoxic peak NAM 7-9 eluted at 17.7 min (see Figure 7.8). The MS of each 
peak was determined from TIC traces of the HPLC TOFMS spectrum (positive 
ionization). 
 
 
0.0 1.3 2.5 3.8 5.0 6.3 7.5 8.8 10.0 11.3 12.5 13.8 15.0 16.3 17.5 18.8 20.0 21.3 22.5 23.8 25.0 26.0
-400
-300
-200
-100
0
100
200
300
400
500
600
700
800
900
1,000
1,100
1,200
1,300
1,400
mAU
min
 
Figure 7.8: HPLC chromatogram of F5890 showing overlay of ELSD (top) for the main 
compounds NAM 7-6, NAM 7-7, NAM 7-8 and NAM 7-9. 
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Compound NAM 7-9 showed a match with the known compound, α-cyclopiazonic acid 
(7.5) from the HPLC-UV/Rt library database (Figure 7.9). 
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Figure 7.9: UV profile of compound NAM 7-9 (black) and the UV library hit (red) with 
the known α-cyclopiazonic acid (7.5) in the HPLC-UV/Rt library database. 
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The UV spectra of the other three compounds, NAM 7-6, 7-7 and 7-8 are shown in 
Figure 7.10 and none of them matched with known compounds when analyzed by the 
HPLC-UV/Rt library database. 
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Figure 7.10: UV profile overlay for NAM 7-6, NAM 7-7 and NAM 7-8 of F5890. 
 
 
The presence of a prominent [M+H]
+
 signal and characteristic UV spectrum readily 
dereplicated compounds NAM 7-6 and NAM 7-8 as roquefortine A (7.6) and viridicatin 
(7.8), respectively based on their MS and UV spectral data search in the AntiMarin 
database and comparison with the published data by Nielsen and Smedsgaard (2003) 
(see Figure 7.11). 
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Figure 7.11: MS and UV spectral data of compounds NAM 7-6 (top) and NAM 7-8 
(bottom). The MS data were obtained from TIC traces of TOFMS spectrum (positive 
ionization) of extract F5890. 
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Compound NAM 7-7 showed the presence of a dimeric cluster ion [2M+H]
+
 that 
allowed assignment of the [M+H]
+
 ion as 281 (see Figure 7.12). A search in the 
AntiMarin database on compounds with molecular weight of 279 – 281 Da resulted in 
150 hits. Compound NAM 7-7 matched cyclopeptin (7.7) based on both their MS and 
UV spectra (Nielsen and Smedsgaard, 2003). It is interesting to mention here that the 
AntiMarin database could not readily dereplicate peak NAM 7-7 as cyclopeptin (7.7). 
Although the known compound (7.7) was one of the 150 hits in the AntiMarin database, 
the UV spectral data was not available (see Figure 7.13). Further searches using both the 
UV and MS spectral data of compound NAM 7-7 in the published database for fungal 
metabolites (Nielsen and Smedsgaard, 2003) resulted in one match with cyclopeptin 
(7.7) (see Figure 7.14). 
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Figure 7.12: MS and UV spectral data of compound NAM 7-7. The MS was obtained 
from TIC traces of TOFMS spectrum (positive ionization) of extract F5890. 
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Figure 7.13: A screenshot of the AntiMarin database search for compound NAM 7-7 
showing one of the 150 hits with known compound, cyclopeptin (7.7). The AntiMarin 
database did not contain the UV spectral data for cyclopeptin. 
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Figure 7.14: A screenshot of a published data for fungal metabolites (Nielsen and 
Smedsgaard, 2003) showing the search result for compound NAM 7-7 with cyclopeptin 
(7.7). 
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7.2.4 Extract F5350 
 
Extract F5350 was obtained from the small scale extraction of isolate KK3T8 grown on 
PYGA medium. This small-scale extract showed fair cytotoxicity (IC505,403 ng/mL) 
and was active against C. albicans (>70% inhibition). The HPLC screening of F5350 
revealed one main compound, NAM 7-10 eluted over the bioactive region (see Figure 
7.15). 
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Figure 7.15: HPLC chromatogram of F5350 showing overlay of ELSD detection (top) 
for compound NAM 7-10 over the bioactive region. 
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Compound NAM 7-10 showed the presence of a dimeric cluster ion [2M+H]
+
 that 
allowed assignment of the [M+H]
+
 ion as 281 (see Figure 7.16). A search in the 
AntiMarin database on compounds with molecular weight of 279 – 281 Da resulted in 
150 hits. Compound NAM 7-10 matched brefeldin A (7.10) based on both the MS and 
UV spectral data (Nielsen and Smedsgaard, 2003). 
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Figure 7.16: MS and UV spectral data of compound NAM 7-10. The MS was obtained 
from TIC traces of TOFMS spectrum (positive ionization) of extract F5350. 
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7.2.5 Extract F5868 
 
Extract F5868 was obtained from the small scale extraction of isolate KK4T14b grown 
on PYGA medium. This small-scale extract showed good cytotoxicity (IC50383 ng/mL) 
but was inactive in the antimicrobial assays. The HPLC screening of F5868 revealed 
two main compounds, NAM 7-11 and NAM 7-12 eluted over the cytotoxic region (11.0 
– 15.0 min) (see Figure 7.17). 
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Figure 7.17: HPLC chromatogram of F5868 showing overlay of ELSD detection (top) 
for compounds NAM 7-11 and NAM 7-12 over the cytotoxic region. 
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The UV spectra of compounds NAM 7-11 and NAM 7-12 are shown in Figure 7.18. 
Compound NAM 7-12 showed an exact match with the known compound, 
mycophenolic acid (7.12), while no hits were found for compound NAM 7-11 from the 
HPLC-UV/Rt library database. 
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Figure 7.18: UV profile of F5868 showing overlay of compound NAM 7-12 (black) and 
the UV library hit (red) with the known mycophenolic acid (7.12) in the HPLC-UV/Rt 
library database. An overlay of the UV spectrum of compound NAM 7-11 is shown in 
blue. 
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The MS data of compound NAM 7-11 (Figure 7.19) indicated the mass to be 366 Da 
([M+H]
+
). A search in the AntiMarin database for compounds with molecular weight of 
364 – 366 Da resulted in 223 hits. Further search in the published database on fungal 
metabolites (Nielsen and Smeedsgaard, 2003) resulted in a match in both UV and MS 
data with the known brevianamide A (7.11). 
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Figure 7.19: ESIMS spectrum of compound NAM 7-11 obtained from F5868. 
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7.3 Dereplication using CapNMR technique 
 
Significant peaks in two extracts that were not readily dereplicated using the HPLC-
UV/Rt library database and HPLC-MS-UV were investigated using the CapNMR 
technique. These were extracts F5962 and F6430 discussed in Sections 7.3.1 and 7.3.2, 
respectively. Details of the procedures were discussed in Chapter Two (Experimental). 
 
7.3.1 Extract F5962 
 
Extract F5962 was obtained from a SCA culture medium of Streptomyces sp. (LA5L4). 
This small-scale extract showed activity against P388 cells (IC501,339 ng/mL) but was 
inactive in the antimicrobial assays. The HPLC screening of F5962 revealed two main 
peaks, NAM 7-13 and NAM 7-14, which were eluted over the cytotoxic region (see 
Figure 7.20). 
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Figure 7.20: HPLC chromatogram of F5962 showing overlay of ELSD detection (top) 
for compounds NAM 7-13 and NAM 7-14 over the cytotoxic region. 
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These two peaks were shown to have virtually identical UV chromophores, suggesting 
that they were closely related in structure (Figure 7.21). The TIC traces from the HPLC 
TOFMS spectrum of F5962 showed that compounds NAM 7-13 and NAM 7-14 had an 
identical molecular mass of 339 Da ([M+H]
+
). A search in the AntiMarin database for 
compounds with molecular mass of 337 – 339 Da, revealed 218 matches and the 
structures could not be readily dereplicated. An attempt to purify these two compounds 
for the CapNMR analysis resulted in partially pure compound NAM 7-14, however no 
suitable amount of compound NAM 7-13 was obtained in the attempt. 
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Figure 7.21: UV profile overlay for compounds NAM 7-13 and NAM 7-14 obtained 
from F5962. 
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Approximately 2 µg of compound NAM 7-14 was analyzed using the CapNMR. The 
1
H 
NMR spectrum of compound NAM 7-14 (see Figure 7.22) indicated the presence four 
aromatic protons appearing at δH 6.8 – 7.6, a singlet methyl (δH 1.45) and another 
singlet methyl (δH 2.51) that could indicate an N-methyl or an aromatic methyl. The 
ESIMS data of compound NAM 7-14, shown in Figure 7.23 confirmed the mass to be 
339 Da ([M+H]
+
). Searching in the AntiMarin database on two singlet methyls and a 
molecular weight of 337 – 339 Da resulted in 19 hits (of 218 matches without the 
1
H 
NMR data input). The indication of the presence of an N-methyl or aromatic methyl in 
compound NAM 7-14 (δH 2.51) was sufficient in reducing the 19 known compounds to 
two; namely thiazostatin A (7.13) and thiazostatin B (7.14). 
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Figure 7.23: ESIMS spectrum of compound NAM 7-14. 
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The 
1
H NMR data of compound NAM 7-14 were compared to those reported for 7.13 
and 7.14 (Shindo et al., 1989) and these are shown in Table 7.1. It was noted that the 
1
H 
NMR spectrum of compound NAM 7-14 presented in Figure 7.22 also contained some 
signals of thiazostatin A (7.13). Based on the comparison in Table 7.1, it was deduced 
that the data of compound NAM 7-14 were more comparable to those for 7.14 rather 
than to those reported for 7.13. Based on these data, compound NAM 7-14 was 
identified as thiazostatin B (7.14). 
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Table 7.1: Comparison of 
1
H NMR data of compound NAM 7-14 and the reported 
compounds 7.13 and 7.14. 
 
δ1H, ppm multiplicity (JHH Hz) Position 
NAM 7-14a 7.13b 7.14b 
1    
2    
3 6.92, d (8.3)c 6.92, dd (0.9, 8.5) 6.93, dd (0.9, 8.5) 
4 7.35, t (8.3, 8.3)c 7.35, ddd (1.5, 7.8, 8.5) 7.35, ddd (1.6, 7.8, 8.5) 
5 6.88, t (8.3, 8.3)c 6.88, ddd (0.9, 7.8, 7.8) 6.88, ddd (0.9, 7.8, 7.8) 
6 7.41, d (8.3)c 7.39, dd (1.5, 7.8) 7.41, dd (1.6, 7.8) 
2'    
4' 5.23 (m) 5.14, dt (3.2, 9.1) 5.23, dt (3.4, 9.0) 
5' 3.41, dd (9.4, 11.2) 3.28, dd (9.1, 11.0) 3.41, dd (9.0, 11.2) 
 3.53, dd (9.4, 11.2)c 3.54, dd (9.1, 11.0) 3.53, dd (9.1, 11.2) 
2" 4.68, d (4.2)c 4.68, d (3.2) 4.68, d (3.4) 
4"    
5" 2.79, d (10.6) 2.85, d (10.6) 2.79, d (12.0) 
 3.34d 3.17, d (10.6) 3.34, d (12.0) 
6"    
7" 2.51, s (CH3) 2.63, s (CH3) 2.50, s (CH3) 
8" 1.45, s (CH3) 1.50, s (CH3) 1.45, s (CH3) 
a These data were recorded at 500 MHz in CD3OD;  
b These data were recorded at 400 MHz in CD3OD (Shindo et al., 
1989). c These values were observed as overlapping signals of compounds (7.13) and (7.14). d This value was not 
fully resolved. 
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7.3.2 Extract F6430 
 
Extract F6430 was obtained from a PYGB culture medium of Paecilomyces sp. 
(PR5L9). This small-scale extract showed a moderately cytotoxic activity against P388 
cells (IC5010,445 ng/mL) but was inactive in the antimicrobial assays.. The HPLC 
screening of F6430 revealed five main compounds, NAM 7-15, NAM 7-16, NAM 7-17, 
NAM 7-18 and NAM 7-19 which eluted over 10.0 – 16.0 min (see Figure 7.24). 
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Figure 7.24: HPLC chromatogram of F6430 showing overlay of ELSD detection (top) 
for compounds NAM 7-15, NAM 7-16, NAM 7-17, NAM 7-18 and NAM 7-19. 
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The HPLC fractionation of 250 µg of crude extract (F6430) gave partially purified 
compounds NAM 7-15, NAM 7-16, NAM 7-17, NAM 7-18 and NAM 7-19 (see Figure 
7.25). Characterization of these compounds is discussed in Section 7.3.2.1 (NAM 7-15 
and NAM 7-17) and Section 7.3.2.2 (NAM 7-16). Compounds NAM 7-18 and NAM 7-
19 are not further discussed as insufficient high quality NMR data were obtained. 
 
 
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0
-200
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
mV
min
 
Figure 7.25: HPLC chromatogram of crude extract F6430 (250 µg) showing the 
fractionation of compounds NAM 7-15, NAM 7-16, NAM 7-17, NAM 7-18 and NAM 
7-19 collected into their respective wells of the microtitre plate. 
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7.3.2.1 Compounds NAM 7-15 and NAM 7-17 
 
Compounds NAM 7-15 and NAM 7-17 had identical UV chromophores (Figure 7.26), 
suggesting they were related structures. Compound NAM 7-15 showed an exact match 
in both UV profile and Rt with the known compound, indole-3-carboxylic acid (7.15) in 
the HPLC-UV/Rt library database. Compound NAM 7-17 also displayed a match with 
the UV spectrum of the indole-3-carboxylic acid (7.15) but the Rt differed significantly. 
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Figure 7.26: UV profile of F6430 showing overlays of compound NAM 7-15 (black) 
and the HPLC-UV/Rt library hit (red) with the known indole-3-carboxylic acid (7.15). 
An overlay of the UV spectrum of compound NAM 7-17 is shown in blue. 
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The 
1
H NMR spectrum of compound NAM 7-17 (2 µg) revealed a singlet methyl group 
(δH 3.88), one singlet aromatic proton (δH 7.95) and another four vicinal coupled 
aromatic protons (δH 7.17 - 8.04) (see Figure 7.27). 
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Figure 7.27: 
1
H NMR spectrum of compound NAM 7-17 in CD3OD obtained from 
F6430. 
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The ESIMS spectrum of compound NAM 7-17 (Figure 7.28) showed a molecular mass 
of 176 Da ([M+H]
+
), indicating an additional 14 mass units compared to compound 
NAM 7-15 (7.15). 
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Figure 7.28: ESIMS spectrum of compound NAM 7-17. 
 
 
A search in the AntiMarin database for indole-related compounds with molecular 
weight of 174 – 176 Da and a singlet methyl resulted in two hits; namely methyl 1H-
indole-3-carboxylate (7.17) and methyl 1H-indole-2-carboxylate (7.18). 
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The 
1
H NMR data of compound NAM 7-17 was compared with the reported 
compounds methyl 1H-indole-3-carboxylate (7.17) (Tan et al., 2004) and 1H-indole-3-
carboxylic acid (7.15) (Yue et al., 2000). These are shown in Table 7.2. Variations in 
the values were expected between compounds NAM 7-17 and 7.17 since the chemical 
shifts of both compounds were referenced against different solvent peaks. The 
1
H 
spectral data of compound NAM 7-17 (excluding the methoxyl protons) were consistent 
with a 3-substituted indole as described for the reported 1H-indole-3-carboxylic acid 
(7.15). The additional mass of 14 of compound NAM 7-17 compared to that of 1H-
indole-3-carboxylic acid (7.15) corresponded to an additional methoxyl group. Based on 
these data, compound NAM 7-17 was identified as methyl 1H-indole-3-carboxylate 
(7.17). 
 
 
Table 7.2: Comparison of 
1
H NMR data of compound NAM 7-17 and of the reported 
compounds 7.15 and 7.17. 
 
δ1H, ppm multiplicity (JHH Hz) Position 
NAM 7-17a 7.15 b 7.17c 
1    
2 7.95, s 8.32, s 7.94, s 
3    
4 8.04, d, br (7.3) 8.27, d (9.0) 8.05, d (7.7) 
5 7.17, ddd (7.3, 7.3, 1.0) 7.25, m 7.16, ddd (7.7, 7.7, 1.2) 
6 7.19, ddd (7.3, 7.3, 1.0) 7.25, m 7.19, ddd (7.7, 7.7, 1.2) 
7 7.43 d, br (7.3) 7.54, d (9.0) 7.43, d (7.7) 
3' 3.88, s 4.70, s  
a These data were recorded at 500 MHz in CD3OD; 
b These data were recorded at 400 MHz in acetone-d6 (Yue et al., 
2000); c These data were recorded at 500 MHz in CD3OD, reference signal value not stated (Tan et al., 2004). 
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7.3.2.2 Compound NAM 7-16 
 
The UV spectrum of compound NAM 7-16 (see Figure 7.29) did not show any match 
with known compounds in the HPLC-UV/Rt library database. Although the 
1
H NMR 
spectrum of compound NAM 7-16 (3 µg) indicated some impurities, the presence of a 
doublet methyl at δH 1.51 and two aromatic protons (δH 6.93 and 8.15) with an ortho-
coupling pattern was clearly shown (see Figure 7.30). 
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Figure 7.29: UV profile of NAM 7-16 obtained from F6430. 
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ppm2345678
Figure 7.30: 
1
H NMR spectrum of compound NAM 7-16 in CD3OD obtained from 
F6430. Crosses indicate impurities. 
 
 
Compound NAM 7-16 had a molecular mass of 223 Da ([M+H]
+
) (Figure 7.31) and a 
search in the AntiMarin database on compounds with a molecular weight of 221 – 223 
Da and a doublet methyl resulted in 14 hits (of 208 hits without the 
1
H NMR data 
input). The coupling constant pattern of the aromatic protons in compound NAM 7-16 
(δH 6.93 and 8.15) was helpful to discriminating against 12 of the 14 possible matches. 
The two compounds that possibly fit the structure for compound NAM 7-16 were (R)-8-
hydroxyl-3-methyl-1-oxoisochroman-5-carboxylic acid (known as 5-carboxymellein) 
(7.16) and (R)-8-hydroxyl-3-methyl-1-oxoisochroman-7-carboxylic acid (known as 
ochratoxin β) (7.19). 
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Figure 7.31: ESIMS spectrum of compound NAM 7-16. 
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The 
1
H NMR data of compound NAM 7-16 were compared to those reported for 5-
carboxymellein (7.16) (Anderson and Edwards, 1983) and ochratoxin β (7.19) (Kraus, 
1981) and these are presented in Table 7.3. Based on the comparison, the data of 
compound NAM 7-16 were consistent with those for 5-carboxymellein (7.16), and was 
thus identified as 5-carboxymellein (7.16). 
 
[M+H]
+
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Table 7.3: Comparison of 
1
H NMR data of compound NAM 7-16 and of the reported 
compounds 7.16 and 7.19. 
 
δ1H, ppm multiplicity (JHH Hz) Position 
NAM 7-16a 7.19 b 7.16c 
1    
2    
3 4.71, m 4.63 – 4.76, m 4.76, m 
4 3.03, dd (11.8, 17.8) 2.8 – 3.2, m 3.02, dd (12.0, 17.5) 
 3.90, dd (3.2, 17.8)  3.80, dd (3.0, 17.5) 
5 6.93, d (9.0) 6.85, d (8.0) 6.96, d (9.0) 
6 8.15, d (9.0) 7.95, d (8.0) 8.07, d (9.0) 
7    
8    
3' 1.51, d, 3H, (6.2) 1.40, d (6.65) 1.45, d (5.5) 
a These data were recorded at 500 MHz in CD3OD;  
b These data were recorded in DMSO-d6 (Kraus, 1981); 
c These 
data were recorded at 500 MHz in DMSO-d6 (Anderson and Edwards, 1983). 
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7.4 Discussion 
 
The dereplication approach using the LC-MS-UV works efficiently if the compounds 
have characteristic UV spectra, simple MS and not too many hits in the AntiMarin 
database search. A conclusive molecular weight cannot always be obtained from a 
single positive ion ESIMS experiment. Too often it is not possible to determine if the 
ion is MH
+
 or MNa
+
 or MNH4
+
 or MHCH3CN
+
 etc. (e.g: Nielsen and Smedsgaard, 
2003) which can lead to confusion over the actual molecular weight. A good example of 
simple application of LC-MS-UV technique in combination with the AntiMarin 
database was presented by the identification of chromomycin A2 (7.1), chromomycin 
A3 (7.2) and chromomycin 02-3D (7.3) from extract F5956 (see Section 7.2.1). The 
AntiMarin database search (<50 hits) greatly aided the identification process. In the case 
of fungal metabolite, particularly from Penicillium spp., the incorporation of the 
published database for fungal metabolites (Nielsen and Smedsgaard, 2003) was useful 
in the process even if the AntiMarin database search resulted in too many hits (e.g: 
>150 hits). The significant peaks could be dereplicated by comparing their MS and UV 
profiles with the published database. UV spectral data was shown to be a valuable tool 
for identification of metabolites with similar MS data. This was seen in compounds 
NAM 7-7 (Section 7.2.3) and NAM 7-10 (Section 7.2.4) where both compounds 
showed similar presence of a dimeric cluster ion [2M+H]
+
 that allowed assignment of 
their [M+H]
+
 ions as 281. These compounds were characterized as cyclopeptin (7.7) 
(NAM 7-7) and brefeldin A (7.10) (NAM 7-10) based on the differences in their 
distinguished UV spectra. 
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The CapNMR technique together with the AntiMarin database enables the dereplication 
of metabolites without having to put effort for total purification of metabolites. Partially 
purified compounds in less than 10 µg could be effectively dereplicated using the power 
of the AntiMarin database. AntiMarin includes NMR-based functional group and many 
types of methyl groups and aromatic spin systems could be usually recognized in the 
1
H 
NMR of partially pure compounds. Partially pure compounds NAM 7-14 (2 µg) 
(Section 7.3.1) and NAM 7-16 (3 µg) (Section 7.3.2.2) were successfully dereplicated 
as thiazostatin B (7.14) and 5-carboxymellein (7.16), respectively, using the CapNMR 
technique. In addition to that, a reasonable pure compound NAM 7-17 (2 µg) (Section 
7.3.2.1) was identified as methyl 1H-indole-3-carboxylate (7.17). The incorporation of 
1
H NMR data in the search profile of the database for compound NAM 7-14 reduced the 
possible hits to 19 from 218 hits of the original search by using only MS data. The 
indication of the presence of an N-methyl or aromatic methyl in compound NAM 7-14 
further reduced the possible 19 hits to two. Similarly, the search profile for compound 
NAM 7-16 was reduced from 208 to 14 hits with known compounds. By considering 
the coupling constant pattern of the aromatic protons in compound NAM 7-16, the 
search was narrowed even further, so that the total number of possible structures was 
reduced from 14 to two. 
 
Rapid dereplication of fungal metabolites was greatly supported by the in-house HPLC-
UV/Rt library database. In this technique, a match with both the UV data and Rt was 
necessary for dereplication of a compound. In cases where related compounds with 
identical UV chromophores but differed in the Rt, further MS or NMR analysis needs to 
be carried out for confirmation. An example is shown by compound NAM 7-17 that 
displayed a UV match with the known indole-3-carboxylic acid (7.15) in the in-house 
library, but the Rt differed significantly. The 
1
H NMR and MS data of compound NAM 
7-17 were found to be in agreement with another type of indole compound, methyl 1H-
indole-3-carboxylate (7.17). 
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Chapter 8 
 
 
Conclusion 
 
 
A series of experiments was conducted to investigate biological and chemical properties 
of marine-derived actinomycetes and fungi from various marine-derived invertebrates in 
New Zealand and Malaysian waters. 
 
Actinomycetes and fungi were successfully isolated from both New Zealand and 
Malaysian marine invertebrates. All isolates grew on both sea water and non-sea water 
media, thus all of them can be classified as facultatively marine. No obligate marine 
microorganisms were isolated. 
 
Some 55% of extracts showed some bioactivity. Of these, 93% showed cytotoxicity 
against the P388 cell lines and the remainder showed variable cytotoxic and 
antibacterial and/or antifungal activity. 
 
The actinomycetes isolated differed from the fungi in that a clear preference was 
evident in the production of cytotoxic metabolites for solid-state fermentation as 
opposed to liquid fermentation. Fungi were very variable in this respect. 
 
Three New Zealand actinomycetes, four New Zealand fungi and a Malaysian fungus 
whose initial screening showed good cytotoxicity (IC50<12,500 ng/mL) were selected 
for bioassay guided chemical characterization. A Malaysian fungus that showed 
IC5012,881 ng/mL was also investigated for chemical characterization due to interesting 
chemical properties. 
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Structural elucidation of metabolites was greatly aided by the in-house dereplication 
techniques using HPLC-UV/Rt library and AntiMarin database. A significant advantage 
was gained by the use of the CapNMR which enabled NMR characterization of very 
small quantities of metabolites (<20 µg). 
 
A new metabolite, S-methyl 2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzothioate (5.15) 
and four known metabolites (bohemamine (5.1), bohemamine B (5.2), montagnetol 
(5.16) and erythrin (5.18)) were isolated and identified from Streptomyces sp. (LA3L2) 
using the CapNMR technique. The structure of S-methyl 2,4-dihydroxy-6-isopropyl-
3,5-dimethylbenzothioate (5.15) was fully characterized by 
1
H, HSQC, HMBC and 
NOE experiments. This new compound is only the third compound reported to contain 
the S-methyl benzothioate group. Streptomyces sp. (LA3L2) is the first reported 
actinomycete to produce montagnetol (5.16) and erythrin (5.18). The known metabolite 
bohemamine (5.1) was produced significantly at a temperature 20 – 28ºC and 4% 
salinity. 
 
The known compounds thiazostatin B (7.14) and three chromomycins (chromomycin 
A2 (7.1), A3 (7.2) and 02-3D (7.3)) were isolated from Streptomyces sp. (LA5L4) and 
Streptomyces sp. (LA3L1), respectively. 
 
Penicillium sp. (LY1L5) yielded two known metabolites, cycloaspeptide A (7.4) and α-
cyclopiazonic acid (7.5). α-Cyclopiazonic acid (7.5) and three other known metabolites 
(roquefortine A (7.6), cyclopeptin (7.7) and viridicatin (7.8)) were dereplicated from 
Penicillium sp. (KK3T23). Penicillium sp. (KK3T8) produced brefeldin A (7.10) while 
mycophenolic acid (7.12) and brevianamide A (7.11) were produced by Penicillium sp. 
(KK4T14b). 
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The effect of salinity on growth and cytotoxicity was investigated for the two 
Penicillium isolates producing the cytotoxic metabolite, α-cyclopiazonic acid (7.5). 
Results indicated that saline conditions were not required for growth but metabolite 
production differed between the two isolates with respect to salinity. Isolate LY1L5 
required saline conditions for α-cyclopiazonic production whereas isolate KK3T23 
produced the metabolite under non-saline conditions and in concentrations of sea salt up 
to 6%. 
 
Three known metabolites, indole-3-carboxylic acid (7.15), indole-3-carboxylate (7.17) 
and 5-carboxymellein (7.16) were identified from Paecilomyces sp. (PR5L9). A unique 
cyclic depsipeptide structure, epi-angolide (NAM 6-1) was characterized from another 
Paecilomyces sp. (PR10T2) by 
1
H, COSY, HSQC and HMBC experiments. 
 
Rapid identification of known fungal metabolites enabled the in-house HPLC-UV/Rt 
library to be enhanced by eight metabolites. An HPLC-UV/Rt library for actinomycete 
metabolites was successfully established with the insertion of eight known metabolites. 
References 
_____________________________________________________________________________________ 
 201 
 
References 
 
 
Abraham, E. P. and Loder, P. B. 1972. In. Flynn, E. H. (ed). Cephalosporins and 
Penicillins: Chemistry and Biology. Academic Press. New York. 
 
Abrell, L. M., Cheng, X. and Crews, P. 1994. Tetrahedron Letters. 35:9159-9160. 
 
Abrell, L. M., Borgeson, B. and Crews, P. 1996. Tetrahedron Letters. 37:8983-8984. 
 
Adinarayana, G., Venkateshan, M. R., Bapiraju, V. V. S. N. K., Sujatha, P., Premkumar, 
J., Ellaiah, P. and Zeeck, A. 2006. Russian Journal of Bioorganic Chemistry. 32:328-
334. 
 
Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffmann, C., Rothcock, J., 
Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., 
Albers-Schonberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J. and 
Springer, J. 1980. Proceedings of the National Academy of Sciences of the United States 
of America. 77:3957-3961. 
 
Amagata, T., Doi, M., Ohta, T., Minoura, K. and Numata, A. 1998. Journal of the 
Chemical Society, Perkin Transactions 1. 21:3585-3600. 
 
Amagata, T., Amagata, A., Tenney, K., Valeriote, F.A., Lobkovsky, E., Clardy, J. and 
Crews, P. 2003. Organic Letters. 23:4393-4396. 
 
Amagata, T., Minoura, K. and Numata, A. 2006a. Journal of Natural Products. 
69:1384-1388. 
 
Amagata, T., Morinaka, B.I., Amagata, A., Tenney, K., Valeriote, F.A., Lobkovsky, E., 
Clardy, J. and Crews, P. 2006b. Journal of Natural Products. 69:1560-1565. 
 
Anderson, J. R. and Edwards, R. L. 1983. Journal of the Chemical Society, Perkin 
Transactions 1. 2185-2192. 
 
Asolkar, R. N., Jensen, P. R., Kauffman, C. A. and Fenical, W. 2006. Journal of 
Natural Products. 69:1756-1759. 
 
Atz, J. W. 1952. Animal Kingdom. 55:175–177. 
 
Barcina, I., Iriberri, J. and Egea, L. 1987. Systematic and Applied Microbiology. 10:85–
91. 
 
Barghoorn, E. S. 1944. Farlowia. 1:434-467. 
 
Barton, S. D. and Nakanishi, K. 1999. Comprehensive Natural Products Chemistry. 
Elsevier, New York. 
 
References 
_____________________________________________________________________________________ 
 202 
 
Belofsky, G. N., Jensen, P. R. and Fenical, W. 1999. Tetrahedron Letters. 40:2913-
2916. 
 
Bergmann, W. and Feeney, R. J. 1951. Journal of Organic Chemistry. 16:981-987. 
 
Bewley, C. A., Holland, N. D. and Faulkner, D. J. 1996. Experientia. 52:716-722. 
 
Bewley, C. A. and Faulkner, D. J. 1998. Angewandte Chemie International Edition. 
37:2163-2178. 
 
Bin Hamat, A. L., Bin Din, L., Bin Samsudin, M, W. and Elix, J. A. 1992. Australian 
Journal of Chemistry. 46:153-156.  
 
Bister, B., Bischoff, D., Strobele, M., Riedlinger, J., Reicke, A., Wolter, F., Bull, A. T., 
Zahner, H., Fiedler, H. P., Sussmuth, R. D. 2004. Angewandte Chemie International 
Edition. 43:2574-2576. 
 
Bloomberg, A. and Adler, A. 1992. Advances in Microbial Physiology. 33:144-212. 
 
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T. and Prinsep, M. R. 2003. 
Natural Product Reports. 20:1-48. 
 
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T. and Prinsep, M. R. 2004. 
Natural Product Reports. 21:1-49. 
 
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T. and Prinsep, M. R. 2005. 
Natural Product Reports. 22:15-61. 
 
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T. and Prinsep, M. R.  2006. 
Natural Product Reports. 23:26-78. 
 
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T. and Prinsep, M. R.  2007. 
Natural Product Reports. 24:31-86. 
 
Bode, H. B., Bethe, B., Hofs, R. and Zeeck, A. 2002. European Journal of Chemical 
Biology. 3:619-627. 
 
Bonnard, I., Manzanares, I. and Rinehart, K. L. 2003. Journal of Natural Products. 
66:1466-1470. 
 
Boot, C.M., Tenney, K., Valeriote, F. A. and Crews, P. 2006. Journal of Natural 
Products. 69:83-92. 
 
Borris, R. P. and Gould, S. J. 1999. Molecular Diversity, Biological Diversity and the 
Search for New Drugs.  
URL: http://www.iupac.org/symposia/proceedings/phuket97/borris.html 
 
References 
_____________________________________________________________________________________ 
 203 
 
Brauers, G., Ebel, R., Edrada R. A., Wray, V., Berg, A., Grafe, U. and Proksch, P. 2001. 
Journal of Natural Products. 64:651-652. 
 
Bringmann, G., Lang, G., Muhlbacher, J., Schaumann, K., Steffens, S.,  
Rytik, P.G., Hentschel, U., Morschhauser, J. and Muller, W.E.G. 2003. Progress in 
Molecular and Subcellular Biology. 37:231-253. 
 
Bringmann, G., Lang, G., Steffens, S. and Schaumann, K. 2004. Journal of Natural 
Products. 67:311-315. 
 
Bubb, M. R., Senderowicz, A. M., Sausville, E. A., Duncan, K. L. and Korn, E. D. 
1994. Journal of Biological Chemistry. 269:14869-14871.  
 
Buchanan, G. O., Williams, P. G., Feling, R. H., Kauffman, C. A., Jensen, P. R., 
Fenical, W. 2005. Organic Letters. 7:2731-2734. 
 
Bugni, T. S., Abbanat, D., Bernan, V. S., Maiese, W. M., Greenstein, M., Van Wagoner, 
R. M. and Ireland, C. M. 2000. Journal of Organic Chemistry. 65:7195-7200. 
 
Bugni, T. S. and Ireland, C. M. 2004. Natural Product Reports. 21:143-163. 
 
Bugni, T. S., Woolery, M., Kauffman, C. A., Jensen, P. R. and Fenical, W. 2006. 
Journal of Natural Products. 69:1626-1628. 
 
Bull, A. T., Ward, A. C., and Goodfellow, M. 2000. Microbiology and Molecular 
Biology Reviews. 64:573–606. 
 
Burja, A. M., Banaigs, B., Abou-Mansour, E., Burgess, J. G. and Wright, P. C. 2001. 
Tetrahedron. 57:9347 
 
Cabrera, G. M., Butler, M., Rodriguez, M. A., Godeas, A. H., Haddad, R. and Eberlin, 
M. N., 2006. Journal of Natural Products. 69:1806-1808. 
 
Capon, R. J., Skene, C. Stewart, M., Ford, J., O’Hair, R. A. J., Williams, L., Lacey, E., 
Gill, J. H., Heiland, K. and Friedel, T. 2003. Organic and Biomolecular Chemistry. 
1:1856-1862. 
 
Chan, W. R., Tinto, W. F., Manchand, P. S. and Todaro, L. J. 1987. Journal of Organic 
Chemistry. 52:3091-3093. 
 
Charan, R.D., Schlingmann, G., Janso, J., Bernan, V., Feng, X., Carter, G.T. 2004. 
Journal of Natural Products. 67:1431-1433. 
 
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., 
Mitsiades, N., Yasui, H., Letai, A. 2005. Cancer Cell. 8:407-419. 
 
Cheng, X., Varoglu, M., Abrell, L., Crews, P., Lobkovsky, E. and Clardy, J. 1994. 
Journal of Organic Chemistry. 59:6344-6348. 
 
References 
_____________________________________________________________________________________ 
 204 
 
Cheng, Y., Schneider, B., Riese, U., Schubert, B., Li, Z. and Hamburger, M. 2006. 
Journal of Natural Products. 69:436-438.  
 
Cho, J. Y., Kwon, H. C., Williams, P. G., Jensen, P. R. and Fenical, W. 2006. Organic 
Letters. 8:2471-2474. 
 
Christian, O. E., Compton, J., Christian, K. R., Mooberry, S. L., Valeriote, F. A. and 
Crews, P. 2005. Journal of Natural Products. 68:1592-1597. 
 
Colquhoun, J. A., Mexson, J., Goodfellow, M., Ward, A. C., Horikoshi, K. and Bull, A. 
T. 1998. Antonie van Leeuwenhoek. 74:27–40. 
 
Crews, P., Manes, L.V. and Boehler, M. 1986. Tetrahedron Letters. 27:2797. 
 
Cruz, L. J., Martinez, I. M., Perez Baz, J., Trujillo, M., Rodriquez-Miaz, R. A., Oliveira, 
E., Giralt, E., Albericio, F. and Canedo, L. M. 2006. Journal of Organic Chemistry. 
71:3335-3338. 
 
Cueto, M., Jensen, P. R. and Fenical, W. 2000. Phytochemistry. 55:223-226. 
 
Culberson, C. F. 1969. Chemical and Botanical Guide to Lichen Products. The 
University of North Carolina Press. Chapel Hill. USA. pp. 112-117. 
 
Culvenor, C. C. J. 1980. In. Smith, R. L. and Bababunmi, E. A. (ed.). Toxicology in the 
Tropics. Taylor and Francis Limited. London. pp. 124-141. 
 
Dalsgaard, P. W., Larsen, T. O., Frydenvang, K. and Christophersen, C. 2004. Journal 
of Natural Products. 67:878-881. 
 
Dalsgaard, P. W., Larsen, T. O. and Christophersen, C. 2005. Journal of Antibiotics. 
58:141–144. 
 
Demain, A. L. 1968. Lloydia. 31:395-418. 
 
Doyle, T. W., Nettleton, D. E. Jr., Balitz, D. M. Moseley, J. E., Grulich, R. E., 
McCable, T. and Clardy, J. 1980. Journal of Organic Chemistry. 45:1324-1326. 
 
Dreyfuss, M., Harri, E., Hotmann, H., Kobel, H., Pache, W. and Tscherter, H. 1976. 
Journal of Applied Microbiology. 3:125-133. 
 
Ebel, R. 2006. In. Proksch, P. and Muller, W. E. G. (eds.). Frontiers in Marine 
Biotechnology. Horizon Bioscience. pp. 73-143. 
 
Edrada, R. A., Wray, V., Berg, A., Grafe, U., Sudarsono, Brauers, G. and Proksch, P. 
2000. Zeitschrift fur Naturforschung C: Journal of Biosciences. 55:218-221. 
 
References 
_____________________________________________________________________________________ 
 205 
 
Edrada, R. A., Heubes, M., Brauers, G., Wray, V., Berg, A., Grafe, U., Wohlfarth, M., 
Muhlbacher, J., Schaumann, K., Sudarsono, Bringmann, G. and Proksch, P. 2002. 
Journal of Natural Products. 65:1598-1604. 
 
Ellis, M. B., Riches, P. and Russel, D. W. 1966. Biochemical Journal. 98:8P-9P. 
 
Elix, J. A., Kalb, K. and Wardlaw, J. H. 2003. Australian Journal of Chemistry. 56:315-
317. 
 
Espinosa, R. M. D. and Webb, C. 2003. World Journal of Microbiology and 
Biotechnology. 19:329-336. 
 
Farrel, J. and Rose, A. 1967. Annual Review of Microbiology. 21:101-120. 
 
Faulkner, D. J. 1994. Natural Product Reports. 11:355-394. 
 
Faulkner, D. J. 1999. Natural Product Reports. 16:155-198. 
 
Faulkner, D. J. 2000a. Natural Product Reports. 17:1-6. 
 
Faulkner, D. J. 2000b. Natural Product Reports. 17:7-55. 
 
Faulkner, D. J. 2001. Natural Product Reports. 18:1-49. 
 
Faulkner, D. J. 2002. Natural Product Reports. 19:1-48. 
 
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., Fenical, 
W. 2003. Angewandte Chemie International Edition England. 42:355-357. 
 
Fenical, W. 1993. Chemical Reviews. 93:1673–1683. 
 
Fenical, W. 1997. Trends in Biotechnology. 15:339-341. 
 
Fernandez, R., Omar, S., Feliz, M., Quinoa, E. and Riguera, R. 1992. Tetrahedron 
Letters. 33:6017-6020.    
 
Fiedler, H. P., Bruntner, C., Bull, A. T., Ward, A. C, Goodfellow, M., Potterat, O., 
Puder, C. and Mihm, G. 2005. Antonie van Leeuwenhoek. 87:37-42. 
 
Filtenbort, O., Frisvad, J. C. and Svendsen, J. A. 1983. Appllied and Environmental 
Microbiology. 45:581–585. 
 
Ford, P. W., Gadepalli, M. and Davidson, B. S. 1998. Journal of Natural Products. 
61:1232-1236. 
 
Frendenhagen, A., Hug, P., Sauter, H. and Peter, H. H. 1995. Journal of Antibiotics. 
48:199-204. 
 
References 
_____________________________________________________________________________________ 
 206 
 
Frisvad, J. and Thrane, U. 1987. Journal of Chromatography. 404:195. 
 
Frisvad, J. C., Filtenborg, O. and Thrane, U. 1989. Archives of Environmental 
Contamination and Toxicology. 18:331–335. 
 
Frisvad, J. C., Smedsgaard, J., Larsen, T. O. and Samson, R. A. 2004. Studies in 
Mycology. 49:201–242. 
 
Frisvad, J. C., Larsen, T. O., Dalsgaard, P. W., Seifert, K. A., Seize, G. L., Lyhne, E. K., 
Jarvis, B. B., Fettinger, J. C. and Overy, D. P. 2006. International Journal of Systematic 
and Evolutionary Microbiology. 56:1427-1437. 
 
Fukushima, K., Arai, T., Mori, Y., Tsuboi, M. and Suzuki, M. 1983a. Journal of 
Antibiotics. 36:1606-1612. 
 
Fukushima, K., Arai, T., Mori, Y., Tsuboi, M. and Suzuki, M. 1983b. Journal of 
Antibiotics. 36:1613-1630. 
 
Furuya, K. 1986. In. Yamasato, H., Udagawa, S., Kodama, T. and Morichi, T. (eds.). 
Marine fungi – Isolation Methods of Microorganisms. R & D Planning. Tokyo. pp. 101.  
 
Gonzalez, A. G., Bermejo, B. J., Rodriguez, P. E. M. and Hernandez, P. C. E. 1992. 
Planta Medica. 58:214-218. 
 
Gonzalez, J. B., Fernandez, F. J. and Tomasini, A. 2003. Indian Journal of 
Biotechnology. 2:322-333. 
 
Gronquist, M., Meinwald, J., Eisner, T. and Schroeder, F.C. 2005. Journal of the 
American Chemical Society.127:10810-10811. 
 
Haefner, B. 2003. Drug Discovery Today. 8:536–544. 
 
Harris, R. F. 1981. In. Parr, J. F., Gardner, W. R. and Elliot, L. F. (eds.). Water 
Potential Relations in Soil Microbiology. Soil Science Society of America. Madison. 
Wisconsin. p. 23-95. 
 
Higgs, R. E., Zahn, J. A., Gygi, J. D. and Hilton, M. D. 2001. Applied and 
Environmental Microbiology. 67:371–376. 
 
Hiort, J., Maksimenka, K., Reichert, M., Perovic-Ottstadt, Lin, W. H., Wray, V., Steube, 
K., Schaumann, K., Weber, H., Proksch, P., Ebel, R., Muller, W. E. G. and Bringmann, 
G. 2004. Journal of Natural Products. 67:1532-1543. 
 
Holler, U., Konig, G. M. and Wright, A. D. 1999. Journal of Natural Products. 62:114-
118. 
 
Hu, J. F., Wunderlich, D., Thiericke, R., Dahse, H. M., Grabley, S., Feng, X. Z., Sattler, 
I. 2003. Journal of Antibiotics. 56:747-754. 
 
References 
_____________________________________________________________________________________ 
 207 
 
Hu, J. F., Garo, E., Yoo, H. D., Cremin, P. A., Zeng, L., Goering, M. G., Johnson, M. O. 
and Eldridge, G. R. 2005. Phytochemical Analysis. 16:127–133. 
 
Huang, Y. F., Tian, L., Fu, H. W., Hua, H. M. and Pei, Y. H. 2006. Natural Products 
Research. 20:1207-1210. 
 
Hughes, G.C. 1975. Oceanographic and Marine Biology Annual Review. 13:69-180. 
 
Huneck, S. and Follmann, G. 1968a. Bryologist. 71:266-267. 
 
Huneck, S. and Follmann, G. 1968b. Pharmazie. 23:156-157.  
 
Imada, C. and Okami, Y. 1995. Journal of Marine Biotechnology. 2:109–113. 
 
Isaka, M., Kittakoop, P. and Thebtaranonth, Y. 2003. In. White, J. F., Jr., Bacon, C. W., 
Hywel-Jones, N. L. and Spatafora, J. W. (ed.). Clavicipitalean Fungi: Evolutionary 
Biology, Chemistry, Biocontrol and Cultural Impacts. Marcel Dekker Incorporation. 
New York. p. 355-398. 
 
Isaka, M., Palasarn, S., Lapanun, S. and Sriklung, K. 2007. Journal of Natural 
Products. 70:675-678. 
 
Itoh, T., Kinoshita, M., Aoki, S. and Kobayashi, M. 2003. Journal of Natural Products. 
66:1373-1377. 
 
Jadulco, R., Proksch, P., Wray, V., Sudarsono, Berg, A. and Graefe, U. 2001. Journal of 
Natural Products. 64:527-530. 
 
Jadulco, R., Brauers, G., Edrada, R. A., Ebel, R., Wray, V., Sudarsono and Proksch, P. 
2002. Journal of Natural Products. 65:730-733. 
 
Jadulco, R., Edrada, R. A., Ebel, R., Berg, A., Schaumann, K., Wray, V., Staube, K. and 
Proksch, P. 2004. Journal of Natural Products. 67:78-81. 
 
Jansen, R., Kunze, B., Reichenbach, H. and Hofle, G. 1996. Liebigs Annalen. 2:285-
290.  
 
Janso, J. E., Bernan, V. S., Greenstein, M., Bugni, T. S. and Ireland, C. M. 2005. 
Mycologia. 97:444-453. 
 
Jenkins, K. M., Renner, M. K., Jensen, P. R. and Fenical, W. 1998. Tetrahedron Letters. 
39:2463-2466. 
 
Jennings, D. H. 1983. Biological Review. 58:423-459. 
 
Jensen, P. R., Dwight, R. and Fenical, W. 1991. Applied and Environmental 
Microbiology. 57:1102–1108. 
 
References 
_____________________________________________________________________________________ 
 208 
 
Jensen, P. R., Mincer, T. J, Williams, P. G and Fenical, W. 2005a. Antonie van 
Leeuwenhoek. 87:43-48. 
 
Jensen, P. R., Gontang, E., Mafnas, C., Mincer, T. J. and Fenical, W. 2005b. 
Environmental Microbiology. 7:1039-1048. 
 
Jones, E. B. G. and Jennings, D. H. 1964. Transactions of British Mycological Society. 
47:619-625. 
 
Kathirgamanathar, S., Williams, D. E., Andersen, R. J., Bombuwela, K., De Silva, D., 
Karunaratne, V. 2005. Natural Products Research. 19:695-701. 
 
Kawano, T., Hidaka, T., Furihata, K., Mochizuki, J., Nakayama, H., Hayakawa, Y. and 
Seto, H. 1990. Journal of Antibiotics. 43:110-113. 
 
Kelecom A. 1999. Anais da Academia Brasileira de Ciencias. 71:249-263. 
 
Kelecom, A. 2002. Anais da Academia Brasileira de Ciencias. 74:151–170. 
 
Kikuchi, H., Miyagawa, Y., Sahashi, Y., Inatomi, S., Haganuma, A., Nakahata, N. and 
Oshima, Y. 2004a. Tetrahedron Letters. 45:6225-6228. 
 
Kikuchi, H., Miyagawa, Y., Nakamura, K., Sahashi, Y., Inamori, S. and Oshima, Y. 
2004b. Organic Letters. 6:4531-4533. 
 
Kikuchi, H., Miyagawa, Y., Sahashi, Y., Inatomi, S., Haganuma, A., Nakahata, N. and 
Oshima, Y. 2004c. Journal of Organic Chemistry. 69:352-356. 
 
Kitagawa, I., Nishino, T., Kobayashi, M. and Kyogoku, Y. 1981. Chemical and 
Pharmaceutical Bulletin. 29:1951–1956. 
 
Klaric, M. S. and Pepeljnjak, S. 2005. Arhiv Za Higijenu Rada I Toksikologiyu. 56:343-
350. 
 
Kobayashi, R., Samejima, Y., Nakajima, S., Kawai, K. I. and Udagawa, S. I. 1987. 
Chemical and Pharmaceutical Bulletin. 35:1347-1352. 
 
Kobayashi, M., Kuroso, M., Ohyabu, N., Wang, W., Fujii, S. and Kitagawa, I. 1994a. 
Chemical and Pharmaceutical Bulletin. 42:2196-2198. 
 
Kobayashi, M., Aoki, S., Ohyabu, N., Kuroso, M., Wang, W. and Kitagawa, I. 1994b. 
Tetrahedron Letters. 35:7969-7972. 
 
Kohlmeyer, J. 1974. Veroeff. Inst. Meeresforsch. Bremerhaven. Suppl. 5:263-286. 
 
Kohlmeyer, J. and Kohlmeyer, E. 1979. Marine Mycology: The Higher Fungi. 
Academic Press. New York. 
 
References 
_____________________________________________________________________________________ 
 209 
 
Kokare, C. R., Mahadik, K. R., Kadam, S. S. and Chopade, B. A. 2004. Current 
Science. 86:593-597. 
 
Kralj, A., Kehraus, S., Krick, A., van Echten-Deckert, G. and Koenig, G. M. 2007.  
Planta Medica. 73:366-371. 
 
Kraus, G. A. 1981. Journal of Organic Chemistry. 46:201-202.   
 
Kupka, J., Anke, T., Steglich, W. and Zechlin, L. 1981. Journal of Antibiotics. 34:298-
304. 
 
Laatsch, H. 2006. In. Proksch, P. and  Muller, W. E. G. (eds.). Frontiers in Marine 
Biotechnology. Horizon Bioscience. p. 225-288. 
 
Lam, K. S. 2006. Current  Opinion in Microbiology. 9:245–251. 
 
Landreau, A., Pouchus, Y. F., Sallenave-Namont, C., Biard, J. F., Boumard, M. C., 
Pont, T. R., Mondeguer, F., Goulard, C. and Verbist, J. F. 2002. Journal of 
Microbiological Methods. 48:181–194. 
 
Lang, G., Blunt, J. W., Cummings, N. J., Cole, A. L. J. and Munro, M. H. G. 2005. 
Journal of Natural Products. 68:810-811. 
 
Lang, G., Mitova, M. I., Ellis, G., van der Sar, S., Phipps, R. K., Blunt, J. W., 
Cummings, N. J., Cole, A. L. J. and Munro, M. H. G. 2006. Journal of Natural 
Products. 69:621-624. 
 
Lang, G., Wiese, J., Schmaljohann, R. Adn Imhoff, J. F. 2007. Tetrahedron. 63:11844-
11849. 
 
Lee, H. K., Lee, D. S., Lim, J., Kim, J. S., Im, K. S. and Jung, J. H. 1998. Archives of 
Pharmacal Research. 21:729-733. 
 
Lee, H. S., Shin, H. J., Jang, K. H., Kim, T. S., Oh, K. B. and Shin, J. 2005. Journal of 
Natural Products. 68:623-625. 
 
Li, F., Maskey, R. P., Qin, S., Sattler, I., Fiebig, H. H., Maier, A., Zeeck, A. and 
Laatsch, H. 2005. Journal of Natural Products. 68:349-353. 
 
Lin, Y., Shao, Z., Jiang, G., Zhou, S., Cai, J., Vrijmoed, L. L. P. and Jones, E. B. G. 
2000. Tetrahedron. 56:9607-9609. 
 
Lin, W., Brauers, G., Ebel, R., Wray, V., Berg, A., Sudarsono and Proksch, P. 2003. 
Journal of Natural Products. 66:57-61. 
 
Lopez, J. M. S., Insua, M. M., Baz, J. P., Puentes, J. L. F. and Hernandez, L. M. C. 
2003. Journal of Natural Products. 66:863-864. 
 
References 
_____________________________________________________________________________________ 
 210 
 
Luesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L. and Corbett, T. H. 2001. Journal 
of Natural Products. 64:907-910. 
 
Macdonald, C. G. and Shannon, J. S. 1964. Tetrahedron Letters. (41-42):3113-3118. 
 
Macherla, V. R., Liu, J., Bellows, C., Teisan, S., Nicholson, B., Lam, K. S. and Potts, B. 
C. M. 2005. Journal of Natural Products. 68:780-783. 
 
Magarvey, N. A., Keller, J.M., Bernan, V., Dworkin, M. and Sherman, D. H. 2004. 
Applied and Environmental Microbiology. 70:7520-7529. 
 
Maldonado, L. A., Fenical, W., Jensen, P. R., Kauffman, C. A., Mincer, T. J., Ward, A. 
C., Bull, A. T. and Goodfellow, M. 2005. International Journal of Systematic and 
Evolutionary Microbiology. 55:1759-1766. 
 
Manam, R. R., Teisan, S., White, D. J., Nicholson, B., Grodberg, J., Neuteboom, S. T. 
C., Lam, K. S., Mosca, D. A., Lloyd, G. K. and Potts, B. C. M. 2005. Journal of Natural 
Products. 68:240-243. 
 
Masuma, R., Yamaguchi, Y., Noumi, M., Omura, S. and Namikoshi, M. 2001. 
Mycoscience. 42:455-459. 
 
Mikami, Y., Yazawa, K., Fukushima, K., Arai, T., Udagawa, S. and Samson, R. A. 
1989. Mycopathologia. 108:195-199. 
 
Miller, J. D. and Savard, M. E. 1989. Proceedings of the Nova Scotia Institute of 
Science. 39:51-58. 
 
Miller, E. D., Kauffman, C. A., Jensen, P. R. and Fenical, W. 2007. Journal of Organic 
Chemistry. 72:323-330. 
 
Mincer, T. J., Jensen, P. R., Christopher, A. K. and Fenical, W. 2002. Applied and 
Environmental Microbiology. 68:5005–5011. 
 
Mincer, T. J., Fenical, W. and Jensen, P. R. 2005. Applied and Environmental 
Microbiology. 71:7019-7028. 
 
Mitchell, S. S., Nicholson, B., Teisan, S., Lam, K. S. and Potts, B. C. M. 2004. Journal 
of Natural Products. 67:1400-1402. 
 
Miyamoto, M., Kawashima, K., Kawamatsu, Y., Shinohara, M., Tanaka, K., Tatsuoka, 
S. and Nakanishi, K. 1967. Tetrahedron. 23:421-437. 
 
Moore, B. S. 1999. Natural Product Reports. 16:653-674. 
 
Munoz, G. M. D. 2006. MSc Thesis. University of Puerto Rico. Mayaguez Campus. 
 
References 
_____________________________________________________________________________________ 
 211 
 
Namikoshi, M., Kobayashi, H., Yoshimoto, T. and Meguro, S. 2000. Chemistry Letters. 
4:308-309. 
 
Namikoshi, M., Akano, K., Kobayashi, H., Koike, Y., Kitazawa, A., Rondonuwu, A. B. 
and Pratasik, S. B. 2002. Journal of Tokyo University of Fisheries. 88:15-20. 
 
Nettleton, D. E., Jr., Balitz, D. M., Doyle, T. W.; Bradner, W. T., Johnson, D. L., 
O’Herron, F. A., Schreiber, R. H., Coon, A. B., Moseley, J. E., Myllymaki, R. W. 1980. 
Journal of Natural Products. 43:242-258. 
 
Newman, D. J. and Cragg, G. M. 2004. Journal of Natural Products. 67:1216–1238. 
 
Nielsen, K. F. and Smedsgaard, J. 2003. Journal of Chromatography A. 1002:111–136. 
 
Nigrelli, R. F., Stempien, M. F., Ruggieri, G. D., Liguori, V. R. and Cecil, J. T. 1967. 
Federation Proceedings. 26:1197–1205. 
 
Numata, A.,  Amagata, T., Minoura, K. and Ito, K. 1997. Tetrahedron Letters. 38:5675. 
 
Oh, D. C., Jensen, P. R. and Fenical, W. 2006. Tetrahedron Letters. 47:8625-8628. 
 
Okami, Y. 1974. Journal of Antibiotics. 27:240-247. 
 
Okami, Y. and Hotta, K. 1988. In. Goodfellow, M., Williams, S. T. and Mordarski, M. 
(ed.). Actinomycetes in Biotechnology. Academic Press. New York. p. 33–67. 
 
Okotore, R. O. and Russel, D. W. 1972. Canadian Journal of Biochemistry. 50:428-439. 
 
Perry, N. B., Benn, M. H., Brennan, N. J., Burgess, E. J., Ellis, G., Galloway, D. J., 
Lorimer, S. D. and Tangney, R. S. 1999. Lichenologist. 31:627-636. 
 
Pettit, G. R. 1997. Fortschritte der Chemie Organischer Naturstoffe: Progress in the 
Chemistry of Organic Natural Products.. 70:1-79. 
 
Piel, J. 2004. Natural Product Reports. 21:519-538. 
 
Pitt, J. I. 1979. The Genus Penicillium and Its Teleomorphic States Eupenicillium and 
Talaromyces. Academic Press. New York. 
 
Pittayakhajonwut, P., Dramae, A., Madla, S., Lartpornmatulee, N., Boonyuen, N., 
Tanticharoen, M. 2006. Journal of Natural Products. 69:1361-1363. 
 
Poch, G. K. and Gloer, J. B.  1991. Journal of Natural Products. 54:213-217. 
 
Poumale, H. M. P., Ngadjui, B. T., Helmke, E. and Laatsch, H. 2006. Zeitschrift fur 
Naturforschung B: Journal of Chemical Sciences. 61:1450-1454. 
 
References 
_____________________________________________________________________________________ 
 212 
 
Preobrazhenskaia, T. P., Kudrina, E. S., Sveshnikova, M. A. and Maximova, T. S. 1959. 
Mikrobiologiya. 28:623-627.  
 
Proksch, P., Edrada, R. A. and Ebel, R. 2002. Applied Microbiology and Biotechnology. 
59:125-134. 
 
Proksch, P., Edrada, R. A. and Lin, W. H. 2006. In. Proksch, P. and Muller, W. E. G. 
(eds.). Frontiers in Marine Biotechnology. Horizon Bioscience. p. 1-19. 
 
Pusecker, K., Laatsch, H., Helmke, E. and Weyland, H. 1997. Journal of Antibiotics. 
50:479-483. 
 
Rahbaek, L., Sperry, S., Piper, J. E., Crews, P. 1998. Journal of Natural Products. 
61:1571-1573.   
 
Rao, V. S. and Seshadri, T. R. 1941. Proceedings – Indian Academy of Science, Section 
A. 13A:199-202. 
 
Rao, V. S. and Seshadri, T. R. 1942a. Proceedings – Indian Academy of Science, 
Section A. 15A:18-23. 
 
Rao, V. S. and Seshadri, T. R. 1942b. Proceedings – Indian Academy of Science, 
Section A. 16A:23-28. 
 
Rath, J. P., Kinast, S., Maier, M. E. 2005. Organic Letters. 7:3089-3092. 
 
Rathnakala, R. R. and Chandrika, V. 1993. Indian Journal of Marine Science. 22:297-
299. 
 
Rehm, H. J. 1980. Industrielle Mikrobiologie. Springer-Verlag, Berlin. 
 
Renner, M. K., Shen, Y. C., Cheng, X. C., Jensen, P. R., Frankmoelle, W., Kauffman, 
C. A., Fenical, W., Lobkovsky, E. and Clardy, J. 1999. Journal of the American 
Chemical Society. 121:11273-11276. 
 
Rezanka, T. and Votruba, J. 1998. Folia Microbiologica. 43:47-50. 
 
Riedlinger, J., Reicke, A., Zahner, H., Krismer, B., Bull, A. T., Maldonado, L. A., 
Ward, A. C., Goodfellow, M., Bister, B., Bischoff, D. 2004. Journal of Antibiotics. 
57:271-279. 
 
Rinehart, K. L. Jr., Gloer, J. B., Hughes, R. G. Jr., Renis, H. E., McGovren, J. P., 
Swynenberg, E. B., Stringfellow, D. A., Kuentzel, S. L. and Li, L. H. 1981. Science. 
212:933-935. 
 
Ritchie, D. 1957. American  Journal of Botany. 44:870-874. 
 
References 
_____________________________________________________________________________________ 
 213 
 
Roberts, M. F. 2005. Saline Systems. 1:5. 
URL:http://www.salinesystems.org/content/1/1/5 
 
Ruggieri, G. D. 1976. Science. 194:491-496. 
 
Russel, D. W. 1965. Journal of the Chemical Society. Sept:4664-4668. 
 
Russel, D. W. 1988. Canadian Journal of Botany. 66:1474-1475. 
 
Sasaki, T., Igarashi, Y., Saito, N. and Furumai, T. 2002. Journal of Antibiotics. 55:249-
255. 
 
Schumacher, R. W., Talmage, S. C., Miller, S. A., Sarris, K. E., Davidson, B. S. and 
Goldberg, A. 2003. Journal of Natural Products. 66:1291-1293. 
 
Selvin J., Joseph, S., Asha, K. R. T., Manjusha, W. A., Sangeetha, V. S., Jayaseema, D. 
M., Antony, M. C. and Vinitha, A. J. D. 2004. FEMS Microbiology Ecology. 50:117–
122. 
 
Sguros, P. L. and Simms, J. 1964. Journal of Bacteriology. 38:346-355. 
 
Shao, N., Yao, G. and Chang, L. C. 2007. Journal of Natural Products. 70:869-871.  
 
Shindo, K., Takenaka, A., Noguchi, T., Hayakawa, Y. and Seto, H. 1989. Journal of 
Antibiotics. 42:1526-1529.  
 
Sitachitta, N., Gadepalli, M. and Davidson, B. S. 1996. Tetrahedron. 52:8073-8080. 
 
Smedsgaard, J. and Frisvad, J. C. 1996. Journal of Microbiological Methods. 25:5-17. 
 
Smith, C. J., Abbanat, D., Bernan, V. S., Maiese, W. M., Greenstein, M., Jompa, J., 
Tahir, A. and Ireland, C. M. 2000. Journal of Natural Products. 63:142-145. 
 
Snider, B. B., Duvall, J. R., Sattlerb, I. and Huang, X. 2004. Tetrahedron Letters. 
45:6725–6727. 
 
Soman, A. G., Gloer, J. B. and Wicklow, D. T. 1999. Journal of Natural Products. 
62:386-388. 
 
Sonjak, S., Frisvad, J. C. and Cimerman, N. G. 2005. FEMS Microbiology Ecology. 
53:51–60. 
 
Stritzke, K., Schulz, S., Laatsch, H., Helmke, E. and Beil, W. 2004. Journal of Natural 
Products. 67:395-401. 
 
Sultan, M. Z., Khatune, N. A., Sathi, Z. S., Bhuiyan, M. S. A., Sadik, M. G., Choudury, 
M. A., Gafur, M. A. and Rahman, M. A. A. 2002. Biotechnology. 1:100-106. 
 
References 
_____________________________________________________________________________________ 
 214 
 
Suzuki, H., Tahara, M., Takahashi, M., Matsumura, F., Okabe, T., Shimazu, A., Hirata, 
A., Yamaki, H., Yamaguchi, H, Tanaka, N. and Nishimura, T. 1990. Journal of 
Antibiotics. 43:129-134. 
 
Tahara, M., Okabe, T., Furihata, K., Tanaka, N., Yamaguchi, H., Nishimura, T. and 
Suzuki, H. 1990. Journal of Antibiotics. 43:135-137. 
 
Tahara, M., Okabe, T., Furihata, K., Tanaka, N., Yamaguchi, H., Nishimura, T. and 
Suzuki, H. 1991. Journal of Antibiotics. 44:255. 
 
Tan, J., Bednarek, P., Liu, J., Schneider, B., Svatos, A. and Hahlbrock, K. 2004. 
Phytochemistry. 65:691–699. 
 
Van Eijk, G. W. and Roeijmans, H. J. 1984. Experimental Mycology. 8:266-268.         
 
Vairappan, C. S., Daitoh, M., Suzuki, M., Abe, T. and Masuda, M. 2001. 
Phytochemistry. 58:291-297. 
 
Vairappan, C. S. 2003. Biomolecular Engineering. 20:255-259. 
 
Vairappan, C. S., Kawamoto, T., Miwa, H. and Suzuki, M. 2004. Planta Medica. 
70:1087-1090. 
 
Votruba, J. and Vanek, Z. 1989. In. Shapiro, S. (ed.) Regulation of Secondary 
Metabolism in Actinomycetes. CRC Press. p. 264 – 281. 
 
Waksman, S. A. 1959. The Actinomycetes: Nature, Occurrence and Activities. Volume 
1. Williams and Wilkins Co. Baltimore. p. 146-147. 
 
Waksman, S. A. and Woodruff, H. B. 1940. Proceedings of the Society for 
Experimental Biology and Medicine. 45:609–614. 
 
Walker, J. D. and Colwell, R. R. 1975. Marine Biology. 30:193–201. 
 
Weinberg, E.D. 1974. Secondary Metabolism: Control by Temperature and Inorganic 
Phosphate. Dev. Ind. Microbiology. 15:70-81. 
 
Weyland, H. 1969. Nature 223:858. 
 
Wilkinson, C. R. 1992. In Reisser, W. (ed.). Algae and Symbioses. p. 112–151. 
Biopress. Bristol. 
 
Williams, S. T., Lanning, S. and Wellington, E.M.H. 1984. In. Goodfellow, M., 
Mordarski, M. and Williams, S. T. (eds.). The Biology of The Actinomycetes. Academic 
Press. London. p. 481–528. 
 
Xin, Z. H., Fang, Y., Du, L., Zhu, T., Duan, L., Chen, J., Gu, Q., and Zhu, W. 2007. 
Journal of Natural Products. 70:853-855. 
 
References 
_____________________________________________________________________________________ 
 215 
 
Yamada, T., Minoura, K. and Numata, A. 2002. Tetrahedron Letters. 43:1721–1724. 
 
Yang, L., Tan, R., Wang, Q., Huang, W. and Yin, Y. 2002. Tetrahedron Letters. 
43:6545–6548. 
 
Yang, R., Li, C., Lin, Y., Peng, G., She, Z. and Zhou, S. 2006. Bioorganic and 
Medicinal Chemistry Letters. 16:4205-4208. 
 
Yin, S. W., Shi, Y. P., Li, X. M. and Wang, B. G. 2005. Chinese Chemical Letters. 
16:1489-1491. 
 
Yoshimura, Y., Koenuma, M., Matsumoto, K., Tori, K. and Terui, Y. 1988. Journal of 
Antibiotics. 41:53-67. 
 
Yoshimura, I. Kinoshita, Y. Yamamoto, Y. Huneck, S. and Yamada, Y. 1994. 
Phytochemical  Analysis. 5:197-205. 
 
Yue, Q., Miller, C. J., White, J. F. and Richardson, M. D. 2000. Journal of Agricultural 
and Food Chemistry. 48:4687-4692. 
 
Yutaka, E., Ushio, S. and Shoji, S. 1970. Phytochemistry. 9:2061-2063. 
 
Zhang, W., Xue, S., Zhao, Q., Zhang, X., Li, J., Jin, M., Yu, X. and Yuan, Q. 2003a. 
Biomolecular Engineering. 20:413-419. 
 
Zhang, Q., Schrader, K. K., El Sohly, H. N. and Takamatsu, S. 2003b. Journal of 
Antibiotics. 56:673-681. 
